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Abstract
Origin, evolution, and global spread of a transmissible cancer clone
Máire Julia Lawlor
Clonally transmissible cancers are malignant cellular clones that spread between
unrelated individuals by the physical transfer of living cancer cells. These clones
can ‘metastasise’ through populations, having adapted to transmit across external
environments and evade the host immune response. Canine Transmissible Venereal
Tumour (CTVT) is a sexually transmitted genital tumour that affects dogs and has
spread throughout dog populations worldwide. CTVT is the oldest known transmis-
sible cancer and first arose thousands of years ago from the somatic cells of a single,
‘founder’ dog.
The broad aim of this thesis was to advance understanding of biological features un-
derlying CTVT’s continued survival, as well as the evolutionary history that framed
the origin of CTVT.
In the first part of this thesis, I profile global tumour diversity using complete mi-
tochondrial genome sequences (mtDNA) from 449 CTVT tumours collected from
39 countries in the first large-scale examination of CTVT clonal diversity. Phyloge-
netic characterisation of this clonal lineage showed that CTVT has captured mtDNA
from transient hosts by horizontal transfer at least five times, defining distinct CTVT
clades. Phylogeographic patterns and timings suggest the rapid, recent, multi-route
dispersal of CTVT, likely via historic sea routes. Negative selection acts on tumour
mtDNA to prevent the accumulation of deleterious mutations and there is evidence
for multiple, complex mtDNA recombinations in CTVT. This is the first observed
instance of mtDNA recombination in cancer. Enrichment of this data set with almost
200 additional mtDNAs uncovered further horizontal transfer and recombination
events. These findings provide genetic evidence underpinning the importance of
functional mitochondria in CTVT evolution.
In the second part of this thesis, by analysing genomic data from ancient and modern
canids alongside CTVT whole genomes, I describe the ancestry of the CTVT founder
and the spatiotemporal origin of the disease. The CTVT progenitor belonged to a
monophyletic lineage of high-latitude dogs that likely originated in North East Asia
and dispersed into the Americas alongside people. Using a pair of CTVT biopsies
derived from a naturally occurring direct transmission with a known transmission
time interval, I estimated the somatic mutation rate in CTVT and inferred the time
of CTVT origin. Finally, I make a case for systematically screening cancers with high
prevalence in wildlife species for a transmissible cancer etiology.
This work traces the emergence of CTVT, along with detailed geographical and
temporal routes of transmissible cancer disease spread over the past two thousand
years, and offers new perspectives on the history of dogs as well as key insights into
biological mechanisms driving the hitchhiking cancer that has accompanied them
around the world.
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Chapter 1
Introduction to transmissible and non-transmissible cancer
This chapter begins by providing a historical perspective on cancer through a non-exhaustive
but representative overview of cancer literature, tracing the major discoveries and findings
that have shaped our current understanding of cancer biology. Following this, I introduce
an alternative cancer paradigm, transmissible cancers, and give a detailed review of the
current knowledge in this field, focusing on the oldest known transmissible cancer, Canine
Transmissible Venereal Tumour. The final section of the introduction will summarise key
aspects of dog population history and canine genetics relevant to questions explored in Chapter
3. This provides the context for the central questions addressed in this thesis, relating to the
emergence and evolution of transmissible cancer in dogs.
1.1 A short history of cancer
1.1.1 An ancient disease
Today, we understand cancer as a family of genetic diseases, all arising from the
abnormal clonal outgrowth of a single somatic cell. Different cancers can develop
from different cell types and have distinct risk factors and epidemiologies (Stratton
et al., 2009). However, all cancer cells converge on a set of acquired capabilities
distinguishing them from normal cells. These "hallmarks" include enabling evasion
of immune system signalling, recruitment of a permissive environment, angiogen-
esis, nutrient acquisition, proliferation and invasion of neighbouring and distant
tissues (Fouad and Aanei, 2017; Hanahan and Weinberg, 2000). Neoplastic disease is
a major cause of mortality in humans, having now surpassed infectious diseases as
the second leading cause of death globally (Ferlay et al., 2015). Fatal cases are usually
associated with metastasis and subsequent emergence of therapy-resistant disease.
2However, cancer is not a recent phenomenon (Faltas, 2011). The earliest histori-
cal record describing a disease consistent with cancer is the Edwin Smith Papyrus,
one the of oldest medical texts, dating back to circa 2,630 BC (Hajdu, 2016). Medi-
cal records from ancient Greece, dating from around the fifth century BC, provide
evidence of attempted surgical treatments of malignant growths (David and Zim-
merman, 2010). While the earliest purported archaeological evidence for cancer is
a 1.7 million year old hominin fossil from South Africa (Odes et al., 2016). Paleo-
epidemiological studies have found evidence for cancer in ancient Egyptian human
remains spanning 3,200–500 BC and individual remains from ancient Germany
dating back to 1,800–1,400 BC (Nerlich et al., 2006). Rhabdomyosarcoma, a rare ma-
lignancy in modern human populations, was histologically diagnosed in a Chilean
mummy, dated between AD 300-600 (Ortner and Aufderheide, 1991).
Cancer susceptibility is an inherent risk of multicellular life. The emergence of
complex multicellularity has taken place at least seven times and is one of the major
transitions in evolution (Smith and Szathmary, 1997). Multicellular organisms are
large, cooperative cell systems where cell-level fitness is sacrificed for organismal
fitness. Cancer arises when a single cell in this system ignores the collective impera-
tive and reverts to atavistic unicellular behaviour.
Cancer is believed to arise in almost all metazoans, including dinosaurs (Rothschild
et al., 1999), fish (Schlumberger and Lucke, 1948), birds (Effron et al., 1977), beetles
(Scharrer and Lochhead, 1950) and molluscs (Barber, 2004). However, the frequency,
age of onset and tissue of origin of cancer can vary enormously between species
(Misdorp, 1996), as well as between individuals within a single species (Brønden
et al., 2010). Interestingly, the observation of naturally occurring tumours in two
species of Hydra (Domazet-Lošo et al., 2014), a basal metazoan, suggests that cancer
has deep evolutionary roots in the metazoan tree. The relationship between organism
size, reproductive lifespan, tissue homeostasis and cancer risk across species remains
poorly understood. Assuming that all cells have an equal chance of becoming cancer-
ous, we would expect organisms with a larger body mass or that live longer to have
an increased risk of developing cancer, constituting a major evolutionary constraint.
However, there is no correlation between lifespan or body size and cancer risk, often
referred to as ‘Peto’s paradox‘ (Caulin and Maley, 2011; Peto et al., 1975).
31.1.2 Omnis cellula e cellula
Improvements in modern light microscopes at end of the nineteenth century, and
their use in clinical pathology, allowed a look into the microscopic world of cancer
and our first real insights into its mechanistic basis. Beginning in 1838, Johannes
Müller, a German microscopist, proposed that cancerous growths were composed
of cells, at a time when the prevailing view was that cancers were formed from
lymph globules or blastema (Haggard and Smith, 1938). He also observed that the
cellular forms generally resembled the tissues in which malignant growths arose
(Müller, 1838). At about the same time, the surgeon Joseph Récamier, based on
observations of secondary deposits in cancer, coined the term "metastasis" from the
Greek "methistemi", meaning to displace or change (Récamier, 1829).
Around the time that Darwin proposed a theory of universal common descent,
one of Müller’s students, Rudolf Virchow, gave a series of lectures suggesting that
something similar might be happening in cancer. Credited with coining the phrase
"omnis cellula e cellula" i.e. "all cells come from cells", he taught that cancer cells
descended from normal cells and that ‘pathological substitutions’ of normal cells
with deviant cells lead to cancer (Wagner, 1999).
By the turn of the twentieth century, Boveri, based on observations of aneuploidy in
cancer cells, postulated that cancer might arise from a progenitor cell with an anoma-
lous complement of chromosomes (Boveri, 1914). A decade earlier, Von Hansemann
had previously described asymmetric mitoses in carcinoma and proposed a link
between between defects arising through aberrant cell division and cancer (Hanse-
mann, 1890). Later work would confirm Boveri’s finding that specific chromosomal
translocations were recurrent in particular cancer types. The best known example
being the “Philadelphia chromosome”, a translocation between chromosomes 9 and
22 occurring in chronic myeloid leukaemia (Rowley, 1973).
In the middle of the twentieth century, the dual discoveries of deoxyribonucleic
acid as the elusive molecular material of inheritance (Avery et al., 1944) and of
its molecular structure (Watson and Crick, 1953) catalysed understanding of the
genetic pathology underlying cancer. DNA was revealed as the "ultimate target
of carcinogenic activation" (Tabin et al., 1982). In 1953, Carl Nordling published
his multi-mutation “theory on cancer-inducing mechanism” (Nordling, 1953). In a
4statistical study of retinoblastoma, Alfred Knudson proposed a ‘two-hit’ model of
tumourigenesis, whereby two mutational events, likely two recessive mutations in
two alleles of the same gene (Knudson, 1973), were sufficient to cause malignancy
(Knudson, 1971). In the inherited form of the disease, the understanding was that one
of these genetic ‘hits’ was present since conception in the germline, requiring only
a single further hit to promote retinoblastoma. This model was later substantiated
by the identification of the biallelic inactivation of RB1, the first identified tumour
suppressor gene, in retinoblastoma (Murphree and Benedict, 1984).
Genetic analyses comparing transforming varieties of the cancer-causing Rous Sar-
coma Virus with non-transforming yet replication-competent varieties showed that
the essential transformative factor was an src gene (v-src), the first identification
of an oncogene (Duesberg and Vogt, 1970). Later discovery of c-src, cellular DNA
homologous to v-src, showed that this viral oncogene had a cellular homologue.
Importantly, transfection of normal NIH3T3 mouse fibroblasts with genomic DNA
from a range of human and animal cancers (Shih et al., 1981) was shown to trans-
form normal cells into cancer cells. This transformation was driven by a number
of different cancer-causing genes, mutant versions of normal growth-controlling
genes, which were termed proto-oncogenes (Perucho et al., 1981; Pulciani et al., 1982).
Shih’s canonical study eventually paved the way towards the identification of the
first human cancer-causing sequence change: a single base G > T substitution in
codon 12 of the HRAS gene (Reddy et al., 1982).
These studies largely established the paradigm that has prevailed in cancer research
over the past 40 years, focussed on the systematic identification of altered genes
(so-called ’cancer genes’), their functional characterisation, and the development of
biochemical strategies to target these genes.
1.1.3 Somatic mutation
Somatic mutations accumulate in all cells over time and may be acquired at any
stage of the cell lineage, from the zygote to the cancer cell. All cancer cell genomes
sampled so far carry somatic mutations. Key somatic changes involved in the evo-
lution of cancer include single nucleotide variants (SNVs), insertions or deletions
(indels) of small or large segments of DNA, copy number changes, and structural
5rearrangements. These somatic changes accumulate over the course of many cell
divisions although not necessarily at a steady rate. In certain circumstances, cells
can be subject to violent bursts of mutation; for example, kataegis, localised muta-
tion clusters of SNVs on the same chromosome and chromosomal strand, has been
described in breast cancer (Nik-Zainal et al., 2012). Other cancer specific mutational
processes include chromoplexy and chromothripsis, both examples of ’all-at-once’
chromosome shattering and rearrangement (Forment et al., 2012).
Mutations can be classified based on the role they play in cancer initiation and
progression. Driver mutations are those that are causally involved in oncogenesis
while deleterious mutations are those that impair cell proliferation or survival Most
drivers arise somatically during the lifetime of a patient, although some may be
inherited in the germline. The majority of somatic mutations in cancer, however, are
selectively neutral ’passenger’ mutations that frequently hitchhike alongside driver
mutations and have no effect on the fitness of the cell (at least none that are detectable
over the lifespan of a cancer). Positive selection acting on somatic cells carrying driver
mutations is the prevailing evolutionary pressure in cancer and negative selection is
scarcely detectable in human cancer (Martincorena et al., 2017).
1.1.4 Clonal evolution
The principles of cancer evolution, first set out by Cairns and Nowell (Cairns, 1975;
Nowell, 1976), follow a Darwinian logic. Classical Darwinian evolution requires
genetic variation among the individuals in a population and competition among
those individuals for limited resources. The progression from normal to prema-
lignant to malignant cell is an evolutionary process driven by somatic mutation,
clonal selection and genetic drift (Stratton et al., 2009). Some somatic mutations
can result in phenotypic changes. Selection acting on this genetic and epigenetic
variation fuels evolution and adaption in populations of cells. It is important to note
that selection takes place within the context of a complex tissue environment, the
tumour microenvironment, and consists not only of tumour cells, but also blood
vessels, lymph vessels, stromal cells, and immune/inflammatory cells. As individual
cells compete with one another for access to host resources, variation that confers a
growth or survival advantage will be selected for and drive waves of clonal expan-
sion and tumour progression (Fig. 1.1). Subsequent dissemination of specialised
6Fig. 1.1. Model of clonal evolution in tumour cell populations. Cancer begins with
an initiating driver mutation that confers a selective survival or growth advantage in
a normal cell. Drivers promote successive waves of clonal expansion in association
with the acquisition of additional mutations.
7metastatic tumour cell subpopulations can seed monoclonal or polyclonal outgrowth
of secondary tumours (metastases) and disease progression (Fidler, 2003; Gundem
et al., 2015).
While the experimental approaches described so far allowed identification of large
genomic events (e.g. copy number changes, chromosomal translocations, etc.), the
advent of sequencing technologies allowed systematic analysis of the cancer genome
at base-pair resolution. Comparison of genetic sequences from a patient’s cancer
cells with a patient’s germline DNA sequences gave the power to observe previously
unseen mutational events (Dulbecco, 1986) and promised significant insights into
the mechanisms of cancer development.
Early systematic genome interrogations using targeted capillary sequencing identi-
fied, what are now, established cancer driver genes including BRAF (Davies et al.,
2002), PIK3CA (Samuels et al., 2004) and EGFR (Guillermo Paez et al., 2004; Lynch
et al., 2004). The rise of next-generation sequencing methods have allowed increas-
ingly faster and cheaper sequencing of cancer genomes. In particular, massively
parallel sequencing has catalysed a technological revolution that has changed the way
we understand cancer. Ambitious large-scale initiatives, primarily the International
Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA), have
sequenced tens of thousands of cancer genomes and matching normal tissues across
different tumour types. Recently, even more sophisticated strategies have emerged
aimed at understanding how the cancer genome changes over time and space; these
strategic advances include multi-region sequencing the same tumour (Gerlinger
et al., 2012), ’longitudinal’ sequencing of the same tumour at different time points
(Ding et al., 2010), single cell sequencing (Navin et al., 2011) and development of
cancer organoid cultures (Gao et al., 2014).
1.1.5 Mutational signatures
Recently developed analytical methods, as well as improved sequencing technologies,
mean that we can now probe the processes causing somatic mutation by extracting
biologically informative ’mutational signatures’ from cancer genomes (Baez-Ortega
and Gori, 2017). A pivotal study by Alexandrov et al. (2013) found that discrete pat-
terns of single-nucleotide variants and the sequence contexts in which they occurred
8in cancer were largely determined by mutagenic processes acting over the lifetime of a
cancer cell (Alexandrov et al., 2013). Distinct signatures are generated by endogenous
cellular processes, such as defective DNA repair or replication (Alexandrov et al.,
2015), and endogenous mutagenic exposures, such as mutagenic enzymes, as well as
exogenous mutagen exposures, like ultraviolet (UV) light (Alexandrov et al., 2013)
and tobacco carcinogens (Alexandrov et al., 2016). For example, melanomas exhibit
far more frequent C>T transitions on the untranscribed compared to transcribed
strands resulting from UV induced formation of pyrimidine dimers (Alexandrov
et al., 2015). Context-specific signatures driving other somatic changes in cancer,
such as genome rearrangements (Nik-Zainal et al., 2016) and copy number changes
(Macintyre et al., 2018), have also since been reported.
1.1.6 Cancer and infectious agents
As well as chemical and physical agents, biological agents, such as viruses, bacteria
and parasites, can also lead to the cancerous transformation of cells. Following the
discovery of a new class of infectious agent, the virus, at the tail end of the nineteenth
century (Ivanowski, 1892; Lecoq, 2001), Peyton Rous first showed that solid tumours
could be induced in healthy chickens by an infectious “filterable agent”, now known
as Rous Sarcoma Virus (Rous, 1911). At the time one of Rous’s senior colleagues
remarked (Becsei-Kilborn, 2010).
“But my dear fellow, don’t you see? They cannot be cancer. You’ve found
their cause!"
Rous was not the first to speculate about the transmissibility of cancer. In 1844, the
Italian physician Domenico Antonio Rigoni-Stern observed that cervical cancer was
vastly more frequent among married women in Verona than in nuns in the surround-
ing countryside (Scotto and Bailar, 1969). These observations were later substantiated
by the discovery of human papilloma virus (HPV) (Dürst et al., 1983). In humans,
infection with viruses such as HPV, Epstein–Barr virus (EBV), hepatitis B virus (HBV),
hepatitis C virus (HCV), human T-cell lymphotropic virus (HTLV-1) and Kaposi’s
associated sarcoma virus (KSHV) is linked to 10-15% of the global cancer burden
(Plummer et al., 2016). Viral infection is also linked with cancer incidence and emer-
gence in animals; some notable examples include a polyomavirus associated with
the occurrence of neuroglial tumours in raccoons (Curry et al., 2000), first reported
in 2013, and Chelonid alphaherpesvirus 5 (ChHV5) linked with fibropapillomatosis
9in marine turtles.
Bacteria have also been linked to oncogenesis; Helicobacter pylori was the first bac-
terium to be classified by the World Health Organization as a carcinogen (on the
Evaluation of Carcinogenic Risks to Humans, 1994) based on causal association
of H. pylori infection and gastric cancers. Infection with pathogenic parasites in-
cluding blood fluke trematodes of the genus Schistosoma haematobium and the liver
flukes Clonorchis sinensis and Opisthorchis viverrini is carcinogenic by the International
Agency for Research on Cancer (IARC Working Group on the Evaluation of Carcino-
genic Risks to Humans, 2012). However, in all cases, these cancers arise through
transformation of the host cells rather than transmission of cancer cells.
So far, I have provided a summary of the landmark genetic and molecular biological
studies leading up to the status quo in our current understanding of cancer genetics.
In the next section, I will present a challenge to the status quo: transmissible cancers.
1.2 Transmissible Cancers
Under ordinary circumstances, cancer is an individuated phenomenon and contin-
ued replication of cancer is normally cut-short by the lifespan of its host. Although
"normal" cancer cells can metastasise to different sites within the body they are
limited to a single host. Transmissible cancers are rare occurrences whereby cancer
cell clones can spread between unrelated individuals, transmitted by the allogeneic
transfer of living cancer cells.
Transmissible cancers arise via a favourable combination of specific host and tu-
mour cell traits. Firstly, a cancer-affected individual must shed cancer cells; these
cells must be robust enough to transmit across external environments and there must
be a route for cell exchange with other individuals in the population. It also requires
either that the sloughed neoplastic cells are pre-adapted to evade immune responses
and can exploit an allogeneic host or a permissive host environment susceptible to
invasion.
Eight transmissible cancer lineages have been described in six different species:
one in domestic dogs (Murchison et al., 2014; Murgia et al., 2006; Rebbeck et al., 2009),
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two lineages in Tasmanian devils (Pearse and Swift, 2006; Pye et al., 2016) as well as
multiple independent lineages in marine bivalves (Metzger et al., 2015, 2016).
Tasmanian devils (Sarcophilus harrisii) are the largest living carnivorous marsupials
and endemic to mainland Tasmania. This species is affected by two transmissible
cancer cell lineages that arose independently about twenty years apart (Table 1.1),
known as devil facial tumour 1 (DFT1) (Pearse and Swift, 2006) and devil facial
tumour 2 (DFT2) (Pye et al., 2016). Both clones appear as facial and oral tumours
with similar gross features, and both diseases are transmitted between devils by
biting. DFT1 and DFT2 are genetically and histologically distinct, while karyotype
studies suggest that DFT2 arose in a male devil and not the female founder of DFT1
(Deakin et al., 2012; Murchison et al., 2012; Pye et al., 2016). However, intriguingly,
there are strong indicators that both DFTs derive from the same tissue type and
arose via similar oncogenic processes (Stammnitz et al., 2018). While DFT2 is so far
limited to a small number of individuals in south-east Tasmania, DFT1 has resulted
in large-scale host population decline and continues to spread (Hawkins et al., 2006).
Five distinct transmissible cancer lineages affect four species of marine bivalves
(Metzger et al., 2015, 2016). Disseminated neoplasia, a leukemia-like disease, is trans-
missible in soft-shell clams (Mya arenaria) (Metzger et al., 2015), mussels (Mytilus
trossulus), golden carpet shell clams (Politatapes aureus) (Metzger et al., 2016) and
cockles (Cerastoderma edule). Analysis of mitochondrial and nuclear markers showed
identical tumour genotypes across affected individuals distinct from host genotypes,
a hallmark of transmissible cancer, confirming widespread transmission of inde-
pendent cancer lineages. Two different lineages of transmissible neoplasia, with
different morphologies, have been described in common cockles (Metzger et al.,
2016), similar to DFT1 and DFT2. Cross-species transmission of cancer cells has
also been demonstrated from the pullet shell clam (Venerupis corrugata) to a related
species in the same region, P. aureus. Although the mechanism of transmission is not
yet clear it has been suggested that engraftment occurs during filtration of seawater
contaminated with transmissible leukemic cells; it is remarkable that clam beds as far
as hundreds of miles apart have been colonised by the same cancer clone (Metzger
et al., 2015).
Although rare in nature, once established, transmissible cancers can propagate
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Table 1.1 Comparison of known transmissible cancers
Species Species of
origin
Cell of
origin
Transmission
route
Earliest
report
Disease Dis-
tribution
Survival
outcome
Dog Dog Myeloid
cell
Mating 1810 Worldwide Rarely fatal
Tasmanian
devil
Tasmanian
devil
Schwann
cell
Biting 1996 Tasmania
(mainland)
Fatal
Tasmanian
devil
Tasmanian
devil
Schwann
cell
Biting 2014 Channel
Peninsula,
Tasmania
Fatal
Soft-shell
clam
Soft-shell
clam
Hemocyte Water filtration 1978
Golden
carpet shell
clam
Pullet shell
clam
Hemocyte Water filtration 1978 Galician Coast,
Spain
Mostly fatal
Common
cockle
Common
Cockle
Hemocyte Water filtration 1978 Galician Coast,
Spain
Mostly fatal
Bay Mussel Bay Mussel Hemocyte Water filtration 1978 Pacific
Northwest
Coast, USA &
Canada
Mostly fatal
through populations widely and quickly and persist for thousands of years. The
discovery of cancer transmission between sessile bivalves shows that physical contact
is not necessary for effective cell transmission. Discoveries of multiple transmissible
cancer lineages in a single host species suggests that some species may be more
susceptible to the development of transmissible neoplasia than others.
The majority of the research carried out during my dissertation has concerned only
one of the transmissible cancers: Canine Transmissible Venereal Tumour. In the
following section I will explore details of this disease and its life history in depth
while elucidating general features of transmissible cancer.
1.2.1 Canine Transmissible Venereal Tumour
1.2.1.1 Overview
Canine Transmissible Venereal Tumour (CTVT) is a clonally transmitted cancer that
affects dogs. Mating is the most common route of CTVT transmission and tumours
usually manifest on the external genitalia of male and female dogs. This remarkable
cancer first arose several thousand years ago in a single founder individual and
survived the death of its host by serially colonising allogeneic hosts.
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Fig. 1.2. Gross clinical presentation of CTVT in a. females b. males and, c.
extra-genital presentation of CTVT in conjunctiva (left) and the nasal cavity (right).
d. Schematic of CTVT clonal transmission and ’metastasis’ through the dog
population. Different shaded dogs represent unrelated individuals in the dog
population. Red circles correspond to CTVT cells. Images in panels b and c. were
provided by Karina Ferreira de Castro, Natalia Ignatenko, Elizabeth Murchison and
Andrea Strakova.
1.2.1.2 Mating and transmission
Cell-transmission between dogs is facilitated by the prolonged copulatory tie in
canids as well as injury to the genital mucosa when dogs attempt to separate (Co-
hen, 1985; Murchison, 2008). Commonly observed extra-genital tumours (Fig. 1.2c)
suggests that CTVT cells can also be transmitted between dogs by licking, biting,
or sniffing, of tumour-affected areas and during parturition. CTVT has been suc-
cessfully experimentally transmitted to different canid species, including wolves
(Dungern, 1912), jackals (Samso, 1965), coyotes (Cockrill and Beasley, 1979) and red
foxes (Wade, 1908).
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1.2.1.3 Distribution and prevalence
CTVT has spread around the world, and persists at low clinical prevalence (approxi-
mately 1 – 5%) in dog populations across at least 90 countries in all inhabited conti-
nents and across a range of diverse altitudes, environments, and climates (Strakova
and Murchison, 2014). Disease is generally more prevalent in rural areas and in coun-
tries where free-ranging or unmanaged dog populations can act as a reservoir for
the disease (Strakova and Murchison, 2014). CTVT largely disappeared from many
Western countries, including the United Kingdom, during the twentieth century due
to improved management of free-roaming dogs. There is no evidence for gender bias
or any variation in susceptibility across different dog breeds (Strakova and Murchi-
son, 2014). Little is known in terms of transmission dynamics; the ‘infective dose’, or
number of cancer cells required to cause infection, has not yet been established. The
incubation period, based on reports of naturally occurring transmissions, can range
from two weeks to three months (Ajello, 1980; Bellingham Smith and Washbourn,
1898; Locke et al., 1975).
1.2.1.4 Clinical description, diagnosis and treatment
Early-stage tumours commonly appear as small, firm, focal nodules while progressive
disease is characterised by multifocal, friable, ulcerated masses with serosanguineous
or pure hemorrhagic preputial or vaginal discharge (Fig. 1.2a and b). Tumours are
rarely necrotic. Extra-genital localisations of primary tumours have been reported in
the conjunctiva (Komnenou et al., 2015), oral and nasal mucosa (Ginel et al., 1995;
Rezaei et al., 2016) and skin. Although metastasis is not a characteristic feature of
CTVT pathogenesis, cases of metastasis to cutaneous sites, lymphoid tissues, and
visceral organs have been reported (Chikweto et al., 2013; Feldman, 1929; Ferreira
et al., 2000; Manning and Martin, 1970; Nak et al., 2004; Oduye et al., 1973; Park et al.,
2006; Rust, 1949; Sastry et al., 1965; Spence et al., 1978; Varughese et al., 2012).
In most cases, tumours regress following single-drug chemotherapy and tumours
are extremely chemosensitive (Brown et al., 1980; Nak et al., 2005). CTVT is routinely
treated with vincristine sulphate, a cytotoxic microtubule inhibitor (Amber et al.,
1990). Vincristine resistant tumours are usually treated with doxorubicin (Calvert
et al., 1982). Other, less commonly used, treatment options include radiotherapy
14
(Ajello, 1980; Osipov and Golubeva, 1976), immunotherapy (Zander et al., 1980) and
surgical debulking.
1.2.1.5 Course of disease
Limited data on the natural clinical course of disease describes long-term persistence
in affected hosts and occasional immune-mediated tumour regression, although the
frequency with which this occurs remains unclear (Bellingham Smith and Wash-
bourn, 1898; Higgins, 1966; Rust, 1949). Spontaneous regression has been regularly
reported in the course of experimental transfer. There is no evidence that CTVT
infection is associated with concurrent disease or infection (Strakova and Murchison,
2014) though CTVT is occasionally reported in association with Leishmania (Albanese
et al., 2002), heartworm (Dirofilaria immitis) and ehrlichia (Chikweto et al., 2013).
CTVT cells have a distinct cytological profile (Fig. 1.3). Tumours are composed of
round cells with large, central nuclei and prominent nucleoli accompanied by clear
cytoplasmic vacuoles and variably prominent intra-tumoural infiltrate of eosinophils.
In clinical practice, CTVT diagnosis is based on gross characteristics and cytology, as
well as environment history (Duncan and Prasse, 1979; Jackson, 1944). Histologically,
CTVT is characterised by diffuse clusters of cells separated by delicate fibrovascular
stroma and variable amounts of host immune cell infiltrate (Cohen, 1985).
1.2.1.6 Clonal origin
A disease consistent with CTVT was first described by a British veterinarian, De-
labere Blaine, in 1810 (Blaine, 1810). Evidence for clonality was first provided by
experimental transplantation of the tumour. In 1876, Mstislav Novinski (Novinski,
1876) carried out the first successful tumour transplantation: serial passage of ‘myx-
osarcoma’ between dogs. He believed that successful transfer was based on the
inoculation of healthy tissue with ’a living element of the tumour’, yet it would be
over a century before the clonal origin of CTVT was confirmed. CTVT continued
to be widely studied and remained a popular model of tumour transplantation for
cancer biologists throughout the late 1800s and early 1900s, before the development
of syngeneic mouse and rat systems (Shimkin, 1955). Transmissibility of CTVT was
demonstrated consistently by further experimental transfer studies (Karlson and
Mann, 1952; Sticker, 1906; Wehr, 1878).
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Fig. 1.3. Characteristic CTVT cytology. Prominent nucleoli and cytoplasmic
vacuoles can be discerned. Image generated using ×100 objective lens and ×10
ocular lens and reproduced, with permission, from Olga Glebova.
Cytogenetic studies showed that all tumours shared a characteristic rearranged
karyotype distinct from the matched host karyotype. The normal karyotype in dogs,
wolves, jackals and coyotes is 76 autosomes, all acrocentric, plus metacentric X and
Y sex chromosomes while the chromosome number in CTVT is 57-59, at least 16 of
which are metacentric (Murray et al., 1969; Oshimura et al., 1973; Weber et al., 1965).
Cytogenetically, at least, CTVT no longer resembles a canid.
Further evidence underpinning the clonal origin of CTVT was provided by molecu-
lar studies identifying the insertion of a long interspersed nuclear element (LINE)
retrotransposon upstream of the MYC (c-myc) locus found uniquely in CTVT (Katzir
et al., 1985). Subsequent analyses of different molecular genetic markers including
microsatellites, major histocompatibility (MHC) loci as well as microarray-based
comparative genomic hybridization (aCGH) of matched tumour and normal host
tissues from naturally occurring tumours collected from five continents (Murgia et al.,
2006; Rebbeck et al., 2009) and whole genome sequencing of two CTVT tumours
collected in Australia and Brazil (Murchison et al., 2014) confirm that CTVT arose
from a single, ancestral somatic cell.
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1.2.1.7 The CTVT founder
Early estimates of when CTVT first arose relied on nuclear microsatellite mutation
rates in mammalian germlines (Murgia et al., 2006; Rebbeck et al., 2009). These have
led to estimates of 250 to 2,500 years (Murgia et al., 2006) and 6,500 to 65,000 years
(Rebbeck et al., 2009) since the emergence of the CTVT clone and 47-470 years since
the most recent common ancestor (MRCA) of group of globally dispersed tumours.
Based on mutation rates estimated from clocklike mutational processes in human
medulloblastoma, CTVT is estimated to have arisen between 10,179-12,873 years ago
with the most recent common ancestor of sampled tumours existing 460 year ago
(Murchison et al., 2014).
CTVT is characterised as a histiocytic tumour and is proposed to be of a macrophage
or dendritic cell lineage. Expression of vimentin, lysozyme, alpha-1-antitrypsin,
and ACM1 antigen in CTVT tissues supports a histiocytic origin of CTVT (Gimeno
et al., 1995; Mozos et al., 1996; Sandusky et al., 1987). The observation of Leishma-
nia infantum within CTVT cells (Section 1.2.1.5) also supports a macrophage origin
(Carreira et al., 2014; Catone et al., 2003; Marino et al., 2012) as macrophages are
the cell type most commonly invaded by Leishmania parasites (Liu and Uzonna, 2012).
Analyses of sex chromosome copy numbers in CTVT revealed that CTVT cells con-
tain a single X chromosome and no Y chromosome (Murchison et al., 2014; Thomas
et al., 2009). This is consistent with tumour emergence in either a male canid with
subsequent somatic loss of the Y chromosome or in a female founder with somatic
loss of the X chromosome. Y chromosome loss has previously been associated with
highly rearranged cancers (Kujawski et al., 2004).
The first studies looking into the ancestry of the CTVT founder suggested that the
disease may have originated in a wolf based on analyses of microsatellite loci, MHC
markers (Murgia et al., 2006) and the polymorphic RPPH1 gene (Rebbeck et al., 2009).
However, these studies were based on limited markers. Analysis of polymorphic
SNP loci across modern dog and wolf populations indicated that Arctic spitz type
dogs, like the Alaskan malamute and Greenland sledge dog, are the closest extant
relatives of the dog that first spawned CTVT (Decker et al., 2015; Murchison et al.,
2014). Low levels of genetic heterozygosity in CTVT suggest that this individual
was relatively inbred and belonged to an isolated, high-kinship population of dogs
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Fig. 1.4. Reconstructed phenotype of the extinct CTVT founder dog based on
analysis of loci associated with canine phenotypic features reported in Murchison
et al. (2014). The founder was likely a medium or large size with a solid black or
agouti coat. (Artist, Emma Werner)
(Murchison et al., 2014; Rebbeck et al., 2009). A previous assessment of genetic
markers associated with phenotypic traits in CTVT suggested that the founder dog
was a medium or large size with an agouti or solid black coat (Murchison et al.,
2014). A mosaic of wolflike and doglike alleles were observed at loci associated with
domestication (Murchison et al., 2014).
1.2.1.8 The CTVT genome
CTVT has evolved as an asexual mammalian clone without any transfer of nuclear
genes between tumours (Rebbeck et al., 2009). Despite thousands of years of muta-
tional onslaught, CTVT appears to have maintained a remarkably stable genome.
While cytogenetics shows that the CTVT genome is grossly aneuploid (Section 1.2.1.6),
its karyotype is relatively stable across globally distributed tumours suggesting a
period of large-scale genomic instability early on in CTVT evolution, during which
the genome became rearranged. Whole genome analysis shows that the genome
remains largely diploid but with widespread loss-of-heterozygosity (Murchison
et al., 2014).
The CTVT genome bears a huge mutational load, even when compared with the
most frequently mutated human cancers (Alexandrov et al., 2013), having acquired
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between 1 to 2 million somatic single base changes as well as thousands of rearrange-
ments, copy number changes and structural variants (Decker et al., 2015; Murchison
et al., 2014). Despite its aneuploidy and massive mutational burden, CTVT appears to
have achieved a genome configuration compatible with long term survival (Rebbeck
et al., 2009).
Potential early driver mutations have been reported in CTVT, including homozygous
loss of CDKN2A and SETD2 as well as rearrangements involving MYC, NEK1 and
ERG, although the extent to which positive selection acts on these has not yet been
explored (Decker et al., 2015; Murchison et al., 2014). The MYC rearrangement is
common to all tumours suggesting that this was either a germline variant present in
the original dog or an early somatic event. If the LINE1 rearrangement was acquired
during tumour progression then subsequent MYC activation could have played a
potential role in the malignant phenotype of CTVT. Given that CTVT is an asexual
pathogen, it’s likely that many genes in the dog genome are unimportant for its con-
tinued survival. At least 646 genes have been inactivated either through homozygous
deletion or biallelic inactivating nonsense mutations (Murchison et al., 2014).
The pattern of somatic mutations observed in CTVT can be explained by a com-
bination of three predominant mutational processes or signatures (Murchison et al.,
2014). These signatures reflect endogenous mutational processes (COSMIC signa-
tures 1 and 5) and exposure to ultraviolet (UV) light (COSMIC signature 7; Forbes et
al., 2015). We would expect cells on the surface of exposed tumours to be exposed
to UV radiation; the UV signature in CTVT is a genetic imprint of long-term trans-
mission and suggests that it is these external cells that slough off during physical
contact and seed further CTVT tumours.
1.2.1.9 Mitochondrial horizontal transfer in CTVT
Despite the established clonal origin of the CTVT nuclear genome (Murchison et al.,
2014; Murgia et al., 2006; Rebbeck et al., 2009), phylogenetic analyses of CTVT mi-
tochondrial sequences showed that CTVT mtDNA clusters in multiple disparate
groups (Murgia et al., 2006). It was later suggested that this was the result of pe-
riodic capture of mtDNA from transient dog hosts (Rebbeck et al., 2011). Lateral
transfer of mitochondrial DNA from host cells to CTVT cells, followed by fixation,
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has occurred at least twice in the recent history of CTVT (Fig. 1.5; Rebbeck et al., 2011).
Clonal transmission of CTVT cells over many thousands of years cells may have lead
to a Muller’s ratchet process in mitochondrial DNA (Charlesworth and Charlesworth,
1997; Muller, 1964): deleterious mutations, that would otherwise be diffused by
sexual recombination, “ratchet up” in asexual populations as a result of genetic drift.
Understanding the phenomenon of mitochondrial capture from host cells is the
driving motivation behind work presented in Chapter 2 and is discussed at length in
that introduction to that chapter.
1.2.1.10 Immunology of CTVT
Although not directly relevant to the results presented in this dissertation, the im-
munology of CTVT warrants some discussion, since one of the central questions
motivating the study of transmissible cancer is how these tumours evade the immune
system of multiple hosts.
All cancers, transmissible or not, rely on immune evasion strategies. Predomi-
nantly these involve down-regulation of MHC, immunoediting and creation of an
immunosuppressive microenvironment. A major constraint of cancer transmission
in mammals is the adaptive immune system. The major histocompatibility complex
is a gene family encoding proteins essential in the regulation of immune response.
MHC gene complexes are present in all jawed vertebrate genomes, though they vary
greatly across birds, marsupials and eutherian mammals (Cooper and Alder, 2006).
Two classes of highly polymorphic genes, MHC class I and MHC class II, enable
allorecognition of antigens, uniquely produced in an individual, by host T-cell re-
ceptors (Rosenberg and Singer 1992). MHC class I can be expressed by all nucleated
mammalian cells and platelets. MHC class II is typically only expressed by antigen
presenting cells. This response primarily mediates graft rejection in unrelated indi-
viduals.
During active growth, CTVT cells do not express MHC class II and show low level
MHC class I expression (Murgia et al., 2006). Downregulation of MHC in CTVT
may result in reduced antigen presentation, enabling the tumour to survive hostile
host environments and evade immune system signalling (Murgia et al., 2006). MHC
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Fig. 1.5. A maximum parsimony phylogeny of mitochondrial sequences from dogs,
wolves, and 37 CTVT samples collected across four continents. Individual samples
are represented by coloured dots. Scattered phylogenetic placement of CTVT
samples suggested that CTVT lineages had periodically acquired the mitochondria
of their hosts. Figure adapted from Rebbeck et al. (2011). RightsLink License
Number 4431400002345.
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expression is restored during spontaneous tumour regression exposing CTVT as a
foreign tissue graft (Cohen et al., 1984; Hsiao et al., 2008; Murgia et al., 2006; Yang
and Jones, 1973). CTVT can also trigger a humoral immune response and antibodies
recognising CTVT antigens can be detected in the sera of CTVT-affected animals
(Cohen and Steel, 1972; Epstein and Bennett, 1974; McKenna et al., 2010).
CTVT has been experimentally transmitted as a xenograft in immunodeficient mouse
models (Harmelin et al., 2001; Holmes, 1981; Stubbs and Furth, 1934) while attempts
to transmit CTVT to immunocompetent rabbits, rats, guinea pigs (Wade, 1908), mice,
cats, hamsters, opossums (Cockrill and Beasley, 1979) have been summarily unsuc-
cessful. Although wolves, coyotes and golden jackals can mate successfully with
dogs (Galov et al., 2015; Randi et al., 2014) and experimental transmission of CTVT
has been carried out successfully in these species (Section 1.2.1.2, naturally occurring
cases of CTVT have only been reported in dogs. This could suggest limited inter-
breeding with wild canids or the existence of some species-specific restriction or
risk factors, perhaps signalling between tumour and host cells is essential for the
tumour to be tolerated; beyond a certain evolutionary distance, this signalling fails
and prevents engraftment.
Tumour progression in CTVT is typically described in terms of three phases: a
progressive phase of initial growth (P phase), a stationary phase of stable growth (S
phase) and regression (R phase; Epstein et al., 1964). Transition from the “S phase”
to regression is characterised by an increase in lymphocyte infiltration, upregulation
of MHC (Siddle and Kaufman, 2013) and release of the inflammatory cytokine, inter-
feron gamma (IFN-gamma).
Aggressive tumour growth and metastasis, along with the absence of tumour-
infiltrating lymphocytes, has been observed in immunosuppressed dogs and new-
born pups infected with CTVT (Yang and Jones, 1973). Pups born to females in
which the tumour had spontaneously regressed were able to limit the growth of the
injected tumour which could be explained by transfer of immunity (Yang and Jones,
1973). In some cases, dogs that have undergone spontaneous regression are reported
to demonstrate immunity to further tumour inoculation (Cohen, 1985).
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1.2.2 Cancer cell transmission in humans
There are no known cases of naturally occurring horizontal transmission of cancer
between more than two humans, however, there have been some exceptional cases
involving transmission between two humans. One of the only viable routes for cancer
cell transmission in humans emerges during gestation and cases include transpla-
cental transmission of lymphoma, acute leukaemia, melanoma and carcinoma from
mother to foetus (Bolze et al., 2013; Tolar and Neglia, 2003), transfer of leukaemia
in utero between monozygotic twins (Tolar and Neglia, 2003) and choriocarcinoma,
whereby embryonic trophoblast cells derived from the fetus develop in the mother. In
one case of maternal-fetal transmission, selective loss of MHC alleles not inherited by
the infant was observed in maternally-derived tumour cells transmitted to the infant
(Isoda et al., 2009). This underlines that MHC-mediated rejection is an important bar-
rier to cancer cell transmission and that cancer cells transmitted between mother and
fetus are more likely to be tolerated because they are semi-allogeneic in their new host.
An unexpected route of cancer cell transmission arises during organ transplan-
tation. Immunosuppression of organ, bone marrow, and blood stem cell transplant
recipients has also lead to transmission and development of a range of different
donor-derived cancers (Braun-Parvez et al., 2010; Kauffman et al., 2002; Sala-Torra
et al., 2006; Strauss and Thomas, 2010). Strikingly, neoplastic cells derived from a
dwarf tapeworm, Hymenolepis nana, were observed in lung and lymph node biopsies
taken from an immunosuppressed patient infected with human immunodeficiency
virus (HIV) (Muehlenbachs et al., 2015).
Cases of cancer transmission outside the context of immune-suppression or re-
latedness between donor and host are extremely rare. Documented cases include
the accidental transfer of a malignant histiocytoma from a patient to a genetically
unrelated (and unlucky) surgeon (Gärtner et al., 1996), accidental needle-stick trans-
mission of colonic adenocarcinoma to a laboratory worker with no history of immune
deficiency (Gugel and Sanders, 1986) and transfer of breast carcinoma to a medical
student following accidental puncture with a syringe. The student passed away
one year after the incident as a result of advanced metastatic disease (Lecène and
Lacassagne, 1926). Chester Southam also famously inoculated inmates at Ohio State
Penitentiary with cancer cells (Moore et al., 1957).
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Overall, the occurrence of cancer cell transmission in humans is rare and the continu-
ous propagation of a clonal cancer lineage in our species remains unlikely. However,
it has been suggested that some human cancers might have the potential to become
clonally transmissible between individuals infected with HIV (Metzger et al., 2016).
Cancers in humans can render themselves immunologically silent through down-
regulation of MHC (Algarra et al., 1999) and perhaps these MHC-negative tumours
might be able to thrive in immunocompetent individuals.
Limitless replicative potential is hallmark of cancer (Hanahan and Weinberg, 2000)
and, given an appropriate environment and nutrients, cancers have the potential for
biological immortality. The first human cells immortalised in vitro (Gey et al., 1952),
known now as HeLa cells, derived from cervical carcinoma cells biopsied, without
informed consent, from Henrietta Lacks in 1951 (Skloot, 2017). HeLa cells constitute
the oldest human cancer cell lineage and share an interesting feature with CTVT
cells as another highly rearranged, but genetically stable, immortal cell line.
1.2.3 Emergence of transmissible cancers in other animal species
While CTVT, DFT1 and DFT2 are the only naturally occurring transmissible can-
cers identified in mammals, clonal transmission of cancer cells in animal laboratory
populations has been reported. Direct transmission of reticulum cell sarcoma was
described in a laboratory population of golden hamsters (Mesocricetus auratus) (Brind-
ley and Banfield, 1961) and demonstrated by karyotype analysis (Cooper et al., 1964).
Examination of tumour cells through electron microscopy and tissue cell culture as
well as failed passage of cell-free material between animals showed that the disease
vector was unlikely to be a viral particle (Cooper et al., 1964). Cell transmission
between individuals took place by subcutaneous implantation and during contact
exposure, most likely via mosquito bite and as a result of cannibalism (Banfield
et al., 1965). Various mouse transplantable cancer cells can be propagated through
unrelated mouse hosts, including S180 (sarcoma cell line), L5178Y (lymphoma cell
line), and EL4 (lymphoma cell line; Patt and Straube, 1956).
Transmission of disseminated neoplasia has been suggested in other species, in-
cluding bay mussels (Mytilus edulis; Elston et al., 1988) and European flat oysters
Ostrea edulis (Barber, 2004); these might be caused by malignant clonal cell lineages.
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Putative transmissible cancers, with unknown etiology, have been described in newts
(Triton alpestris; Champy and Champy, 1935) and climbing perch (Anabas scandens)
as well as transplantable tumours in bullhead catfish (Ameiurus nebulosus), axolotls
(Siredon mexicanum) and leopard frogs (Rana pipiens; Schlumberger, 1957). Cancer
epidemics with unconfirmed aetiology have also been observed in California sea
lions and green turtles (Chelonia mydas; McAloose and Newton, 2009).
The incidence of transmissible cancer outbreaks in nature could be underestimated
as no attempt has been made to systematically screen available wildlife data sets for
the presence of clonally transmitted malignant cells. Failure to recognise contagious
cancers may be because outbreaks are self-limiting in local populations, having been
eliminated from the population due to their detrimental impact on host fitness or
may have resulted in species extinction outright (Ujvari et al., 2016). This would
be especially true of highly virulent outbreaks. Furthermore, cancer prevalence
data relating to cancer in mammals, and in particular birds and reptiles, is limited,
scattered and frequently challenging to access (McAloose and Newton, 2009). It is
possible that, for these reasons, we have underestimated the frequency with which
contagious cancers can arise.
1.3 Dog origins and genetics
A major part of Chapter 3 is framed in terms of dog population history and, for this
reason, I include here a brief discussion of the relationship of dogs to wild canids
and overview their origin and domestication.
Canidae, a family of enigmatic terrestrial carnivores, is formed by 36 extant canid
species including wolves, jackals and coyotes (Wayne et al., 1997). Dogs (Canis lupus
familiaris) were the first domesticated species of plant or animal, and the only animal
species to be domesticated years before the advent of settled agriculture (Larson et al.,
2012). Modern global dog populations trace their ancestry to a single population of
extinct late Pleistocene grey wolves (Canis lupus) that expanded from Beringia, the
land bridge joining Alaska and Eurasia that is now submerged, ~20,000 years ago
(Fan et al., 2016; Loog et al., 2018). However, the geographic and temporal origin
of the dog, along with the number of independent wolf domestications involved,
remains hotly contested and debate roils within the fields of canine archaeology and
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genetics (Callaway, 2013; Grimm, 2015; Lallensack, 2017).
The earliest unequivocal dog remains appear in the Middle East around 12,000
BP (Dayan, 1994), in Europe at 15,000 BP (Pionnier-Capitan et al., 2011), in North
America up to 10,190 cal BP (Perri et al., 2018) and in Africa between 6,300-5,600
BP (Mitchell, 2015). Recent genomic estimates have placed the timing of wolf-dog
divergence somewhere between 11,000-16,000 BP (Axelsson et al., 2013; Freedman
et al., 2014; Wang et al., 2013). However, a number of contested paleontological
reports point towards the presence of “incipient” dogs up to 40,000 BP, before the
peak of the Last Glacial Maximum (LGM) across sites in Europe (Belgium, Germany,
Czech Republic) and Siberia (Camarós et al., 2016; Germonpré et al., 2015, 2012, 2009;
Ovodov et al., 2011). MtDNA analysis of a putative dog specimen dating to 33,000
years from the Altai mountains in central Asia ago support an earlier domestication
window (Druzhkova et al., 2013). A molecular timescale of dog and wolf population
history, recalibrated using an ancient Siberian wolf genome, places their divergence
~27,000-40,000 years ago (Skoglund et al., 2015).
A single domestication origin has been suggested in Central Asia (Shannon et al.,
2015), East Asia (Savolainen et al., 2002; Wang et al., 2016), Europe (Thalmann et al.,
2013) and the Middle East (Vonholdt et al., 2010). Recently, a consilient dual domes-
tication origin was suggested in East Asia and Western Eurasia based on combined
genetic and archaeological results (Frantz et al. 2016; see Table 1.2 for a brief sum-
mary of the major dog domestication studies). The process by which wolves were
domesticated, including the specific selected traits and how these were selected, is
not well characterised. Given that wolves are large carnivorous predators it seems
likely that scavenging wolf commensals initiated a self-domestication process, taking
advantage of feeding ecologies provided by human activity and carving out a niche
in which the modern dog could emerge (Larson et al., 2012; Pitulko and Kasparov,
2017; Zeder, 2012).
The development of the modern domestic dog is associated with two population
bottlenecks: one following domestication and the divergence of wolves and dogs and
a far more recent, tight bottleneck following breed creation (Karlsson and Lindblad-
Toh, 2008). In early dogs, gene flow between dog and wolf populations was likely
an important source of variation for artificial selection (Vilà et al., 1997). Nowadays,
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Table 1.2 Overview of dog domestication studies
ND, not determined, signifies either that studies did not propose a geographic
origin for domestication, did not propose a temporal origin for domestication, or did
not comment on the number of domestication events involved. Ybp, years before
present.
Domestication
centre
Dog time-of-origin Domestication
events
Data Publication
ND <135,000 ybp ND partial mtDNA Vilà et al. (1997)
East Asia ~15,000 ybp ND complete
mtDNA
Savolainen et al. (2002)
East Asia <16,300 ybp 1 complete
mtDNA
Pang et al. (2009)
Middle East ND Vonholdt et al. (2010)
Europe 18,800-32,100 ybp 1 complete
mtDNA (an-
cient & modern)
Thalmann et al. (2013)
ND 11,000-16,000 ybp 1 nuclear DNA Freedman et al. (2014)
Central Asia <15,000 ybp 1 nuclear, Y & MT
markers
Shannon et al. (2015)
East Asia (south-
ern)
<33,000 ybp 1 nuclear DNA Wang et al. (2016)
East Asia; West-
ern Eurasia
20,000-60,000 ybp 2 nuclear DNA
(ancient &
modern)
Frantz et al. (2016)
ND 20,000-40,000 ybp 1 nuclear DNA
(ancient &
modern)
Botigué et al. (2017)
there are almost 400 modern dog breeds, most of these resulting from a program
of intense artificial selection, beginning in the nineteenth century (Parker et al.,
2004). However, the majority of dogs are free-roaming village dogs, a geographically
widespread and genetically diverse population (Shannon et al., 2015).
1.4 Thesis structure and rationale
This thesis has the following plan. Chapters 2 to 4 describe experimental projects
carried out during the course of my dissertation and the results obtained. The first
part of Chapter 2 describes the analysis of mitochondrial genomes from a global
population of CTVTs; the second part of Chapter 2 describes analysis of an extended
set of mtDNAs. I used this data to determine the frequency and timing of mtDNA
horizontal transfer in CTVT as well as the potential contribution of selection and
recombination to CTVT mtDNA evolution.
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Chapter 3 reconstructs the genetic profile of the ‘founder dog’ in which CTVT first
arose along with providing a detailed evolutionary history of the early dog popula-
tion to which the founder belonged. This chapter also provides a CTVT time-of-origin
estimate based on mutation count data from a case of direct CTVT transmission.
Chapter 4 proposes that an infectious aetiology, namely transmissible cancer, could
explain wildlife cancer epidemics and specifically tests the hypothesis that urogenital
carcinoma in California sea lions is clonally transmitted.
Chapter 5 summarises the key findings and implications of this thesis, which follow
from the explicit research questions framed in each chapter, and suggests future
directions of research arising from this work.
At the beginning of each chapter I present a focused introduction, providing back-
ground details relevant to work presented therein. I include a Discussion section at
the end of each chapter, in which I summarise my work and results, as well as the
limitations of this work, and future research directions.
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Chapter 2
Exploring the mitochondrial genetic diversity and evolution of
globally distributed canine transmissible tumours
2.1 Chapter abstract
Mitochondria play a crucial role in cellular pathways frequently disrupted in cancer
cells, including energy metabolism and apoptosis. A report of multiple mtDNA
horizontal transfers from host to CTVT cells suggested that, in particular, mitochon-
dria might play an important role in CTVT biology and evolution (Section 1.2.1.9).
Furthermore, distinct CTVT mitochondrial haplotypes arising as a result of mtDNA
horizontal transfer provide a unique means of tracing routes of CTVT phylogeo-
graphic spread along with historical global dispersals of dogs.
In the first part of this chapter, I analyse complete mitochondrial genome sequences
(mtDNAs) from 449 CTVT tumours collected from 39 countries around the world.
This analysis revealed that CTVT has captured mtDNA from its transient hosts at
least five times over the last two thousand years. Further analysis of an extended
data set of 640 CTVT samples uncovered a total of twenty horizontal transfer events
as well as frequent uptake of host mtDNA belonging to a specific haplogroup.
Somatic mtDNA mutations have been shown to accumulate with age (Wallace, 2010).
This may be expected to lead to a high mitochondrial DNA mutation load in CTVT,
similar to the nuclear genome, given the opportunity for mutations to accumulate
since its ancient origin. However, CTVTs persistence in spite of this suggests that
negative selection, acting to remove deleterious mutations, could be a major force in
CTVT evolution. This chapter explored explicitly whether negative selection operates
on CTVT mitochondrial genomes and compared this with the effects of selection in
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short-lived human cancers. This analysis demonstrated the activity of negative se-
lection operating to curb the accumulation of deleterious mutations in CTVT mtDNA.
Lastly, this chapter exposes an unprecedented genetic mechanism in cancer, mtDNA
recombination, which may be a widespread DNA repair mechanism although chal-
lenging to detect in cancers that remain in one host. Altogether, these data present
some new perspectives on recent dog migration history, as well as novel insights
into the evolutionary processes driving the cancer that has doggedly followed them
around the world.
2.2 Publications associated with this chapter
Results from analyses performed in this chapter (Data Set 1 only; Section 2.6) were
published as a Short Report in eLife on May 17th 2016, of which I am co-first au-
thor along with Andrea Strakova (Strakova et al., 2018; see Appendix 2 for the full
reference). A manuscript including the main results from analysis of Data Set 2
(Section 2.7) is currently in preparation (Strakova et al., 2018).
2.3 Introduction
This introduction briefly summarises aspects of mitochondrial biology relevant
to the research questions addressed in this chapter. I begin by considering the
origin of mitochondria along with their structure and function in eukaryotic cells. I
introduce some important features of mitochondrial genetics, including how somatic
mitochondrial mutations arise and selection and the role of mitochondrial mutation in
cancer. I then review recent findings regarding mitochondrial dynamics, specifically
horizontal transfer, recombination and mitochondrial-nuclear genome fusions. I
conclude by setting out the central questions of this chapter.
2.3.1 Mitochondrial structure and function
Mitochondria are double membrane bound organelles found in almost all eukaryotic
cells (Cavalier-Smith, 1987). These intracellular organelles are the direct descendents
of a primitive proteobacterium, related to α-Proteobacteria, that became associated
with a prokaryotic cell through a fateful endosymbiosis approximately 2 billion years
ago (Margulis, 1970).
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Since this endosymbiotic origin, mitochondria have co-evolved with nuclear DNA
and become indispensable for eukaryotic life. Mitochondria are the primary genera-
tors of adenosine triphosphate (ATP), the energy currency of the cell, through the
process of oxidative phosphorylation (OXPHOS) and are critical to the regulation
of other cellular functions including apoptotic cell death and calcium signalling
(Tait and Green, 2010). Individuals cells can contain 103-104 mitochondria with
the number of mitochondria varying by cell type and higher mitochondrial copy
number observed in conjunction with greater metabolic demands (Robin and Wong,
1988; Wai et al., 2010). Mitochondria can replicate, even in non-dividing cells, semi-
autonomously of nuclear DNA (Westermann, 2010) and are frequently fusing and
dividing. These organellar dynamics determine their structure; in some cell types,
mitochondria can fuse to form a networked mitochondrial complex (Rafelski, 2013).
Mitochondria are usually assumed to be clonally inherited. For this reason, mitochon-
drial genotypes are popular markers in forensics and in reconstructing population
histories.
2.3.2 The mammalian mitochondrial genome
The hypothesis for a symbiotic origin was supported by the discovery that mitochon-
dria contain their own genome. In the course of mitonuclear coevolution, most genes
from the ancestral mitochondrion have relocated to the nucleus (Kleine et al., 2009).
The mitochondrial (MT) genome is a circular molecule, roughly 14-20 kilobase (kb)
in animals. In humans and dogs, this compact genome can be divided into a large
coding region, encoding 13 proteins, 22 transfer RNAs (tRNAs) and 2 ribosomal
RNAs (rRNAs) and a short, non-coding region, called the displacement loop (D-loop)
or control region (Kim et al., 2012). Mitochondria lack introns and, apart from the
D-loop, intergenic sequences are limited to a few bases.
The MT genome is composed of two complementary mitochondrial DNA (mtDNA)
strands: a heavy and a light strand (referring to molecular weight). There is a dis-
tinct asymmetry between mitochondrial strands in terms of gene distribution and
nucleotide content. The heavy strand is guanine-rich and encodes for 12 out of the
13 proteins, as well as most tRNAas and rRNAs; only one protein-coding mitochon-
drial gene, ND6, is transcribed from the corresponding cytosine-rich light strand
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(Andrews et al., 1999). According to the ’strand-displacement’ model of mtDNA
replication, transcription within the non-coding mtDNA D-loop initiates replication
and proceeds clockwise from the origin of heavy-strand replication (OH) until the
origin of light-strand replication (OL) is exposed; this allows light-strand synthesis
to proceed clockwise until the entire molecule is copied. The mtDNA genetic code is
not the same as that of the nuclear genome. Importantly, in vertebrate mtDNA, UGA
is not a stop codon (as in the nuclear genome) and the two arginine triplets, AGA
and AGG, are recoded as stop codons (Stewart and Chinnery, 2015).
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2.3.2.1 Dog mtDNA
Fig. 2.1. Phylogeny of modern dog
(unlabelled) and wolf (open squares)
mtDNA haplotypes. Dog sequences
were assigned into six phylogenetic
groups (clades A, B, C, D, E and F).
Branch lengths are according to the
indicated scale; the branch leading to
the outgroup (coyote) was reduced by
50%. Reproduced from Savolainen
et al. (2002). RightsLink License
Number 4410730872207.
The complete dog mitochondrial genome se-
quence was published in 1998 and derived
from a native Korean dog, the Sapsaree (Kim
et al., 1998). Dog mtDNA comprises 16,727
base pairs and the structure of the genome is
the same as that in humans (outlined in Sec-
tion 2.3.2). Dog mitochondrial haplotypes
can be divided into six main phylogenetic
groups (clades A, B, C, D, E, and F; Fig. 2.1)
with almost all modern dog haplotypes be-
longing to clades A, B and C (Savolainen
et al., 2002; Vilà et al., 1997). Clade D, E,
and F haplotypes are rare and have a strong
geographic signal. It has been suggested
that these rarer haplotypes derive from lo-
calised hybridisation with wolf populations
(Savolainen et al., 2002). Interestingly, dogs
have accumulated non-synonymous muta-
tions in mitochondrial genes at a faster rate
than wolves. It has been suggested that re-
laxation of the selective constraint on mito-
chondria in dogs occurred as a result of do-
mestication (Björnerfeldt et al., 2006).
2.3.3 Mutation and selection
Somatic mutations can arise in the mitochon-
drial genome just as they do in the nuclear
genome and with each cell cycle the replica-
tion MT genome can acquire de novo muta-
tions. In mtDNA, somatic variants originate
on a single molecule in a single organelle in
a single cell (Stewart and Chinnery, 2015)
resulting in heteroplasmy. Heteroplasmy
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arises when multiple distinct mtDNA populations coexist within the mitochondrion,
the cell, or the individual. Clonal expansion of heteroplasmic mtDNA mutations
can lead to fixation or homoplasmy, so that the mutation now affects all molecules
(Fig. 2.2c.).
In mammals, the rate of mutation in the mitochondrial genome is higher than the
in nuclear genome (Lynch et al., 2006). A number of important factors are likely to
underlie this elevated mutation rate including: (i) mitochondria generate reactive
oxygen species (ROS) as a byproduct of respiration; oxidative damage plays a known
role in mitochondrial mutagenesis, (ii) mtDNA lack protective histones, and (iii)
mtDNA damage repair is relatively inefficient compared with nuclear DNA repair
(Stewart and Chinnery, 2015). This could be, in part, because high mitochondrial
copy number has a buffering effect against the deleterious effects of stochastic muta-
tion.
Random genetic drift (Coller et al., 2001), host-beneficial or selfish selection can
result in the proliferation of mutant mtDNAs. For example, smaller mitochondria
carrying pathogenic deletions have a selfish replicative advantage and have been
observed to preferentially accumulate over time in animal and human models (Clark
et al., 2012; Diaz et al., 2002). Purifying or negative selection can act to eliminate
defective variant mtDNAs. A key example are the mitochondrial bottlenecks that
occur in the developing germline, thought to be responsible for the maintenance
of homoplasmy and purifying selection of highly deleterious mutations during
germline transmission (Stewart et al., 2008). Lastly, balancing selection can lead to a
state of stable heteroplasmy (Ma et al., 2014). It is also worth noting that patterns of
selection can operate at multiple levels: between mitochondrial genomes, between
mitochondria within cells or between cells (Fig. 2.2) and that selection at different
levels can lead to genetic conflicts.
2.3.4 Mitochondria and cancer
While mutations in nuclear cancer genomes have been studied extensively, the role of
mitochondrial DNA mutations in cancer is not yet completely understood, although
somatic mutations in mtDNA have for a long time been suspected to contribute to
cancer progression (Chatterjee et al., 2006; Ohta, 2006; Yuan et al., 2017; Zong et al.,
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Fig. 2.2. Mutation and selection in mitochondria.
a. Levels of selection within an individual b. Multiple levels of selection: between
cells, between mitochondria within cells and between mtDNA within mitochondria.
c. Fixation of mtDNA mutations d. Between-cell selection acting against
gene-disrupting mutations effective only with MT bottlenecks
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2016). It has been hypothesised that because of the critical role of mitochondria in
energy metabolism and apoptosis, mitochondrial mutations can contribute to cancer
development. Notably, cancer cells are characterised by an altered energy metabolism
(Hanahan and Weinberg, 2000) and early interest in the role that mitochondria might
play in cancer stemmed from this observation. Otto Warburg famously observed
that cancer cells metabolise glucose in a way that differs from normal differentiated
cells, the so-called “Warburg effect”, and primarily rely on aerobic glycolysis for ATP
synthesis rather than mitochondrial OXPHOS (Vander Heiden et al., 2009; Warburg
et al., 1924).
Despite this, comprehensive analysis of somatic mtDNA variants in 1,675 tumours (Ju
et al., 2014) found that somatic mutations in the mitochondrial genome accumulate
largely neutrally as a result of an endogenous mechanism linked with replication.
The same study did report, however, that protein-truncating mtDNA mutations in
human cancer cells undergo negative selection indicating the need for a sufficient
number of functioning mitochondria in order to maintain fitness of the cancer cell
(Ju et al., 2014).
2.3.5 Horizontal transfer
The extent of mitochondrial horizontal transfer between mammalian cells in different
tissues and contexts is currently unknown. Lateral transfer of mtDNA has been
observed in many different human and animal cell culture systems (Berridge et al.,
2015; Cho et al., 2012; Rustom et al., 2004; Spees et al., 2006) as well as in normal and
cancer mouse cells in vivo (Berridge et al., 2015, 2016; Dong et al., 2017; Hayakawa
et al., 2016; Spees et al., 2006; Tan et al., 2015). There is also evidence that many
cell types, including cancer cells, can receive mitochondria (endothelial, epithelial,
macrophage; Berridge et al., 2016) and that intercellular mitochondrial trafficking
can take place between the same or different cell types.
Mitochondria are sensitive to changes in the cellular environment, and are among
the first organelles to be damaged under stressful conditions, like low oxygen levels
or rapid reperfusion. These damaged mitochondria can quickly become drivers
of apoptosis. It has been suggested that horizontal transfer can act to rescue cell
function and may be a response to metabolic stress or other changes within the cell
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environment. For example, tumour cell uptake of donor DNA from host cells in the
microenvironment has been shown to rescue mitochondrial respiratory function in
tumour cells with severely damaged mtDNA and to promote tumour growth (Spees
et al., 2006; Tan et al., 2015). It is likely that the selective advantage provided by the
new mtDNA haplotype, following mitochondrial uptake, drives its expansion (Fliss
et al., 2000; Habano et al., 1998; Polyak et al., 1998).
Intercellular MT transfer has also been suggested to play a role in mesenchymal stem
cell (MSC)-mediated tissue repair (Spees et al., 2016). MSC-mediated mitochondrial
delivery has been observed to repair cigarette smoke and UV induced damage in
vitro (Liu et al., 2014; Wang and Gerdes, 2015) and recent work suggests that cell
damage plays a role in directing the organelle delivery process (Mahrouf-Yorgov
et al., 2017). Interestingly, a previous study has shown that transfer of mtDNA in vitro
is enhanced by the chemotherapeutic agents cytarabine, etoposide and doxorubicin
(Moschoi et al., 2016).
As mentioned in the introduction (Section 1.2.1.9), phylogenetic analyses have demon-
strated that multiple horizontal transfers of mitochondria have taken place in CTVT.
Normally, detecting intercellular mtDNA transfer within an individual would be
extremely challenging given that mtDNA haplotypes would be highly similar, if not
identical. Rebbeck et al. (2011) noted at least two mtDNA horizontal transfer events
in thirty seven CTVT samples originating from seven countries (Mexico, Israel, South
Africa, Thailand, Kenya, Greece and Malaysia). This process has been suggested to
provide a functional advantage to CTVT cells - as CTVT mtDNA acquire an increas-
ing number of mutations with time, their efficiency may decline, and the infusion
of fitter, host mitochondria, may provide either a selective advantage to CTVT cells
or that competition between mitochondria leads to the selfish expansion of ’fitter’
mtDNA haplotypes(Rebbeck et al., 2011). Cellular uptake of donor mitochondria
could also suggest that the long-term survival of CTVT has put pressure on basic
cellular metabolic processes. However, we cannot exclude that this intriguing case of
mitochondrial thievery occurs, and is subsequently maintained, in CTVT by entirely
neutral processes.
The exact mechanism of mtDNA horizontal transfer between cells is unknown
(Berridge et al., 2015; Tan et al., 2015). Two leading theories are that mitochon-
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dria transit between cells through transient cytoplasmic bridges known as tunnelling
nanotubules (TNTs) or via engulfment of microvesicles containing mitochondria.
Considerable evidence supports the view that TNT-like structures are involved.
While shuttling of mtDNA between cells may be a normal physiological process
occurring during tissue homeostasis, development and aging (Berridge et al., 2016),
it is likely that horizontal mtDNA transfer occurs in response to mtDNA damage.
Overexpression of Miro1, a Rho-GTPase that traffics mitochondria along an actin
“highway” within tunneling nanotubes, has been shown to enhance the ability of
mesenchymal stem cells to donate mitochondria and to rescue damaged epithelial
cells in vitro as well as in a mouse model of airway inflammation (Ahmad et al., 2014).
A mechanistic explanation for how host mtDNA is captured has not been estab-
lished. Given that CTVT is likely to be derived from a histiocytic or macrophage
lineage (Section 1.2.1.7), it may be that tumour cells may be pre-adapted to fuse with
host cells and engulf foreign material.
2.3.6 Mitochondrial recombination
Generally, mtDNA is assumed to be recombinationally inert. However, mtDNA
recombination has been observed in various eukaryotes (Bergthorsson et al., 2003;
Gantenbein et al., 2005; Hoarau et al., 2002; Ladoukakis and Zouros, 2001; Lunt and
Hyman, 1997; Ujvari et al., 2007) as well as in human cell extracts (Thyagarajan et al.,
1996) showing that mammalian mtDNA is capable of recombining. In rare cases,
where paternal mitochondria has been transferred to the ooctye during fertilisation,
recombination of maternal and paternal mtDNA haplotypes has been observed in
humans (Kraytsberg et al., 2004; Zsurka et al., 2005).
While mtDNA recombination has previously been proposed as a mechanism for
mtDNA repair (Thyagarajan et al., 1996) it has not, so far, been detected in cancer
cells. One reason for this could be that mtDNA genomes in most individuals are
identical given the clonal expansion of maternal mitochondria within the ovum
once fertilisation occurs. It is far easier to detect occurrences of MT recombination
that involve transfer of genetic material between two distinct mtDNA molecules as
opposed to two similar molecules. In CTVT, multiple distinct mtDNA haplotypes
may co-exist in the same cell following horizontal transfer. This situation provides a
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unique opportunity to a investigate novel genetic mechanism, possibly functioning
in DNA repair, previously undetected in cancer
2.3.7 Nuclear copies of mitochondrial DNA
Nuclear copies of mtDNA (NuMTs) are fragments of mtDNA that have been in-
serted into the nuclear genome and can be subject to subsequent genetic drift, with
individual NuMTs picking up polymorphic mutations in different lineages. Rapid
mobilisation of mtDNA sequences has been reported in humans (Turner et al., 2003),
plants (Wang et al., 2012) and yeast (Cheng and Ivessa, 2010). Over 150 NuMTs
have been identified in the canine genome (Verscheure et al., 2015) and somatically
acquired NuMTs have also been described in human cancer (Ju et al., 2015). It is im-
portant in the context of this chapter to consider the possibility of mitochondrial DNA
transfer into the nuclear genome. NuMT sequences are homologous to mtDNA and
may be amplified alongside their mitochondrial counterparts, becoming a source of
contamination in mtDNA analysis and, in particular, confound short-read analyses.
2.3.8 Summary
This introduction has given a broad overview of our current understanding of mito-
chondrial biology and highlighted the role of mitochondrial function in cancer and
in response to cell damage. This establishes the context in which I will address the
following questions related to mitochondrial function in CTVT:
(i) What is the frequency of mitochondrial capture in CTVT?
(ii) At what points in CTVT evolution have independent horizontal mtDNA trans-
fers taken place?
(iii) What is the geographical distribution of tumours within each horizontal transfer
group?
(iv) What can the inferred CTVT phylogeny along with the estimated timing of
horizontal transfer events tell us about the global spread of CTVT?
(v) Can any signature of selection be detected in CTVT mitochondria?
(vi) What mutational processes affect CTVT mitochondria?
(vii) Using phylogenetic methods, can we detect any instances of mtDNA recombi-
nation in CTVT mitochondria?
40
Methods
The methods section is divided into two parts relating to the analysis of two data
sets: (i) analysis of 449 complete CTVT mtDNAs (Data Set 1) generated from low-
coverage whole-genome sequencing, and (ii) analogous analysis of 640 complete
CTVT mtDNAs (Data Set 2) generated from both whole-exome and low coverage
whole-genome sequencing and including 437 tumour samples from Data Set 1.
2.4 Methods (Data Set 1)
2.4.1 Sample collection and DNA extraction
Biological sample collection was approved by the Department of Veterinary Medicine,
University of Cambridge, Ethics and Welfare Committee (reference number CR174).
Tumour and host (gonad, skin, blood or liver) tissue samples were collected into
RNAlater solution and stored at 4°C until processing. Genomic DNA was extracted
using the Qiagen DNeasy Blood and Tissue extraction kit. Sample collection was
coordinated by Andrea Strakova and Elizabeth Murchison. A list of the veterinary
collaborators that contributed sample material analysed in Data Set 1 is provided in
the Preface. DNA extractions were performed by Andrea Strakova. Sample informa-
tion is provided in Appendix 1: Supplementary file 2.1.
Sampling from matched host individuals was a vital aspect of the sample collection
protocol as use of host sample sequences allowed us to identify and exclude con-
taminating host reads present in tumour samples. Unmatched CTVT tumours arose
where collaborators were unable to provide a matched host sample or where it was
not possible to successfully extract, sequence, or analyse DNA from the matched
host tissue.
2.4.2 CTVT diagnosis
An initial diagnosis of CTVT was provided by veterinary collaborators based on
either histopathology or clinical presentation. Diagnostic quantitative PCR (qPCR)
assays were performed to confirm CTVT diagnoses via detection of a CTVT-specific
LINE-MYC rearrangement (Katzir et al., 1985).
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Relative levels of host contamination were estimated by qPCR amplification of a
region of the cyclin-dependent kinase inhibitor 2A (CDKN2A) locus; since CDKN2A
is homozygously deleted in CTVT but is present in two copies in host, amplification
would be expected to correspond to host contamination. qPCR assays assessing host
contamination and confirming CTVT diagnoses were performed by Andrea Strakova
(Appendix 1: Supplementary file 2.3).
2.4.3 Low coverage whole genome DNA sequencing
DNA quantification and quality control were performed by the Wellcome Trust
Sanger Institute Sample Management Team. Whole genome sequencing libraries
were constructed using standard protocols according to manufacturer’s instructions
with insert size 100 to 400 base pairs (bp). Sequencing was performed on an Illu-
mina HiSeq2000 instrument with 75 bp paired end reads. Library preparation and
DNA sequencing of CTVT tumour and host samples was performed at the Core
Sequencing Facility, Wellcome Trust Sanger Institute, Hinxton. Sequence reads were
aligned with the CanFam3.1 dog reference genome (Lindblad-Toh et al., 2005) using
the Burrows-Wheeler Aligner’s (BWA) tool (v0.5.9) (Li and Durbin, 2009). Whole
genome sequencing was performed to an average whole genome depth of approxi-
mately 0.3×; average mtDNA coverage was approx. 70× across 449 CTVT tumours
and 338 CTVT hosts.
Samples 1380T and 1381T were extracted and sequenced separately at the Kunming
Institute of Zoology, as previously described (Pang et al., 2009). DNA extractions
and PCR amplifications were performed by Ting-Ting Yin according to a previously
published protocol (Pang et al., 2009). The sequenced fragments were assembled
using the DNASTAR SeqMan software and the complete mitochondrial genomes
were aligned with the dog mitochondrial reference genome (Genbank accession
U96639.2; Kim et al. 1998).
2.4.4 Mitochondrial copy number
Relative mitochondrial copy number represents the abundance of mtDNA relative
to nuclear DNA. This was calculated using the following equation:
(COVMT/COVnucl) ∗ P
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n where COVMT corresponds to average coverage across the mitochondrial genome,
COVnucl is average coverage across the nuclear genome and P is ploidy. CTVT
tumours and hosts were treated as diploid (Murchison et al., 2014). Host and tu-
mour samples with average MT coverage greater than 300×, which may result from
degraded DNA, were excluded from the copy number calculations (Appendix 1:
Supplementary file 2.2a).
2.4.5 Whole genome copy number
Simple whole genome copy number profiles were generated from low-coverage
sequencing data. Briefly, for each sample we computed read depths in 10 KB windows
across chromosomes 1-38 using bedtools ’coverage’ v2.23.0 (Quinlan and Hall, 2010).
Total copy number was inferred from read depth profiles (Fig. 2.3). Read depth plots
were assessed as a quality control step in order to screen for tumour contaminated
hosts and host contaminated tumours with aberrant copy number profiles. Code for
this analysis was provided by David Wedge.
2.4.6 Substitution calling and filtering
Point substitutions were called using CaVEMan (Cancer Variants through Expecta-
tion Maximisation), an in-house variant calling algorithm, as previously described
(Nik-Zainal et al., 2012). As CaVEMan was developed for matched tumour-normal
data, and CTVT tumours and normals are unmatched (i.e. they are different individ-
uals), I used simulated reads generated from the reference genome as the ’normal’.
Single base substitutions in tumours and matched hosts were called all relative to
this. Data from samples 1380T and 1381T was processed separately at the Kunming
Institute of Zoology. Substitutions in 1380T and 1381T were called using MEGA
(Molecular Evolutionary Genetics Analysis) (Tamura et al., 2013). Substitution calling
in samples 1380T and 1381T was performed by Ting-Ting Yin.
The following list of in-built post-processing filters was applied after initial call-
ing to improve the specificity and sensitivity of substitution calls:
• At least one third of reads supporting the mutant allele must have base quality
>25.
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Fig. 2.3. Read depth profiles generated from low resolution whole genome
sequencing used to infer total copy number for a. 100H, the matched host of tumour
100T; a characteristic host profile b. 100T, a clade 1 CTVT tumour sampled in
Nicaragua; a characteristic tumour profile c. 104T, a clade 2 CTVT tumour sampled
in India. Chromosomes are indicated. Read depth profile generated for 100H
corresponds to normal diploid copy number.
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• Mean mapping quality of reads supporting a substitution variant call must be
≥21.
• Substitution variant calls supported only by the first or last 15 bp of reads were
discarded.
• Substitution variants were discarded if they occurred 10 bp upstream or down-
stream of an unfiltered indel called in the same sample (as detected by the
indel-calling algorithm cgpPindel; Section 2.4.7). The 10 bp range was extended
by the REP value for samples where an indel had been called with REP>0; REP
represents the number of times the inserted or deleted base(s) occurs in the
sequence directly 5’ or 3’ of the putative indel.
• Substitution variant calls were discarded if they occurred within the simple
repeat region MT:16129-16430 inclusive. Coordinates for the dog reference
genome, CanFam3.1, were obtained from UCSC table browser (http://genome.
ucsc.edu/).
• Substitution variants where the wild type allele was supported by at least
one read on both the forward and reverse strand but the mutant allele was
supported on only one strand were discarded.
2.4.6.1 Variant allele fraction plots
A variant allele fraction was reported for each substitution detected in the CaVEMan
substitution calling pipeline. VAF corresponds to the number of reads supporting
the substitution variant as a fraction of the total number of reads covering the substi-
tution variant position). Variant allele fraction plots, displaying VAF value versus
mitochondrial genomic position (Fig. 2.4), were frequently used during analyses as a
tool for quality control. Germline mtDNA variants detected in hosts were mostly
homoplasmic and supported by 100% of reads (Fig. 2.4b). Tumour mitochondrial
VAF profiles were distinct from matched host profiles, as expected (Fig. 2.4a).
2.4.6.2 Somatic substitutions in tumours with matched hosts
To remove tumour substitutions caused by host contamination, substitutions that
were called in both tumour and matched host, but had VAF<0.9 in the tumour,
were discarded. Substitutions with VAF>0.9 in both tumour and matched host were
considered to be likely germline substitutions shared between host and tumour,
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Fig. 2.4. Sample variant allele fraction (VAF) plots for a a. CTVT tumour and b.
matched host. Characteristic tumour and host VAF bands are indicated. In tumour
VAF plots, substitutions found in both tumour and host are present in 100% of reads.
Tumour-only substitutions are present in a fraction of reads that corresponds to the
amount of host contamination e.g. where host contamination is 20%, tumour-only
variants are expected to be supported by 80% of reads.
and were removed. Low coverage hosts (defined as average mitochondrial genome
coverage <20×) were additionally checked for evidence of substitutions at positions
where substitutions were called in the corresponding tumour, and the substitution
was discarded in the tumour if at least one read supporting the substitution was found
in the low coverage host. All tumour substitutions with VAF<0.5 were discarded if
the matched host was of low coverage. Low-level tumour-contaminated hosts were
additionally checked for the presence of substitutions identified in other tumours
and any substitutions arising due to contamination were discarded.
2.4.6.3 Somatic substitutions in tumours without matched hosts
Variant allele fractions were used to identify the fraction of host contamination in each
tumour as well as substitutions likely arising due to host contamination in tumours
for which matched hosts were not available (Appendix 1: Supplementary file 2.1 for
list of unmatched tumours). I discarded substitutions below a VAF cutoff, specified
uniquely for each tumour based on its estimated level of host contamination (for most
tumours, the VAF cutoff was 0.5 or 0.6). If VAF plots did not show clear distinctions
between tumour substitutions and host contamination (i.e. host contamination was
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greater than ~40%; this category included 9 tumours), we identified likely tumour
substitutions as those which were present in phylogenetically-related tumours. Any
remaining substitutions that were also found in normal dogs were removed (see
Appendix 1: Supplementary file 2.4f for list of germline substitutions present in
normal dogs); those substitutions that were not found either in phylogenetically-
related tumours or in normal dogs were kept as putative somatic substitutions.
2.4.6.4 Germline substitutions in hosts
Filters described in Section 2.4.6 were described to substitutions in hosts. Low
coverage hosts (average mtDNA coverage <20×; see Appendix 1: Supplementary
file 2.2a) were further checked for evidence of substitutions at positions where a
substitution was called in the corresponding tumour as described in Section 2.4.6.2.
Substitutions called in low coverage hosts and hosts with regions of low coverage
(137H, 402H, 423H, 469H, 513H, 530H1, 764H, 82H1, 835H, 859H, 90H) may still
contain false negatives due to low coverage.
2.4.6.5 Further quality checks and validation
Additional quality filtering was performed in low coverage regions, regions with
low-mapping quality, and regions containing variable-length polyC homopolymer
tracts (Fregel et al., 2015). Substitutions that were subsequently completely excluded
from the analysis as a part of this check are as follows: 16705C>T was frequently mis-
called due to low coverage in this region (the notation 16705C>T is used to indicate a
G>A substitution at MT base position 16705); 15931A>G, 16672C>T were frequently
miscalled in samples due to their presence in the middle of a homopolymer tract;
15632C>T, 15639T>A, 15639T>G were frequently miscalled due to poor mapping
quality in this region;15493G>A, 15505T>C were inconsistently called across samples
due to low coverage and poor mapping quality in this region.
Substitutions that were discarded due to proximity to an indel (Section 2.4.6) were
visually inspected using Integrative Genomics Viewer (IGV) (Robinson et al., 2011;
Thorvaldsdóttir et al., 2013). The following subset of these substitutions had sub-
stantial support and were rescued: 381T>A, 1481T>C, 1683T>C, 2682G>A, 2683G>A,
3028A>C, 6629T>C, 6882A>G, 7014T>G, 8281T>C, 8368C>T, 8703G>A, 9825G>A,
9896T>C, 13708C>T, 14977T>C, 15524C>T, 15526C>T, 16660T>C, 16663C>T, 16671T>C.
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2.4.6.6 Host contamination
Host contamination levels in each tumour were estimated from VAF plots (Sec-
tion 2.4.6.3). Substitutions that were present in tumours but not in matched host
were identified, and their average VAF used to estimate the proportion of tumour
mtDNA. Substitution VAFs were normalised to take account of host contamination.
While it is most likely that tumour variants with normalised VAF< 1 represent
heteroplasmic variants, we cannot exclude that these represent cellular subclones
harbouring distinct homoplasmic mtDNA populations.
2.4.6.7 Recurrent mutations and back mutations
Back mutations are two mutations (either two somatic mutations or a germline and a
somatic mutation) at the same position leading to a reversion to the reference allele.
Recurrent mutations are when the same somatic variant arises independently in
different CTVT tumours or when a somatic variant occurs at the same position as a
germline variant.
Back mutations and recurrent mutations occurring in tumours were identified by
inspecting positions of tumours carrying each substitution on phylogenetic trees
(See Appendix 1: Supplementary file 2.15 for a summary of back mutations).
2.4.6.8 Extracting substitution variants from publicly available dog
sequences
In order to enrich the germline substitution panel created from 338 CTVT hosts,
an additional 252 publicly available complete dog mtDNA genomes were included.
Freely available complete dog mtDNA sequences were downloaded from the Na-
tional Center for Biotechnology Information (NCBI). To extract substitution variants,
FASTA sequences were aligned with the dog mitochondrial reference genome (Gen-
bank accession U96639.2) using Clustal Omega (Sievers et al., 2011). SNP-sites (Page
et al., 2016) was used to call variants in the multiple sequence alignment. Alignment
errors, usually due to miscalls caused by closely mapped indels, were inspected
manually and corrected to minimise gaps. For those samples missing data in regions
MT:15510-15532 and MT:16040-16550 I substituted the most likely substitution at
polymorphic sites based on phylogenetic position. The previously outlined filtering
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rules (Sections 2.4.6) were applied to the substitution set where applicable. Substitu-
tions called before MT:48 or after MT:16671 were excluded due to low coverage in
these regions of sequencing data. Substitutions represented by International Union
of Pure and Applied Chemistry (IUPAC) codes R, Y, S, W, K or M where one of the
two possible calls was the same as the reference were changed to the base which was
different to the reference. In cases where the IUPAC code represented >2 bases (B,
D, H, V, or N), the reference base was substituted.
2.4.7 Indel calling and filtering
Small insertions and deletions (indels) were extracted from the sequencing data
using cgpPindel, a modified version of Pindel (Ye et al., 2009). The following list of
in-built filters was used to improve the specificity and sensitivity of indel calls:
• Indels were required to have ≥3 supporting reads on either the forward or
reverse strands or≥2 supporting reads on both the forward and reverse strands
• Indel calls with at least 4 supporting pindel-mapped reads were required to
have at least 1 supporting BWA-mapped read or, failing that, if REP= 0 (Sec-
tion 2.4.6), then at least one supporting pindel-mapped read on both strands.
• Indels within the simple repeat region MT:16129-16430 inclusive were dis-
carded. Coordinates for the dog reference genome, CanFam3.1, were obtained
from UCSC table browser (http://genome.ucsc.edu/).
Samples with very high coverage of the mitochondrial genome (1T, 2T, 3T, 4T, 4H,
498H, 432T, 455T1, 231T, 79H, 79T) were excluded from this analysis due to an in-
creased false discovery rate.
Samples 1380T and 1381T were processed separately at Kunming Institute of Zoology.
Indels were not called in these samples and they were not included in this analysis.
2.4.7.1 Somatic indels
Indels called in tumours that were also called in at least one host were discarded
as possibly arising due to host contamination. Indels that were uniquely called in
tumours without matched hosts were discarded, as the possibility that they were
caused by host contamination could not be ruled out. All remaining indels were
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Table 2.1 Indels discarded from CTVT mitochondrial variant analysis
Base Posi-
tion
Indel Sample Basis for discarding indel
9891 TGATTTATCTCATAATTATCA>
TATCTCATAATTATCATG
324T2 False positive called due to close
proximity to two other indels
9910 C>CAT 401T False positive called due to the
presence of a substitution at the
same position
visually validated using IGV (Robinson et al., 2011; Thorvaldsdóttir et al., 2013).
The indels listed Table 2.1 were discarded from the analysis as miscalls. In total, 27
somatic indels were included in the analysis, including recurrent indels (Appendix
1: Supplementary file 2.5a).
2.4.7.2 Germline indels
Germline indels were those which were considered homoplasmic (average VAF≥0.9)
in CTVT hosts and which passed a visual validation performed using IGV (Robinson
et al., 2011; Thorvaldsdóttir et al., 2013). In total, 7 CTVT host homoplasmic germline
indels were identified (Appendix 1: Supplementary files 2.5a and 11).
2.4.7.3 Recurrent indels
Recurrent indels occurring in tumours were identified by inspecting phylogenetic
positions of tumours carrying each indel.
2.4.7.4 Calculating Indel Allele Fraction
Although primary indel calling was carried out using cgpPindel, indel allele frac-
tion for wild type and mutant indels was calculated using vcfCommons (in-house
software developed at the Wellcome Trust Sanger Institute). The algorithm takes all
mapped and unmapped reads in the region of an indel and performs an alignment
of the reference and the predicted mutated path using Exonerate (Slater and Birney,
2005). The predicted mutated path is the reference with the change predicted by
cgpPindel applied to it. Based on this alignment, reads are classified into 3 categories:
(i) aligns to reference path
(ii) aligns to mutated path
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(iii) ambiguous; a read sequence aligns to the reference and mutated path with
identical scores which makes it impossible to determine the true path
2.4.8 Phylogenetic analyses
Phylogenetic analyses were used to infer evolutionary relationships between CTVT
tumours. Trees were constructed using a maximum likelihood (ML) method im-
plemented in PhyML 3.0 (Guindon et al., 2010) using the General Time Reversible
(GTR) nucleotide substitution model allowing for the transition/transversion (ts/tv)
ratio, gamma distribution shape parameter and proportion of invariant sites to be
estimated in PhyML for each data set. Phylogenetic trees constructed using RAxML
v8.2.6 with a rapid hill-climbing algorithm and identical model specification were
consistent with the phylogenetic trees obtained using PhyML. Prior to tree con-
struction, jModelTest2 (Darriba et al., 2012) was used to determine the best fitting
substitution model for the alignment, inferred using the Akaike Information Criteria
(AIC). The tree topology was estimated using a combination of Nearest Neighbor
Interchange (NNI) and Subtree Pruning and Regrafting (SPR) (Hordijk and Gascuel,
2005) algorithms. Trees were visualised using Dendroscope (v3.2.10; Huson and
Scornavacca, 2012). Bootstrap support values were obtained from 100 bootstrap repli-
cates. The long branch-lengths observed in CTVT clade 4 were further investigated
by visually validating sequence alignments involving these samples. Source data is
available in Appendix 1: Supplementary files 2.12, 2.13 and 2.14.
2.4.9 Confirming independent mtDNA horizontal transfer events
2.4.9.1 Classification of tumour substitutions
CTVT tumour substitutions were classified based on their inferred origin as follows:
Germline clade-defining substitutions
Tumour germline clade-defining substitutions are those identified within the pool
of germline substitutions (n = 1152; Appendix 1: Supplementary file 2.4f) in the
sampled normal dog population (338 CTVT host samples and 252 publicly available
dog mitochondrial genomes). There variants were inferred to be present on the
donor dog mtDNA haplotype which founded an individual horizontal transfer event
and, by definition, these variants are shared by all tumours within a phylogenetic
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grouping or clade derived from the original CTVT cell which received the horizon-
tally transferred donated mtDNA. A complete list of tumour germline clade-defining
substitutions is provided in Table 2.2.
Somatic substitutions
Tumour somatic substitutions are variable within the set of tumours in one clade and
thus are phylogenetically informative. These variants are not present in the current
dog population and were inferred to have arisen somatically after the horizontal
transfer event that founded a clade (see Appendix 1: Supplementary file 2.4b for
a complete list). Substitutions associated with the inferred recombination event in
559T (i.e. present uniquely in 559T) were excluded (Section 2.4.12).
Conservative somatic substitutions
Conservative tumour somatic substitutions were variable and phylogenetically infor-
mative within the set of tumours in one clade and inferred to have arisen after the
clade-defining horizontal transfer event (as above). However, somatic substitutions
within this set which had the potential to be germline were excluded (see Appendix 1:
Supplementary file 2.4c for a full list of ’conservative’ somatic mutations). In order to
curate a set of high-confidence or ’conservative’ somatic substitutions the following
variant sets were excluded:
• Variants associated with inferred recombination events (Section 2.4.12).
• Variants uniquely present in clade 3; clade 3 tumours carry very few somatic
mutations, and so the possibility that clade 3 tumours arose from several
independent mtDNA horizontal transfer events cannot be excluded
• Variants occurring on basal trunks of the CTVT mtDNA tree; these include
trunks leading to haplogroups CTVT_1A, CTVT_1B1 and CTVT_2A (labelled
in Fig. 2.7). Due to their ancestral divergence, it cannot be excluded that these
haplotypes are derived from independent mtDNA horizontal transfer events
• Putative somatic substitutions variants in tumours without hosts (Section 2.4.6.3).
This set of substitutions was used for the analyses described in Section 2.4.13 and
Section 2.4.14.
Potential somatic substitutions
Tumour potential somatic substitutions are those common to all tumours within a
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single clade but not present in the pool of 590 normal dogs analysed (Appendix 1:
Supplementary file 2.4f). It could not be determined if these substitutions were rare
germline variants present on the ’donated’ dog mtDNA genome that founded each
clade, or if these were early somatic substitutions that arose after the clade-defining
horizontal transfer event, but prior to the divergence of tumours analysed in this
chapter. See Table 2.2 for a full list of tumour potential somatic substitutions for all
clades identified in Data Sets 1 and 2.
2.4.9.2 Characterising CTVT clades
A CTVT clade was defined as a group of tumours deriving from a single horizon-
tal transfer event. Independent clades were defined on the basis of the tumour
substitution classification outlined above as follows:
1. CTVT tumours from the same clade arose from a single donor mtDNA hap-
lotype and therefore share the same set of germline substitutions which was
inferred to be originally present on the donor mtDNA haplotype (germline
clade-defining substitutions; Section 2.4.9.1).
2. CTVT tumours from the same clade clustered together on the phylogenetic tree
(Fig. 2.6).
3. The reconstructed donor mtDNA haplotype for each clade has a phyloge-
netically closely related or identical mtDNA haplotype in the sampled dog
population.
2.4.10 Haplotype nomenclature
2.4.10.1 Host
The host haplotype naming system used in this chapter was adapted from the cladistic
canine mitochondrial DNA phylogeny nomenclature proposed by Fregel et al. (2015).
See Appendix 1: Supplementary file 2.9 for host haplotype names. Corresponding
CTVT normal dog host samples were assigned into one of the major clades (A, B, C, D,
E and F; Section 2.3.2.1). For subsequent levels, haplogroups were defined by specific
diagnostic variants, as defined by Fregel et al. (2015). A unique number, following an
underscore after the haplogroup name, distinguished distinct haplotypes within each
haplogroup. Haplogroup-defining variants 15632C>T, 15639T>A and 15639T>G
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Table 2.2 CTVT germline and potential somatic clade-defining substitutions
(Data Set 1).
Germline clade-defining substitutions are those shared between all samples within a
clade and also present in the pool of dog host substitutions. There are no potential
somatic clade-defining substitutions for clades 2 and 3.
CTVT Clade 1 CTVT Clade 2 CTVT Clade 3 CTVT Clade 4 CTVT Clade 5
2683 G>A 5367 C>T 1351 A>G 295 G>C 229 C>T
2833 C>T 5444 T>C 2683 G>A 395 A>T 2322 T>A
2962 C>T 6065 A>G 2962 C>T 530 T>C 2683 G>A
3196 T>C 6257 G>A 3196 T>C 885 G>A 2962 C>T
3641 G>A 8368 C>T 4940 T>C 955 C>T 3196 T>C
4591 G>A 8807 G>A 5367 C>T 1481 T>C 5367 C>T
5367 C>T 13299 T>A 5444 T>C 2683 G>A 5444 T>C
5444 T>C 15814 C>T 6065 A>G 3628 A>T 6065 A>G
5700 G>A 16025 T>C 6401 C>T 3897 A>T 6401 C>T
6065 A>G 6554 T>C 3936 T>C 6494 A>G
6302 A>G 7593 T>C 5367 C>T 7324 G>A
8242 G>A 8281 T>C 5444 T>C 7593 T>C
8281 T>C 8368 C>T 6065 A>G 8281 T>C
8368 C>T 8807 G>A 6068 T>C 8368 C>T
8807 G>A 10611 A>T 6744 A>T 8408 C>T
9790 G>A 10992 G>A 8368 C>T 8807 G>A
9896 T>C 13299 T>A 8565 T>C 8961 A>G
10304 G>A 14977 T>C 8807 G>A 9372 C>T
10992 G>A 15214 G>A 10313 G>A 10467 A>T
11657 C>A 15620 T>C 10618 A>T 10497 A>T
12505 T>C 11945 C>T 10992 G>A
13299 T>A 12330 A>G 11975 G>A
15214 G>A 12336 G>A 12345 C>T
15627 A>G 13299 T>A 12290 C>T
15814 C>T 13620 C>T 12858 G>A
16025 T>C 13971 A>T 13299 T>A
15814 C>T 14554 A>G
16025 T>C 14977 T>C
15214 G>A
15613 A>G
15627 A>G
15814 C>T
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were excluded from this analysis (Section 2.4.6.5) and, thus it was not possible
to distinguish between haplogroups A1c and A1e. Haplotypes which did not fit
into any haplogroup were classified as ’unassigned’. Haplotypes of hosts with low
coverage (<20×) and low coverage regions were individually assessed and assigned
to haplogroups.
2.4.10.2 Tumour
We devised a CTVT mtDNA haplotype naming system adapted from the cladistic
canine mtDNA phylogeny nomenclature proposed by Fregel et al. (2015). See Ap-
pendix 1: Supplementary file 2.9 for a complete list of tumour haplotype names.
Each CTVT haplotype has a prefix ’CTVT_’, indicating a tumour haplotype. The
five CTVT clades are numbered (CTVT_1, CTVT_2, CTVT_3, CTVT_4 and CTVT_5).
For subgroups within clades, hierarchical notation was used, where subsequent
haplogroups are distinguished by alternating letters and numbers and the maximum
number of levels included in the hierarchical notation was five – i.e. 3 numbers and 2
letters (e.g. 1A1a1). The first letter is an upper case Roman letter; subsequently-used
letters are lower case Roman letters. Any haplogroups beyond the maximum number
of levels were considered as a single subgroup, in which individual haplotypes were
distinguished using a non-hierarchical numbering system - an underscore followed
by a number (e.g. 1A1a1_1, 1A1a1_2, etc.). Underscores were only used to distinguish
individual haplotypes after the haplotype has been assigned to all 5 hierarchical
levels (e.g. 1A_1 does not exist, as this haplotype would be classified as 1A1 instead).
2.4.10.3 Reconstructed donor haplotypes
A ’donor haplotype’ was reconstructed for each of the clades, representing the in-
ferred donor mtDNA haplotype in each horizontal transfer event, and was used
to root the trees for each clade. Donor haplotypes were reconstructed from the
clade-defining germline substitutions and the clade-defining potential somatic sub-
stitutions (Section 2.4.9.1). The phylogenetically closest haplotype present in the
current dog population is shown in the same figure. The clade-defining germline
variants represent substitutions present on the reconstructed donor mtDNA.
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2.4.11 Estimated timing of clade divergence
The timing of clade divergences was estimated using the following three independent
methods:
• timing based on nuclear DNA (Alexandrov et al., 2013; Murchison et al., 2014),
• timing based on number of cell divisions per homoplasmic mitochondrial
mutation (Cohen and Steel, 1972; Ju et al., 2014), and
• timing based on number of mitochondrial mutations per year (Ju et al., 2014).
All estimated divergence times assume a constant rate of accumulation of somatic
mtDNA mutations both within and between clades as well as constant activity of
selection. The average number of somatic mutations within each clade was calculated
for each of the five clades (Tables 2.4 and 2.5). As the number of somatic mutations
influences the estimated time of divergence, estimates both with and without poten-
tial somatic mutations are included in this analysis (Tables 2.4 and 2.5).
The presence of mitochondrial recombination in haplogroup CTVT_1B2b2 (CTVT
clade 1) was taken into account when calculating the average number of mutations
per clade (Section 2.6.8).
2.4.11.1 Timing based on nuclear DNA
Based on the most recent common ancestor of samples 24T (identified in the previous
analysis as a CTVT clade 1 sample) and 79T (identified in the previous analysis as a
CTVT clade 2 sample) which is estimated to have existed approximately 460 years
ago (Murchison et al., 2014), it can be assumed that the maximum age of CTVT clade
2 (the more recent of CTVT clades 1 and 2) is 460 years. Calibrated according to this
dating (Alexandrov et al., 2013; Murchison et al., 2014) and assuming a constant rate
of accumulation of mutations with time, the maximum number of CTVT somatic
mtDNA mutations per year is 0.0205 (calculated using average number of mutations
in clade 2 = 9.437). The calculated maximum time since origin of clades 1, 3, 4 and 5
is shown in Tables 2.4 and 2.5.
2.4.11.2 Timing based on number of cell divisions
A study of mtDNA mutations in human cancers estimated that one homoplasmic
somatic mtDNA mutation arises every ~1000 cell generations in human cancers (Ju
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et al., 2014). An experimental study estimated CTVT cell generation times to be 4
days for first stage tumours and >20 days for second stage tumours (Cohen and
Steel, 1972). Using 4 days and 20 days as a minimum and maximum generation time,
and assuming a constant somatic mtDNA mutation rate in CTVT, we estimated a
minimum and maximum mutation rate of ~0.0183 and ~0.0913 mutations per year
respectively. See Tables 2.4 and 2.5 for corresponding calculations of minimum and
maximum time since clade origins.
2.4.11.3 Timing based on number of mtDNA mutations per year
A previous study correlated somatic mtDNA mutation accumulation in human
cancers with patient age (Ju et al., 2014). This suggested an approximate rate of ~0.025
mutations per year. Assuming a similar rate in CTVT somatic mtDNA mutations and
a constant CTVT somatic mtDNA mutation rate, the time since mtDNA horizontal
transfer events was estimated (Tables 2.4 and 2.5).
2.4.12 Mitochondrial recombination analyses
We screened for potential mtDNA recombination in CTVT tumours using phyloge-
netic methods. If recombination had occurred in CTVT mtDNA then the expectation
would be that phylogenetic trees generated using different regions of the mitochon-
drial genome would result in incongruent phylogenies.
2.4.12.1 Automated recombination analysis
The RDP4 package (Martin et al., 2015) was used to detect recombination events
within the complete sample set (449 CTVT tumours, 338 CTVT hosts and 252 addi-
tional dogs) using a Bonferroni corrected p-value cutoff of 0.05. Default parameters
were used for the following programs implemented within the RDP package: RDP
(Martin and Rybicki, 2000), MaxChi (Maynard Smith, 1992), Chimaera (Posada and
Crandall, 2001), 3Seq (Boni et al., 2007) and SiScan (Gibbs et al., 2000).
2.4.12.2 PacBio long read sequencing
The PacBio single molecule, real-time (SMRT) sequencing technique was used to
validate the finding of recombinant mtDNA sequences. SMRT sequencing can gen-
erate ultra-long reads (>30,000 bp) with extremely high consensus accuracy and this
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technique had previously been used to sequence whole mitochondrial genomes (Ma
and O’Farrell, 2015).
A genomic library was created directly using 5µg of genomic DNA from sample 559T,
not utilising shearing or amplification techniques, as previously described (Coupland
et al., 2012). The library was sequenced using two PacBio SMRT cells using the Pacific
Biosciences RS sequencer. Each SMRT cell yielded ~1 Gb of sequence data with mean
read length 11,421 bp and N50 read length 19,382 bp. Average sequence coverage
across the mitochondrial genome was 111.3×. PacBio long read sequencing was
overseen by Andrea Strakova. Library preparation and sequencing was performed
at the Core Sequencing Facility, Wellcome Trust Sanger Institute, Hinxton.
2.4.12.3 PacBio data analysis
PacBio sequence reads aligning to mtDNA were viewed in SMRT view as well as in
Integrative Genomics Viewer (IGV) (Robinson et al., 2011; Thorvaldsdóttir et al., 2013)
and used to phase the mitochondrial substitutions previously called in 559T. This
analysis was performed by Andrea Strakova. The three most common recombinant
haplotypes were completely phased (Fig. 2.12). Additional haplotypes, which were
present at very low levels (less than 5%), were also identified. However, it was
not possible to phase these completely. Reads derived from 559H, the host of 559T
(haplotype B1_1), were also identified.
2.4.13 Selection analyses
Next, we assessed the functional effects of somatic mtDNA mutations and searched
for evidence of selection by comparing variant allele fraction across different cate-
gories of somatic mutations and using dN/dS estimates. The details of these analyses
are outlined below.
2.4.13.1 Substitution and indel variant allele frequency
Variant effect predictor (VEP) (McLaren et al., 2010) was used to predict the functional
impact of single point substitutions and indels (see Appendix 1: Supplementary files
2.6 and 2.7). Normalised VAF values for somatic substitutions and indels were calcu-
lated as described in Section 2.4.6.6. Cumulative distribution functions of normalised
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variant allele fractions were plotted for nonsense (n = 10), missense and synonymous
substitutions (n = 610), using the conservative somatic list (Section 2.4.9.1; Appendix
1: Supplementary file 2.4c). Cumulative distribution functions of normalised variant
allele fractions were plotted for frameshift (n = 18) and non-frameshift (n = 9) indels.
Statistical significance was tested using the two-sample Kolmogorov-Smirnov test
implemented in R (Team, 2013).
2.4.13.2 dN/dS
A widely used measure of selection is the dN/dS ratio; the ratio of non-synonymous
(dN) to synonymous substitutions (dS). dN/dS was estimated using a method
adapted from Martincorena et al. (2015). Briefly, a context-dependent model was
used with 192 substitution rates (12 possible substitution types C>A, C>G, C>T, T>A,
T>C, T>G, A>C, A>G, A>T, G>A, G>C, G>T x 4 possible 5’ bases x 4 possible 3’
bases), accounting for any confounding context-dependent effects by 1 nucleotide
upstream and downstream. The substitution rate was modelled as a Poisson pro-
cess where the product of the underlying mutation rate and the impact of selection
give the rate. A likelihood ratio test was used to test the deviation from neutrality
(wMIS=1 or wNON=1), giving a p-value for the evidence of selection. To avoid any
confounding effects due to the highly strand-biased CTVT mtDNA mutation spec-
trum (Section 2.4.14), ND6, the only mitochondrial-encoded gene transcribed from
the light strand (Section 2.3.2), was excluded from this analysis.
Each mutation type is modelled as a Poisson distributed random variable with
a rate given by the product of the mutation rate and the impact of selection. By
calculating the mutability of each trinucleotide in the coding strand, the model also
accounts for immediate context-dependent mutagenesis and transcriptional strand
bias in mutation rates.
2.4.14 Mutation spectrum
As described in the introduction to this chapter, mtDNA is composed of a heavy
and light strand. The reference strand in CanFam3.1 corresponds to the light strand.
Each mutation on the conservative somatic list (n = 835; Appendix 1: Supplementary
file 2.4c) was classified as one of six possible substitutions in the pyrimidine context
(C>A, C>G, C>T, T>A, T>C, T>G) and assigned to a strand relative to the reference
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(i.e. pyrimidine mutations (i.e. C>, T>) with respect to the reference were defined as
light strand mutations; purine mutations (i.e. A>, G>) with respect to the reference
were defined as heavy strand mutations). The immediate 5’ and 3’ sequence contexts
for each CTVT mutation was extracted from the dog mitochondrial reference genome
for mutations on the heavy and light strands, yielding a maximum of 96 mutation
types (6 possible substitutions x 4 possible 5’ bases x 4 possible 3’ bases).The number
of observations of each substitution type was normalised to the triplet frequency
extracted from the canine mitochondrial genome.
The following example illustrates how to calculate the observed/expected ratio
for T[C>T]G occurring on the heavy strand. A total of 835 substitutions occurring
across the MT genome was observed; given that the TCG triplet is observed 117
times in the dog mitochondrial reference genome heavy strand, the frequency of
TCG triplets occurring in the dog mtDNA heavy strand is 117/16727 = 0.007, where
16,727 bp is the length of the dog mitochondrial genome. Using the frequency of
TCG triplets in the reference genome, the expected number of T[C>T]G substitution
types on the heavy strand can be calculated as (total number of mutations) x (TCG
frequency on the heavy strand) / 3 (as there are 3 possible C>N substitutions) i.e. ex-
pected number of T[C>T]G substitutions on the heavy strand = 835 x 0.007/ 3 ≈ 1.95.
As we observed 22 T[C>T]G mutations on the heavy strand, the observed/expected
ratio for this mutation type was 22/1.95 = 11.28.
Triplets within region MT:16129–16430 inclusive (Section 2.4.6), as well as a set of
specific sites (Section 2.4.6.5) were excluded from this analysis. This was accounted
for during the calculation of expected substitutions described above.
2.4.15 NuMTs
Finally, in this subsection I describe analysis carried out to evaluate the contribution
of NuMTs (Section 2.3.7) to the CTVT mtDNA variant catalogue.
To assess the potential contribution of NuMTs present within the CanFam3.1 as-
sembly to variant calling, wgsim (https://github.com/lh3/wgsim) was used to
simulate sequence reads from CanFam3.1 (excluding the MT chromosome) to a
coverage of 0.3× (i.e. the average nuclear genome sequence coverage obtained for
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Data Set 1). Reads were then aligned to the MT reference sequence using BWA (Li
and Durbin, 2009) and Samtools depth (Li, 2011) was used to assess MT genome
coverage. Any MT genome coverage detected from this analysis would be expected
to arise from NuMTs.
2.5 Methods (Data Set 2)
In the following subsections I describe implementation of an improved variant calling
pipeline developed using the Platypus tool. A new pipeline was designed, largely
in order to minimise the amount of manual curation of mtDNA variants required
(Section 2.4.6.5), and applied to an extended data set of mtDNA sequences from
whole-genome and whole-exome sequencing data.
2.5.1 Summary of Data Set 2
Data Set 2 comprised of 640 CTVT tumours and 494 CTVT hosts from 44 countries
collected between 2001 and 2016. This sample set includes 437 of the CTVT tumours
analysed previously (whole exome and whole genome data was available for 338 of
these samples) and an additional 203 samples for which only whole exome data was
available. 304 hosts from Data Set 1 are also included in this analysis.
Sample collection and sequencing data related to Data Set 2 will become publicly
available upon publication of Baez-Ortega et al. (2018), currently under review (see
Appendix 2).
2.5.2 Sample collection and DNA extraction
Samples were collected from gonad, skin, blood or liver tissue into RNAlater and
stored at 4°C until processing. Sample collection was coordinated by Andrea Strakova
and Elizabeth Murchison. DNA extractions were performed by Andrea Strakova
as described in Section 2.4.1. A list of the veterinary collaborators that contributed
sample material analysed as part of Data Set 2 is provided in the Preface.
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2.5.3 Confirmation of CTVT diagnosis
CTVT diagnoses were confirmed using qPCR assays as previously described (Sec-
tion 2.4.2).
2.5.4 Exome Pull-Down and Sequencing
Hybrid-capture target enrichment was performed using a custom Agilent exome
capture kit. The canine whole exome enrichment kit was designed based on the
latest CanFam3.1 reference genome. The total size of the design was 43 Mb across
190,958 regions.
Whole genome sequencing libraries were constructed with insert size 100 to 400
bp, as previously described (Section 2.4.3). Captured DNA was sequenced on an
Illumina HiSeq 2000 instrument with 75 bp paired end reads. Average depth cov-
erage ranged from 30× to 100×. Reads were aligned against the CanFam3.1 canine
reference genome using BWA (Li and Durbin, 2009).
Although this exome capture kit was not designed to target canine mtDNA genes, the
high copy number of mtDNA in mammalian cells (Section 2.3.1) makes it possible to
obtain mtDNA sequencing data using off-target reads coming from the MT genome
(Ju et al., 2014).
Phylogenetic analysis of the CTVT nuclear genome, using the exome sequencing
data included in Data Set 2, was carried out by Adrian Baez-Ortega.
2.5.5 Variant calling and filtering
Substitutions and short indels were called using Platypus v0.8.1 (Rimmer et al., 2014)
(https://github.com/andyrimmer/Platypus), a haplotype-based variant caller, im-
plemented as part of a custom computational pipeline (Mitotypus) tailored to call
somatic and germline variants in unmatched tumour and host tissues. Platypus
produces genotype calls, and so offers a huge advantage over CaVEMan and cgpPin-
del, the variant calling softwares used in the analysis of Data Set 1 (Section 2.4.6).
This population-based variant calling approach ensured that, by sharing information
across samples during the genotyping step, variants with low read support in a
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subset of samples, or even a single sample, could be called based on robust support
for that variant in another sample. This strategy enhanced variant calling capabilities
in regions of low coverage. No additional post-processing steps were required for
low coverage samples unlike the CaVEMan variant calling pipeline, as described in
Section 2.4.6.5. In this pipeline, the genotyping step allowed us to call any variants
present at low-allelic frequency in low coverage samples, which would have appeared
as false negatives before.
The design rationale of the initial variant calling and filtering steps outlined below
is based largely on Somatypus (Somatypus v1.3; https://github.com/baezortega/
somatypus), also a Platypus based variant caller developed by Adrian Baez-Ortega.
Individual variant calling
Variant calling was carried out in two stages on a sample-by-sample basis. In the
first execution, default settings were used along with the following requirements
• ≥3 supporting reads with mapping quality ≥ 20 were necessary for a substitu-
tion or indel call to be called (–minReads=3).
For SNPs, the base qualities of supporting reads must be ≥ 20.
• Variant calls were not excluded on the basis of their Phred score value (–
minPosterior=0)
The second execution was run with default settings and with the following options
• –minReads=3 (see above)
• –minPosterior=0 (see above)
• Indel candidates were not excluded on the basis of the number of reference-
matching bases on either side of the indel site (minFlank=0)
• Base-qualities within 10 bp of the end of reads were set to 0 (–trimReadFlank=10)
Filtering variant calls
In-built filters, listed below were used to filter variants prior to genotyping. These
filters specifically targeted variants with either low base quality, low mapping quality,
low Phred quality scores, a skewed strand distribution or within low sequence
complexity regions.
• Bad Reads: Variants were discarded if supporting reads within 7 bp upstream
or downstream of the variant call site had a median base quality <15 .
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• Mapping Quality: Variants were excluded where the root-mean-square mapping
quality across all reads mapped to a variant site was below 40. The mapping
quality statistic was computed using all mapped reads, before any filtering.
• Strand Bias: Reads supporting a variant call were compared to a binomial
distribution where the mean of the distribution equals the ratio of forward and
reverse strands observed in all reads. Variants were rejected if the p-value<0.001.
• Sequence Complexity: A sequence complexity statistic was computed measuring
the contribution of the two most frequent nucleotides among the 21 flanking
a variant site; if this measure exceeded 95%, variant calls were flagged and
discarded.
• Quality over depth: Variant calls where the ratio of variant quality (Phred score)
to number of supporting reads was below 10 were excluded.
Filtered SNV and indel calls from all samples then were merged. Only bi-allelic
indels were included in the filtered indel call set.
Genotyping
To allow for multi-allelic SNVs (with up to three observed alleles differing from the
reference allele) SNV genotyping was split into three steps. Substitution variants
called ≤ 5 bp upstream or downstream of an indel (SNVs-near-indels) in any sample
were extracted from the SNV data set and genotyped separately. Filtered and merged
indels were genotyped across the entire sample set. Indel genotyping involved a
single step.
Generating a final variant set
Variants flagged during genotyping by any of the quality checks outlined in ’Filtering
variant calls’ were discarded. Any indel flagged during the genotyping step was
excluded from all samples. SNVs-near-indels with median read coverage <20× or
median VAF <0.2 or >0.9 were discarded.
2.5.5.1 Somatic substitutions in tumours with matched hosts
Substitutions called in both tumours and matched hosts with VAF<0.9 were discarded
as a means of filtering tumour substitutions likely arising from host contamination.
Substitutions with VAF>0.9 in tumour and matched host were retained.
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2.5.5.2 Somatic substitutions in tumours without matched hosts
Tumours matched to host samples contaminated with tumour tissue were treated
as tumours without matched hosts and the corresponding host was discarded from
the analysis. Tumour samples with evidence of high host contamination were also
discarded from the analysis. Variant allele fraction versus MT genome coordinates
were plotted for each sample and used these to determine the level of contamination
(tumour or otherwise) in each host sample as well as the level of contamination
(host or otherwise) in each tumour sample. For example, in a pure host sample we
would expect to see a band of homozygous SNPs at VAF = 1.0. In the case of tumour
contaminated host samples, this band will instead appear at VAF<1.0. The level of
tumour contamination corresponds to the gap between the expected VAF band at
1.0 and the observed VAF band at less than 1.0. By looking at the median VAF of all
variants called in a host sample after filtering, we were readily able to detect sample
contamination.
2.5.6 Phylogenetic analysis
2.5.7 Additional filtering, quality checks and validation
The control region of the canine mitochondrial genome is a non-coding region ap-
proximately 1200 bp in length formed of two hypervariable regions flanking a simple
repeats region. In some literature this is referred to as the Variable Number of
Tandem Repeats (VNTR) region. This region consists of a 10 bp tandem repeat
5’-GTACACGT(A/G)C-3’ with variable repeat numbers, both between and within
individuals (Kim et al., 1998).
Variants called in the simple repeats region (MT:16129-16430) of the MT genome were
discarded. Variants called in the region MT:15524-15535 were also discarded. I iden-
tified the expansion of a poly-C tract, 5’-TCCCCTCCCCT-3’, in this region resulting
in alignment problems and leading to false positive variants. Two further homo-
polymeric regions were identified between MT:15926-15938 (5’-TTTTTAGGGGGGGAA-
3’) and MT:16662-16672 (5’-CCTTTTTTTTCC-3’) which were excluded from the anal-
ysis. I also excluded all variant calls in the region MT:1-75, i.e. one read-length from
the beginning of the MT contig, where we identified the occurrence of false negatives
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Table 2.3 CTVT germline and potential somatic clade-defining substitutions
(Data Set 2).
These substitutions are shared between all samples within a clade and also present
in the pool of substitutions found in normal dogs(Section 2.4.9.1). Potential somatic
clade-defining substitutions appear in italics. These substitutions are shared
between all samples within a clade but absent from the pool of substitutions found
in normal dogs. * indicates clade-defining variants that are absent from recombinant
clade 1 samples. † indicates clade-defining variants that are absent from
recombinant clade 3 samples (Section 2.6.8).
CTVT Clade 1 CTVT Clade 2 CTVT Clade 3 CTVT Clade 4 CTVT Clade 6 CTVT Clade 7
*2683 G>A 5367 C>T 1351 A>G 295 G>C 615 G>A 2683 G>A
*2833 C>T 5444 T>C 2683 G>A 395 A>T 807 T>C 5367 C>T
*3196 T>C 6065 A>G 2962 C>T 530 T>C 1084 A>G 5444 T>C
*3641 G>A 6257 G>A 3196 T>C 885 G>A 1405 G>A 6065 A>G
*4591 G>A 8368 C>T 4940 T>C 955 C>T 2036 T>C 8368 C>T
5367 C>T 8807 G>A 5367 C>T 1481 T>C 2683 G>A 8536 C>T
5444 T>C 13299 T>A 5444 T>C 2683 G>A 2833 C>T 10165 C>T
5700 G>A 15814 C>T 6065 A>G 3628 A>T 2962 C>T 13299 T>A
6065 A>G 16025 T>C 6401 C>T 3897 A>T 3196 T>C 14474 G>A
6302 A>G 6554 T>C 3936 T>C 3641 G>A 15639 T>A
8242 G>A 7593 T>C 5367 C>T 3934 T>C 15814 C>T
8281 T>C 8281 T>C 5444 T>C 4591 G>A 16025 T>C
8368 C>T 8368 C>T 6065 A>G 5105 C>T
8807 G>A 8807 G>A 6068 T>C 5367 C>T
9790 G>A 10611 A>T 6744 A>T 5444 T>C
9896 T>C 10992 G>A 8368 C>T 5700 G>A
10304 G>A 13299 T>A 8565 T>C 5712 G>A
10992 G>A 14977 T>C 8807 G>A 6065 A>G
11657 C>A 15214 G>A 10313 G>A 6302 A>G
11813 A>G †15620 T>C 10618 A>T 8086 G>A
12505 T>C 15627 A>G 11945 C>T 8368 C>T
13299 T>A 15639 T>A 12330 A>G 8807 G>A
15214 G>A 15814 C>T 13299 T>A 9401 A>G
15505 T>C 13620 C>T 10014 G>A
15627 A>G 13971 A>T 13299 T>A
15639 T>A 15639 T>A 14079 T>C
15814 C>T 15814 C>T 15639 T>A
16025 T>C 16025 T>C 15814 C>T
16025 T>C
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due to mapping errors at the start of the contig. Repetitive regions identified were
masked in all samples.
2.6 Results (Data Set 1)
The results of this chapter are divided into two parts. In the first part, I present
results obtained from phylogeographic, mutational signature, selection and mtDNA
recombination analyses of 449 CTVT tumours (Data Set 1).
2.6.1 Mitochondrial copy number
MtDNA was sequenced at ~70× coverage, indicating that each CTVT cell carries
approximately 470 mtDNA copies (Appendix 1: Supplementary file 2.2). This is
coincident with the amount of mtDNA observed in human cancer cells (~500 copies)
(Ju et al., 2015).
2.6.2 Mutational processes in CTVT mitochondria
We identified 1005 single point substitution variants (Appendix 1: Supplementary file
2.4a) and 27 short indels in the CTVT mtDNA population (Appendix 1: Supplemen-
tary file 2.5a). CTVT mtDNA somatic substitution mutations had the characteristic
profile that is observed in human cancers (Ju et al., 2014), dominated by C>T and
T>C mutations showing a striking strand bias (Fig. 2.5). This mutational process is
probably replication-coupled, and mutations associated with this process appear to
accumulate at a roughly constant rate in human cancers (Ju et al., 2014).
2.6.3 CTVT phylogeny
A maximum likelihood phylogenetic tree constructed with mtDNA sequences from
CTVT, matched hosts and hundreds of additional dogs revealed that CTVT mtDNAs
cluster in five distinct groups within dog mtDNA haplogroup A1 (Fig. 2.6). These
data suggest that CTVT mtDNAs have at least five independent origins, demarcating
five distinct horizontal transfer groups or clades. The geographic distribution and
phylogenies of the five CTVT clades reveal the dynamic recent history of the CTVT
lineage (Fig. 2.7a and c). Clades 1 and 2, which occur most frequently in the CTVT
population analysed, both have a global distribution. Tumours that diverged early
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Fig. 2.5. CTVT mtDNA somatic mutation spectrum.
CTVT somatic mutations displayed by mutation type (in pyrimidine context) with 5’
and 3’ context and strand. Only conservative somatic substitutions were used to
generate the spectrum (Section 2.4.9.1). Each of 96 mutation classes is displayed on
the horizontal axis, with mutations occurring on the heavy strand displayed in red
on the positive axis, and light strand mutations displayed in blue on the negative
axis. The normalised substitution rate represents the number of observed mutations
divided by the number of expected mutations, given mtDNA genome triplet content.
Distinctive peaks are individually labelled.
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Fig. 2.6. Maximum likelihood phylogenetic tree constructed with complete mtDNA
sequences from 449 CTVTs and 590 dogs (including matched hosts). Coloured and
black dots represent CTVT and dog mtDNA respectively. Scale bar indicates base
substitutions per site. See Appendix 1: Supplementary file 2.12 for source data.
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in the clade 1 lineage occur in Russia, Ukraine, China and India, suggesting an Old
World origin for this clade. CTVT samples from the Gambia appear to represent an
early, divergent branch of CTVT clade 2 tumours (Fig. 2.7c).
The more recent clade 3 lineage is found in Central and South America and India,
and the less frequent clades 4 and 5 occurred only in India and Nigeria respectively
(Fig. 2.7). The extensive and recent global expansion detected in the CTVT lineage is
consistent with signals of widespread admixture observed in worldwide populations
of domestic dogs (Shannon et al., 2015), highlighting the extent to which canine
companions accompanied human travellers on their global explorations.
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Table 2.4 Estimated timing of clade divergence excluding potential somatic
mutations (CTVT clades 1-5).
Clade # somatic mutations (mean) Divergence times (ybp)
Nuclear
DNA
# cell divisions
(first stage)
# cell divisions
(second stage)
# mutations
per year
1 18.7 911.3 204.7 1023.6 747.8
2 9.4 460 103.3 516.7 377.5
3 5 243.7 54.8. 273.8 200
4 18.7 909.9 204.4 1022.1 746.7
5 0.0 0.0 0.0 0.0 0.0
Clade 4 may have been widespread in central Asia in the past and now replaced by the
more recent clades 1 and 2. CTVT tumours sampled from India represent the most
divergent phylogenetic group. Two clade 4 tumours that diverged approximately
900 years ago were both sampled in Jaipur suggesting that clade 4 may have been
present in this area since that time.
2.6.4 Timing of horizontal transfer events
The estimated number of somatic mtDNA mutations acquired by each clade since
mtDNA capture was used to investigate the relative time since each mtDNA hor-
izontal transfer event in CTVT. Somatic substitution analysis showed that clade 1
mtDNA carry more than double the number of somatic mtDNA mutations (22.5
mutations average) compared with clade 2 mtDNA (9.4 mutations average). Whole
genome sequences of two CTVT tumours derived from clades 1 and 2 indicated that
these two clades shared a common ancestor approximately 460 years ago (Murchison
et al., 2014). Assuming that the clade 2 mtDNA horizontal transfer event occurred
no more than 460 years ago, this analysis suggests a maximum time since mtDNA
uptake of 1,097 years for clade 1, 244 years for clade 3, 1,690 years for clade 4 and 585
years for clade 5, assuming a constant somatic accumulation of mutations in CTVT
mtDNA. Importantly, two additional mutation rate estimates, derived using human
data (Ju et al., 2014), provided similar estimates for CTVT clade temporal origins
(Section 2.4.11).
2.6.5 Tracing CTVT phylogeography
Clade 1 tumours in Central and South America share a single common ancestor that
probably existed no more than 511 years ago, suggesting introduction of CTVT to
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Fig. 2.7. a. Geographical distribution of clades. Each dot represents the location of
CTVT sample collection, coloured by CTVT mtDNA clade. b. Number of somatic
substitution mutations per CTVT tumour. Coloured bars indicate somatic
substitutions acquired by each tumour since mtDNA capture. Grey bars indicate
potential somatic substitutions; thus the early somatic or rare germline status of
these variants is unknown. c. Simplified representation of maximum likelihood
phylogenetic trees for each clade. Trees illustrate nodes with bootstrap support >60,
and shaded triangles represent coalescence of individual branches within each
group. Basal trunks leading to haplogroups 1A, 1B1, and 2A are labelled. Two
tumours were collected in the United States and the Netherlands from dogs
imported from Guatemala and Romania, respectively. Discontinuous grey lines
represent contributions of potential somatic substitutions. Assuming a constant
accumulation of mutations within and between clades, approximate number of
somatic mutations and estimated timing is shown. Figure adapted from Strakova
et al. (2016). See Appendix 1: Supplementary file 2.13 for source data.
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Table 2.5 Estimated timing of clade divergence including potential somatic
mutations (CTVT clades 1-5)
Clade # somatic mutations (mean) Divergence times (ybp)
Nuclear
DNA
# cell divisions
(first stage)
# cell divisions
(second stage)
# mutations
per year
1 22.5 1097.1 246.5 1232.4 900.2
2 9.4 460 103.3 516.7 377.5
3 5 243.7 54.8 273.8 200
4 34.7 1689.9 379.6 1898.2 1386.7
5 12 585.0 131.4 657.1 480
the Americas coincident with colonial contact. Similarly, this analysis suggests a
single introduction of CTVT to Australia after European arrival (maximum 116 years
ago; Section 2.4.11). The distribution pattern and timing of clade 2 suggest a rapid
burst of expansion from a single place and that this clade may have been transported
between continents along maritime trans-Atlantic and Indian Ocean trade routes.
2.6.6 MtDNA haplotype of the CTVT founder dog
This analysis indicates that the original CTVT mtDNA haplotype, present in the
dog that first spawned CTVT, has been replaced and is not detectable in any of the
analysed tumours. Moreover, as mtDNA in CTVT has been acquired by horizontal
transfer, analysis of CTVT mtDNA could not cast light on the timing of CTVT’s
origin.
2.6.7 Selection
We searched for evidence of mtDNA functionality in CTVT cells by examining
CTVT mtDNA for signals of negative selection. If present, negative selection would
be expected to operate on mtDNA to prevent homoplasmy of deleterious muta-
tions. Consistent with this prediction, the VAF of nonsense substitutions (p=0.00019;
Fig. 2.8a) and frameshift indels (p=3.03x10−05; Fig. 2.8b) was significantly lower than
VAF for other substitutions and indels. Furthermore, dN/dS for somatic mtDNA
mutations in CTVT showed significant deviation from neutrality (namely dN/dS
<1) both for nonsense (0.187, p=1.02x10−07) and missense (0.748, p=4.18x10−03,) mu-
tations (Fig. 2.9).
These findings provide evidence for the activity of negative selection operating to
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Fig. 2.8. Cumulative variant allele fraction distribution functions for
gene-disrupting a. substitutions and b. indels. P-values were calculated using
two-sample Kolmogorov-Smirnov tests. Indel VAF values were normalised to take
account of host contamination. Figure adapted from Strakova et al. (2016).
Fig. 2.9. dN/dS for somatic nonsense and missense substitutions. P-values were
calculated using a likelihood ratio test with parameters estimated using a Poisson
model. Error bars indicate 95 percent confidence intervals. ** P<0.01, **** P<0.0001
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Fig. 2.10. Ancient mtDNA recombination in CTVT
a. Maximum likelihood phylogenetic trees constructed using clade 1 CTVT mtDNA
segments MT:1–5429 and MT:5430–16176. Three clade 1 mtDNA haplogroups are
represented by coloured dog silhouettes, and their geographical distributions are
colour-coded on the map. Bootstrap values were calculated from 100 iterations. See
Appendix 1: Supplementary file 2.14 for source data. b. Simplified haplotype
diagrams for clade 1 CTVT mtDNAs derived from groups shown in a. A1/A1c/A1e
dog haplotype represents the donor mtDNA that founded clade 1. The regions
putatively replaced by recombination is outlined with a grey box. Figure adapted
from Strakova et al. (2016).
prevent homoplasmy of deleterious coding variants and preserve mtDNA function
in CTVT. Together with evidence of reduced VAF for truncating mtDNA mutations
in human cancers (Ju et al., 2014; Stewart et al., 2015; Yuan et al., 2017), this suggests
that, in some cancers, functional mtDNA is required to drive cancer.
2.6.8 Ancient mtDNA recombination in CTVT
Given the opportunity for multiple distinct mtDNA haplotypes to coexist in CTVT
cells, we searched for evidence of mtDNA recombination in CTVT using the recombination-
detection algorithms 3seq (Boni et al., 2007) and SiScan (Gibbs et al., 2000). These
algorithms detected evidence for mtDNA recombination in CTVT clade 1, detecting
recombination breakpoints near positions MT:5430 and MT:16176. Maximum likeli-
hood phylogenetic trees constructed using segments MT:1–5429 and MT:5430–16176
derived from CTVT clade 1 mtDNAs showed distinct topologies (Fig. 2.10a). Fur-
ther inspection of clade 1 mtDNA haplotypes suggested that a recombination event
replaced MT:1–5429 in a clade 1 mtDNA haplotype (Fig. 2.10b) that diverged from
Central American clade 1 CTVTs and that subsequently colonised regions in South
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Fig. 2.11. Variant allele fraction plots illustrating mtDNA recombination in tumour
559T and showing a. the dog mtDNA haplotype (Host A1d1a_1) and CTVT clade 1
haplotype (CTVT_1B2b1_29) involved in recombination and b. the three most
common recombinant haplotypes present within the 559T mtDNA population,
inferred from the phasing of long-read data.
and Central America (Panama, Ecuador, Chile, Paraguay and Colombia). These data
provide evidence of an mtDNA recombination event in an ancestral CTVT lineage.
2.6.9 Recent mtDNA recombination in CTVT
Evidence of more recent mtDNA recombination was assessed by examining out-
liers on CTVT mtDNA phylogenetic trees. This analysis identified 559T, a CTVT
tumour derived from a male golden retriever in Nicaragua. Further investigation of
mtDNA in 559T revealed what appeared to be a CTVT clade 1 mtDNA haplotype
(CTVT_1B2b1_29) superimposed upon a dog mtDNA haplotype (A1d1a_1), neither
of which resembled the mtDNA haplotype found in normal tissues from the matched
host dog, 559H (B1_1 haplotype; Fig. 2.11).
Phasing of mtDNA variants in 559T using long sequence reads indicated the pres-
ence of at least three distinct mtDNA haplotypes in this tumour, each representing
a recombination product that appeared to be derived from mtDNA haplotypes
CTVT_1B2b1_29 and A1d1a_1. These data suggest that a tumour antecedent of 559T
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Fig. 2.12. Recent mtDNA recombination in CTVT
Recombination detected in CTVT sample 559T from Nicaragua. The estimated
percent contribution of each recombined haplotype to the mtDNA population
within 559T CTVT cells is shown, and grey shaded arrows indicate putative regions
of mtDNA recombination. Figure adapted from Strakova et al. (2016).
captured haplotype A1d1a_1 mtDNA from its host. Recombination was initiated
between mtDNA haplotypes CTVT_1B2b1_29 and A1d1a_1, and cells containing
these recombination products were passed to host 559H. Alternatively it is possible
that 559H received a mixture of both normal and CTVT cells from its CTVT donor
animal, and mtDNA capture and recombination occurred within 559H. It must also
be mentioned that the A1d1a_1 haplotype resembles the CTVT clade 3 donor hap-
lotype. The possibility that the recombination observed in sample 559T involved
horizontal transfer between CTVT clade 1 and clade 3 tumours that occurred within
the same animal cannot be excluded.
2.7 Results (Data Set 2)
In the second part, I present results from phylogeographic and recombination analy-
ses applied to an extended data set of 640 CTVT samples.
2.7.1 mtDNA recombination
A further instance of recent mtDNA recombination was identified in 1315T, a CTVT
tumour derived from a female dog in Granada, Nicaragua. The donor haplotypes ob-
served in 1315T were identical to the donor haplotypes described earlier in 559T (Sec-
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Fig. 2.13. Variant allele fraction plot for recombinant CTVT sample, 1315T.
MtDNA recombination in 1315T involved a dog mtDNA haplotype (Host A1d1a_1)
distinct from the 1315H matched host haplotype (A1a1a_28) and a CTVT clade 1
haplotype (CTVT_1B2b1_29). These are the same donor mtDNA haplotypes
observed in 559T.
tion 2.6.8): a likely CTVT clade 1 mtDNA haplotype (CTVT_1B2b1_29) interspersed
with a dog mtDNA haplotype (A1d1a_1), distinct from the mtDNA haplotype found
in normal tissues from the matched host dog, 1315H (A1a1a_28 haplotype).
2.7.2 Recent mtDNA horizontal transfer
Two samples out of 640 were identified in which a second horizontally transferred
host mtDNA haplotype could be detected. In sample 1281T, a third mtDNA hap-
lotype at ~34% from the B1 haplogroup (along with the tumour haplotype and
contaminating host mtDNA haplotype) was detected (Fig. 2.14). This is the first
horizontally transferred mtDNA not derived from the dog Clade A haplogroup. In
sample 349T2, a host A1a1a haplotype was detected at ~15% (Fig. 2.14).
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Fig. 2.14. Variant allele fraction plots for CTVT samples a. 1281T and b. 349T2 in
which three different mtDNA haplotypes were identified.
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Clade A1d1 horizontal
transfer group
Location Sample(s) Haplogroup
5 1 Ibadan, Nigeria 627T1, 628T1 A1d1
8 2 Corozal District, Belize 464T, 738T, 739T, 740T,
782T, 839T1, 1340T
A1d1a1
9 3 San Juan del Sur, Nicaragua 94T A1d1a
10 3 Granada, Nicaragua 559T, 1315T A1d1a
11 4 Granada, Nicaragua 540T, 550T, 551T, 555T,
564T, 572T, 1283T,
1284T, 1288T, 1290T,
1297T, 1298T, 1304T,
1311T
A1d1a1
12 5 Kombo, The Gambia 1172T A1d1a1
13 6 Grenada 342T A1d1a1
14 7 Asuncion, Paraguay 363T, 364T, 365T, 366T A1d1a
15 8 Jaipur, India 313T, 411T, 980T A1d1a
16 9 Los Andes, Chile 958T A1d1a1
17 10 Manizales, Colombia 1539T A1d1a
18 11 Manizales, Colombia 1353T A1d1a1
19 12 Mexico 369T* A1d1a1
Table 2.6 Summary of recurrent horizontal transfers of A1d mtDNA haplogroup
Individual horizontal transfer events were inferred based on comparison with the
nuclear CTVT phylogenetic tree. Sample 369T is marked with an asterisk as this
sample was not included in the exome sequencing sample set.
2.7.3 Recent and repeated horizontal transfer of a single mtDNA
haplotype
Comparison of CTVT phylogenetic trees generated using mitochondrial and nuclear
genomic data (Fig. 2.15) unexpectedly showed that CTVT clade 3 tumours were not
monophyletic, as was suggested during analysis of Data Set 1. Instead, nuclear data
implied that what appeared to be a single clade was in fact 13 independent horizontal
transfers involving the same mitochondrial donor haplogroup (A1d1). This is the
only instance observed so far in CTVT mitochondria where a specific haplogroup
has undergone repeated horizontal transfer.
2.7.4 Expanded CTVT phylogeny
Analysis of 640 complete CTVT mitogenomes confirmed the previous CTVT phylo-
genetic structure and revealed two new clades, 6 and 7, identified in Armenia and
Mexico, respectively (Fig. 2.15). To date, twenty horizontal transfer events involving
distinct mtDNA haplotypes have been detected in CTVT. In seventeen of these cases,
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Fig. 2.15. Schematic of maximum likelihood phylogenetic trees generated from a.
nuclear and b. mitochondrial CTVT sequence data. Phylogeny inferred from
whole-exome data was constructed by Adrian Baez-Ortega. Triangles, coloured
according to CTVT clade, represent the collapsed tree branches of phylogenetic
tumour groups. Each tip is a single tumour sample. Sample locations are labelled.
Numbers beside tumour groups count independent horizontal transfers of the A1d1
mtDNA haplogroup. An asterisk (*) is used to label the phylogenetic tumour group
made up of the samples with recombinant mtDNA, 559T and 1315T.
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Table 2.7 Estimated timing of clade divergence excluding potential somatic
mutations (CTVT clades 5-19)
Clade # somatic mutations (mean) Divergence times (ybp)
Nuclear
DNA
# cell divisions
(first stage)
# cell divisions
(second stage)
# mutations
per year
5 0.0 0.0 0.0 0.0 0.0
6 1 48.78 54.64 10.95 40
7 0.0 0.0 0.0 0.0 0.0
8 2.86 139.37 156.13 31.29 114.29
9 0 0.0 0.0 0.0 0.0
11 0.5 24.39 27.32 5.48 20
12 0.0 0.0 0.0 0.0 0.0
13 0.0 0.0 0.0 0.0 0.0
14 1.25 60.98 68.31 13.69 50
15 0.0 0.0 0.0 0.0 0.0
16 0.0 0.0 0.0 0.0 0.0
17 0.0 0.0 0.0 0.0 0.0
18 0.0 0.0 0.0 0.0 0.0
19 0.0 0.0 0.0 0.0 0.0
the captured mtDNA has become fixed: CTVT clades 1, 2, 4, 6, and 7 along with
12 independent captures of a specific A1d1 haplotype, while in three cases, 559T
and 1315T (Clade 10; Table 2.6), 1281T and 349T2, the mtDNA appears to have been
captured recently and has not become fixed. It is possible that mtDNA horizontal
transfer takes place in CTVT cells more frequently than estimated in this data set
but that the majority of these events do not result in the fixation of the transferred
mtDNAs and so, are not observed.
2.7.5 NuMTs
Analysis of germline NuMTs confirmed that NuMTs that form part of the CanFam3.1
assembly did not have an impact on the variant analysis performed in this chapter
(Section 2.4.15). The average MT genome coverage from this analysis was 0 (Fig. 2.16),
indicating that the NuMTs known to be present within CanFam3.1 are at insufficient
copy number and/or are too divergent to map to the MT reference genome using
the alignment parameters used in this chapter.
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Table 2.8 Estimated timing of clade divergence including potential somatic
mutations (CTVT Clades 5-19)
Clade # somatic mutations (mean) Divergence times (ybp)
Nuclear
DNA
# cell divisions
(first stage)
# cell divisions
(second stage)
# mutations
per year
5 10 0 0 0
6 11 48.78 54.64 10.95 40
7 0 0 0 0 0
8 2.86 139.37 156.13 31.29 114.29
9 4 195.12 218.58 43.81 160
11 0.5 24.39 27.32 5.48 20
12 1 48.78 54.64 10.95 40
13 1.0 48.78 54.64 10.95 40
14 2.25 109.76 122.95 24.64 90
15 0.67 32.52 36.43 7.30 26.67
16 5 243.90 273.22 54.76 200
17 0.0 0.0 0.0 0.0 0.0
18 0.0 0.0 0.0 0.0 0.0
19 1 48.78 54.64 10.95 40
Fig. 2.16. NuMT DNA sequence contribution
Sequence read depth across the MT genome for representative CTVT (146T) and
host (100H1) samples sequenced in this chapter to ~0.3× whole genome average
coverage. Sequence read depth for simulated reads from CanFam3.1 (excluding the
MT chromosome) is also shown in red; reads were simulated to ~0.3× whole
genome average coverage.
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2.8 Discussion
2.8.1 Horizontal mtDNA transfer in CTVT
Following previous work by Rebbeck et al. (2011), this analysis of CTVT mtDNA
shows that independent mtDNA horizontal transfer has occurred at least twenty
times, with eighteen of these transfers defining tumour clades whose global distribu-
tions track two millennia of CTVT spread and trace the movement of dogs around
the world.
Given the findings of this chapter, an interesting direction for future research would
be understanding the mechanisms underlying mitochondrial behaviour in CTVT.
In particular, an interesting direction for future work would be understanding the
mechanism of intercellular horizontal mtDNA transfer in CTVT and the molecular
signals driving this process. For example, it is not yet known whether naked mito-
chondria are transferred from host donor cells to recipient CTVT cells or whether
mtDNA is packaged within extracellular vesicles and transferred to CTVT cells along
with other host ’cargo’ (e.g. mRNA, proteins, lipids; Sansone et al. 2017).
2.8.2 Selection pressures in CTVT mitochondria
Negative selection has operated in CTVT to maintain mtDNA integrity by preventing
the accumulation of gene-disrupting (nonsense and missense) mutations in captured
mtDNA. This finding demonstrates that maintenance of functional mtDNA is impor-
tant for the biology of CTVT. This supports the importance of functional mtDNA
in cancer and reveals novel biological mechanisms that have operated in an ancient
mammalian somatic cell lineage.
Despite showing that negative selection operates in CTVT mitochondrial genomes,
our findings could also suggest that this activity is not sufficient to maintain func-
tional mtDNA over the course of thousands of years and, eventually, recruitment of
host mtDNA may provide a selective advantage to cells. This could explain why the
earliest mtDNA capture identified in this data set took place ~2,000 years ago, 9,000
years after the estimated emergence of CTVT (Murchison et al., 2014). However, the
possibility that mtDNA horizontal transfer may have taken place much earlier in
unsampled CTVT lineages cannot be excluded.
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2.8.3 Frequent horizontal transfer of a specific mtDNA haplotype
One of the most exciting results of this analysis is the finding of repeated and specific
mitochondrial uptake of a host mtDNA haplotype. It had previously been observed
that clade 3 tumours did not form a monophyletic group in the context of normal
dog haplotypes (Appendix 1: Supplementary file 2.12). However, this could be
explained if somatic mutations arising in clade 3 samples occurred at sites also found
in germline haplotypes closely related to the clade 3 donor haplotype. This seemed
plausible given that we found germline and somatic mtDNA mutational processes
are equivalent (Section 2.6.2) and clade 3 was initially interpreted as a single clonal
lineage.
Instead, nuclear data has indicated repeated horizontal transfer of mtDNA from a
specific dog mtDNA haplogroup. A number of different hypotheses could explain
this observation. It could indicate that A1d1 mtDNA haplotypes are recruited by
CTVT cells via horizontal transfer more frequently than other haplotypes. It is also
possible that horizontal transfer of mtDNA occurs frequently in CTVT and all dog
mitotypes are equally likely to undergo horizontal transfer. However, the majority of
transferred mtDNAs and do not persist. A1d1 mtDNA haplotypes might possess a
proliferative or survival advantage and become fixed in the mitochondrial population.
To study the timing of the newly detected horizonal transfer events we again esti-
mated the number of somatic mtDNA mutations accumulated by each clade since
host mtDNA uptake. This analysis revealed that mtDNA derived from horizontal
transfers involving A1d1 haplotypes (clades 5, 8-19) carry few somatic mutations
(Tables 2.7 and 2.8) and all A1d1 horizontal transfers occurred relatively recently,
most within the last decades (Tables 2.7 and 2.8).
Given that CTVT has been routinely treated with vincristine sulphate, a cytotoxic
microtubule inhibitor, since the 1980s (Amber et al., 1990; Section 1.2.1.4) and the ev-
idence that chemotherapeutic agents can enhance mitochondrial horizontal transfer
in vitro (Moschoi et al.,2016; Section 2.3.5), combined with the recent and repeated
recruitment of A1d1 mtDNA haplotypes from host cells, it is worth considering
what role chemotherapy related effects might play in this phenomenon. For one, it
could be that A1d1 haplotypes specifically are more likely than other haplotypes to
undergo horizontal transfer when CTVT is exposed to chemotherapy. Alternatively,
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chemotherapy treatment could increase the opportunity of horizonal transfer for
all mtDNA haplotypes but A1d1 haplotypes may have a selective advantage over
incumbent CTVT mtDNA haplotypes. Another hypothesis would be that vincristine
does not make a difference to the rate of horizontal transfer in CTVT cells but that
after uptake, A1d1 haplotypes are more like to persist in vincristine exposed CTVT
cells. However, testing these hypotheses is beyond the scope of the present disserta-
tion.
Lastly, the observation of multiple mtDNA horizontal transfer events in Data Set
1 at first suggested that mtDNA capture from hosts might be a positively selected
adaptive mechanism (Spees et al., 2006; Tan et al., 2015) and that capture of host
mitochondria could offer a fitness advantage to the cell (Rebbeck et al., 2009). How-
ever, we cannot exclude the possibility that the acquired mtDNA haplotypes became
homoplasmic as a result of selfish advantage, e.g. increased replicative efficiency
relative to other haplotypes, which might not be of benefit to the CTVT cell or that
CTVT cells have simply acquired host mtDNA via drift.
2.8.4 mtDNA Recombination
Ancient mtDNA recombination occurred in a clade 1 mitotype that subsequently
colonised the Pacific coast of South America and there is evidence for the occurrence
of complex, recent recombination in at least two tumours, possibly to repair damaged
mtDNA. Further studies might explore the extent of mtDNA recombination on a
wider scale in CTVT and in cancer in general, including human cancers.
Two tumour samples were identified in which A1d1a and CTVT_1B2b1_29 hap-
lotypes have undergone recombination. The most likely explanation for these data
is that a tumour antecedent of 559T and 1315T captured an A1d1a_1 mtDNA hap-
lotype from its host. Recombination was initiated between mtDNA haplotypes
CTVT_1B2b1_29 and A1d1a_1, and cells containing these recombination products
were passed to hosts 559H and 1315H. Less plausible scenarios are that
(i) Both 1315H and 559H received a mixture of normal and CTVT cells from the
same CTVT donor animal; mtDNA capture and recombination was initiated
independently within both 559H and 1315H.
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(ii) Both 559H and 1315H were co-infected with CTVT clade 1 and clade 3 tumours;
the observed recombination in samples 559T and 1315T resulted from horizontal
transfer between these clade 1 and clade 3 mtDNAs.
(iii) Dog 1315H was directly infected with tumour cells from dog 559H; a fraction
of cells from 559T carrying mtDNA recombination products not detected or
sampled in this study were transmitted and seeded 1315T.
(iv) Dog 559H was directly infected with tumour cells from dog 1315H; a fraction
of cells from 1315T carrying mtDNA recombination products not detected or
sampled in this study were transmitted and seeded 559T.
The latter two scenarios are unlikely given that clinical records show dog 559H was
neutered at the time of sampling (July 2013) and so, is unlikely to have mated suc-
cessfully with 1315H subsequent to that.
At the time of sampling (March 2015), dog 1315H’s tumour was roughly 4 inches
in size. Unless there is a large variation in tumour growth rates, tumour 1315T is
unlikely to have resulted from an infection >2 years prior. Given this time frame,
1315T is unlikely have resulted from direct infection by cells from 559T and unlikely
to have caused tumour 559T by direct transmission of cells from 1315T.
Although there was no evidence of mtDNA recombination in CTVT beyond that
described, it cannot be excluded that recombination is more widespread in CTVT
mtDNA than detected. It is possible, therefore, that the phylogenetic, mutation
rate and selection analyses presented in this chapter have been influenced by an
undetected recombination signal. However, the following observations suggest that
if such a signal is present in this data set, it is at a low level:
(i) the presence of a set of clade-specific markers in all non-recombining CTVT
mtDNAs,
(ii) the absence of distinctive phylogenetic outliers (beyond 559T and 1315T),
(iii) the very low frequency of back-mutation,
(iv) the strong somatic signal identified in the CTVT mtDNA mutational spectrum,
and
(v) the failure of recombination-detection algorithms to detect further recombina-
tion.
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Detection of mtDNA recombination in ordinary cancers using the approaches de-
scribed in this chapter poses significant challenges; clonal inheritance of mitochondria
means that most recombination events would be ’silenced’ by a lack of biomarkers
allowing different MT molecules to be distinguished.
The mechanism by which different mtDNA molecules are able to interact within
the cell and the nature of the signals that trigger onset of mtDNA recombination
remains unclear. It is interesting to observe that a truncating nonsense mutation in
COX3 (9064 G>A) was found in some of the recombinant 559T haplotypes (Fig. 2.12).
Further analysis may determine if DNA damage signalling is involved, as previously
suggested (Thyagarajan et al., 1996). Many intriguing open questions remain includ-
ing whether mtDNA recombination in CTVT occurs sporadically or is triggered,
whether mtDNA recombination be triggered by mitochondrial diversity within the
cell.
2.8.5 NuMTs
While it has been shown that NuMTs present in the CanFam3.1 assembly are unlikely
to have impacted the mutation calling performed in this chapter (Section 2.7.5), it
remains possible that NuMTs not captured in the assembly could confound the
variant analysis. The following observations argue against the possibility that NuMT-
derived variants have had a significant impact on tumour variant calling:
(i) CTVT is a clonal lineage, therefore somatically acquired NuMT-derived variants
would be expected to appear as low level heteroplasmic variants across all
tumours within a phylogenetic group; variants with these features were not
observed,
(ii) The mutation spectrum observed in CTVT mtDNA has the distinctive pro-
file characteristic of the known somatic mtDNA mutational process (Ju et al.,
2014). As this mutational process is specific to cytoplasmic mtDNA, this find-
ing suggests that the majority of variants within the somatic variant set are of
cytoplasmic origin.
In addition, I have not directly assessed the presence or frequency of mitochondrial-
nuclear DNA fusions in CTVT. The observation of mtDNA horizontal transfer and
recombination implies the movement of mtDNA within intracellular and/or extra-
cellular compartments; this could allow for a high frequency of contact between
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mitochondrial and nuclear DNA. A recent study by Ju et al. (2015) observed that
nuclear transfer of mtDNA is unexpectedly frequent in human somatic cells. Alto-
gether, it is likely that novel NuMTs, which diverge from those in the canine genome,
have been introduced into the CTVT genome.
One interesting possibility for future analysis would be assessing the presence and
frequency of somatic NuMTs in the CTVT genome. Some of these mito-nucear fusion
events may have taken place early in CTVT’s evolutionary history, even before the
earliest mtDNA horizontal transfer event ~2,000 years ago, and involved the nuclear
capture of ancient mitochondrial dog haplotypes.
2.8.6 Summary
The ability of CTVT cells to uptake mitochondria from host stromal cells represents
an emerging paradigm of cell-to-cell signalling in cancer. All cancers manipulate
their host environment, but transmissible cancers, and in particular CTVT, have had
much more time to do this. Recombination and horizontal mtDNA transfer may be
considered as specialised adaptations that have helped CTVT co-opt its host niche
and one of the ways in which this tumour manipulates its host. On the whole, the
findings in this chapter show how CTVT‘s metastatic spread through a global host
population can provide unique insights into evolutionary processes operating in
cancer.
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Chapter 3
Reconstructing the spatiotemporal origin of CTVT using ancient
and modern genomes
3.1 Chapter abstract
CTVT has persisted in the dog population for thousands of years and first arose in
an ancient population of dogs (Murchison et al., 2014; Murgia et al., 2006; Rebbeck
et al., 2009). Genome-wide and SNP-base analyses of germline variation in the CTVT
genome showed that the founder’s closest modern relatives are the Arctic spitz
breeds, such as Alaskan malamutes and huskies (Decker et al., 2015; Murchison et al.,
2014). Analysis of two CTVT whole-genomes also suggested that the disease is likely
to have arisen in a genetically isolated population of early dogs (Murchison et al.,
2014). The mitochondrial CTVT phylogeny, described in Chapter 2, supports a model
whereby CTVT originated in Central or Northern Asia. The goal of this chapter was
to consolidate these findings and to further define the ancestry and origin of the
CTVT founder animal as well as the timing of CTVT emergence.
Each CTVT tumour contains a living ancient genome: the long-dead CTVT founder
dog’s DNA has been preserved largely intact through the millennia by the cancer that
its somatic cells spawned. Moreover, a recent boom in ancient sequencing studies
has made the first genome-scale ancient canid DNA data sets available (Botigué et al.,
2017; Frantz et al., 2016; Skoglund et al., 2015)and this prompted us to consider a
new approach to uncovering the origin of CTVT: paleogenomics. This idea lead
to a collaborative project with Greger Larson’s lab at the Research Laboratory for
Archaeology and History of Art (University of Oxford) and led by Laurent Frantz on
the ancient DNA side. Initially, this study was directed at identifying the ancient
ancestry of the CTVT founder individual; however, our findings provoked further
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questions about the ancestral population of dogs to which the founder individual
belonged and the scope of the work changed to address these questions (Section 3.3.4).
We sequenced 71 mitochondrial and 7 nuclear genomes from ancient North Ameri-
can and Siberian dog remains from time frames spanning ~9,000 years. This revealed
that the CTVT founder was closely related to a population of pre-contact dogs (PCD)
that were once widespread across North America and present in the Americas prior
to arrival of European colonists. Analysis showed that this dog population were not
derived from North American wolves but were, instead, the descendants of early
Asian dogs introduced to the Americas during human migrations between 17,000
and 13,000 years ago. This dog population remained in North America until its
almost complete disappearance following the arrival of Europeans, with minimal
genetic contribution from pre-contact dogs observed in modern dog populations.
Surprisingly, this implies the closest extant vestige of native American dogs is the
canine transmissible venereal tumour.
Finally, in order to estimate CTVT’s temporal origin, we sequenced the genomes of
two CTVT tumours obtained from a non-experimental direct transmission and used
these to calibrate a tumour specific mutation rate. I estimated that the CTVT founder
dog lived up to 8,225 years ago, a time frame compatible with the possibility that
CTVT arose in a dog population in North America.
Overall, this chapter provides new insights into when and where one of the oldest
known cancers first appeared along with answering broader questions about the
past population dynamics of early dogs.
3.2 Publications associated with Chapter 3
The majority of the results and analyses of this chapter were published as a Report
in Science on the 6th July 2018, of which I am co-first author along with Angela Perri,
Evan-Irving Pease, Kelsey Witt and Anna Linderholm (Ní Leathlobhair et al. (2018);
see Appendix 2 for the complete reference).
The somatic variation analysis presented in Section 3.10 formed the basis of a Poisson
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Bayesian model estimation of the CTVT time-of-origin reported in Baez-Ortega et al.
(2018), currently under review (see Appendix 2 for the complete reference).
3.3 Introduction
While the focus of this thesis up until now has been CTVT, in this chapter we shift
focus somewhat in order to address questions related to the host population in
which CTVT first established its parasitic niche. Here, I will introduce findings that
contextualise results presented later in this chapter related to the initial CTVT host
population. Since I will later demonstrate that dogs were not domesticated in the New
World, I first raise the issue of the timing of human migrations in the Americas since
people were likely responsible for the introduction of dogs. I then give a brief synopsis
of the history of dogs and other canids in the Americas and summarise relevant
methods that can be applied to genetic data for analysing population histories. I
wrap up the introduction by setting out the research questions I sought to answer in
this chapter.
3.3.1 Human migrations in the Americas
The Americas were the last of the inhabited continents to be populated. The most
recent findings suggest a four wave population model of migrations from Asia
(Skoglund and Reich, 2016). Over 15,000 years ago, an ice free corridor opened up
between the Cordilleran and Laurentide ice sheets and a substructured population
entered the Americas from Beringia via a Pacific coastal route with the majority
of modern Native American groups tracing their ancestry to this ’First American’
population. This population seems to have spread rapidly and colonised most of both
North and South America. Archaeological and genetic evidence suggest that people
colonised Arctic regions of the Americas at least twice over the last 6,000 years during
two major post-glacial migrations, staring with the Paleo-eskimo migration, reaching
as far as Greenland ~4,500 BP. The Paleo-eskimo population was almost entirely
replaced by an expansion of the direct ancestors of modern day Inuit populations
(Raghavan et al., 2014), the Thule people ~1,000 years ago. Entry into the Americas is
associated with a genetic bottleneck, such that modern Native American populations
have the lowest levels of genetic diversity of any continental group (Wang et al.,
2007).
92
3.3.2 Dogs in the Americas and Arctic
The earliest confirmed evidence of dogs in North America appears roughly 4,500
years after the first evidence of human activity on the continent (Goebel et al., 2008;
Jakobsson et al., 2017). In Central and South America, the earliest dog remains appear
in Mexico at around 3,200 BC (Mitchell, 2015) and in Ecuador between 3,000 and
2,500 BC (Stahl, 1985), thousands of years after the first evidence of humans ~14
thousand years ago (kya) (Dillehay and Collins, 1988). Previous studies have sug-
gested that early dogs present in the Americas before European contact (pre-contact
dogs) were transported by humans migrating from Asia (Leonard et al., 2002; van
Asch et al., 2013) while others suggest these dogs were independently derived in situ
from American wolves (Koop et al., 2000; Witt et al., 2015). Evidence suggests that
dogs played a number of functional roles in early American cultures in fending off
predators and hauling goods and people, in addition to being a source of fur and
food. In fact, prior to the recent direct radiocarbon dating of the oldest dog remains
in the Americas (Perri et al., 2018), the earliest evidence for dogs came from occipital
bones (9,260 cal BP) preserved in a human coprolite (Tito et al., 2011).
By the time of European contact, dogs were widespread in the Americas and early
European settlers described indigenous dogs as diverse in appearance and pervasive
throughout the continent (Ubelaker and Sturtevant, 2007). Studies of the mitochon-
drial DNA control region suggest that the pre-contact American dog population
was largely replaced following the arrival of European dogs after colonisation and
the introduction of Eurasian Arctic dogs, such as Siberian huskies, during the 19th
century Klondike Gold Rush (Brown et al., 2015; Castroviejo-Fisher et al., 2011; Witt
et al., 2015) but the fate of these pre-contact dogs remains largely unknown. It has
been suggested that some modern dogs in the Americas may retain a degree of
ancestry from the pre-contact population including the Carolina dog, chihuahua,
and Mexican and Peruvian hairless dogs (Shannon et al., 2015; van Asch et al., 2013).
This suggestion remained controversial, however, since the nuclear ancestry of pre-
contact American dogs had not been established.
Arctic dogs represent a highly genetically divergent, basal lineage of modern dogs
(Larson et al., 2012; Vonholdt et al., 2010). It is suggested that they are likely to have
undergone recent admixture with wild canids, given their close proximity to exten-
sive wolf and coyote populations (Vonholdt et al., 2010; Wang et al., 2016). Modern
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high-latitude dog breeds, like the Greenland sledge dog and Siberian husky, show
evidence of introgression from a 35,000 year old wolf from the Taimyr Peninsula in
Northern Siberia (Skoglund et al., 2015). Malamutes, Greenland dogs and huskies
also show strong signals of admixture with Eurasian dogs, in particular with East
Asian lineages (Frantz et al., 2016; Wang et al., 2016). It has previously been suggested
that this is due to several waves of dogs migrations to the Americas alongside human
colonisers at different time periods (Wang et al., 2016).
3.3.3 Inferring population histories from genetic data
A number of different tests are applied to genetic data sets in this chapter in order
to analyse the population history of the CTVT founder alongside early dogs in the
Americas, and so a brief overview of these methods is in order. The majority of
the methods used are based on allele frequencies at variant sites and the general
assumption that similar allele frequencies indicate that individuals or populations
have a shared ancestry. For example, principal component analysis (PCA), based
on this assumption, allows unsupervised clustering of individuals based on their
ancestry (Patterson et al., 2006). Model-based clustering methods implemented in
STRUCTURE (Hubisz et al., 2009) and ADMIXTURE (Alexander et al., 2009) are
commonly used approaches that assign individual ancestry based on a specified
number of ancestral components.
Allele frequency differentiation statistics (f -statistics; Green et al., 2010), comprising
the f2, f3 and f4 statistics, and a statistic very similar to the four-population test
known as the D-statistic (Patterson et al., 2012), are a standard means of describing
patterns of allele frequency correlations across populations. It is worth nothing that
at various points throughout this chapter, the D-statistic is also referred to as the
ABBA BABA test. Here ’A’ is the ancestral allele and ’B’ is the derived allele; ’ABBA’
and ’BABA’ refer to genotype patterns. The three and four-population tests can be
used as formal tests of admixture and, in the case of the f4 or D-statistic tests, provide
information about the directionality of gene flow. These methods can be applied
to most genetic data, as they rely only on information about the allele frequencies
observed in populations, without any marked constraints on the density or number
of markers, excepting that markers are not in strong linkage disequilibrium. Various
other methods, such as PCAdmix (Brisbin et al., 2012) and HAPMIX can additionally
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make use of genetic linkage information to identify the ancestry of chromosomal
segments from individuals in admixed populations. However, these haplotype based
methods require phased data and, in order to exploit linkage information, haplotype-
based inference methods also require a high density of variants, such as that obtained
by whole-genome sequencing or high-density genotyping arrays.
3.3.4 Summary
The primary aim of this chapter was an understanding of the dog population to
which the CTVT founder belonged. To begin with, the study was motivated by the
following questions:
(i) What is the likely geographic origin of CTVT?
(ii) What is the temporal origin of CTVT?
(iii) Which ancient or modern dog population is the CTVT founder most closely
related to?
The discovery of a genetic affinity between the CTVT founder and native American
dogs lead to more detailed questions regarding the inceptive host population:
(i) What is the origin of pre-contact dogs?
(ii) What was the fate of pre-contact dogs?
(iii) What is the genetic contribution of pre-contact dogs to modern dog popula-
tions?
(iv) How are pre-contact dogs related to other ancient and modern dog populations?
(v) Previous studies have divided modern dog populations into two "core" groups
of East Asian and West Eurasian dog groups; where do pre-contact dogs fit in?
(vi) What was the interaction between pre-contact dogs and other canid populations
in the Americas?
A large part of this chapter is centred on the above questions related to the enigmatic
pre-contact American dog population.
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3.4 Methods
3.4.1 Archaeological background
This section presents site descriptions for all ancient dog samples sequenced in this
study. Archaeological site descriptions were provided by Angela Perri and Carly
Ameen and I have adapted these for this chapter. Morphological descriptions of
canid remains as well as the historical details provided give a necessary and relevant
context for interpretation of the genetic analyses that follow. Study sample numbers
appear in parentheses. The nomenclature ‘Canis spp.’ is used to refer to two or more
unspecified species of the genus Canis.
3.4.1.1 USA
Cox, Alabama (Cox6)
The Cox mound site is located in Jackson County, Alabama and dates to the Middle
Woodland period (AD 1-500) (Moore, 1915). Multiple dogs have been recovered
from the site, one of which is included in this analysis.
Flint River, Alabama (FR11)
The Flint River site was a village with a large circular shell mound (2 m tall, 15 m in
diameter) located on the Flint River near Courtland, Alabama (Moore, 1915). Over
200 human burials have been recovered from the site, as well as 19 dog burials (Webb
and DeJarnette, 1948a). Dogs were interred throughout the period of occupation,
and did not share graves with humans. The dog analysed in this study may be Late
Archaic or Mississippian (Warren, 2004).
Little Bear, Alabama (LB2)
The Little Bear Creek site is an Archaic shell mound located at the mouth of the
Little Bear Creek, in Colbert County, Alabama (Webb and DeJarnette, 1948b). Dog
remains recovered from this site were all dated to the Late Archaic period, and were
deliberately buried in the mound, similar to human interments, however dogs and
humans were not found buried together at this site (Barkalow, 1972).
Perry, Alabama (P35, P59)
The Perry site is a large shell mound located in northern Alabama, on the Tennessee
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River (Webb and DeJarnette, 1948c). The shell mound contains hundreds of human
burials that have been dated to the middle Archaic to Mississippian periods, based
on the artefacts present with the burials, as well as a large assemblage of stone tools
(Futato, 2002). Over 100 dogs have also been buried in the shell mound, some of
them with humans. The age of these dog burials is largely unknown, as the majority
of the dogs were buried without associated grave goods.
Channel Islands, California (CINHA, CINH7, CIAS, CICVD, CAW2, CAO1)
The Channel Islands are located in the Pacific Ocean, off the coast of southern Califor-
nia, and have been occupied for 13,000 years (Rick et al., 2005). Dogs have lived on the
islands for at least 6,000 years, and were almost certainly introduced by humans (Rick
et al., 2008). They were likely not used as hunters, but may have been an occasional
food source, and were found on all of the Channel Islands. Six individuals from two
islands, as well as one mainland archaeological site, were included in this study. Two
dogs were recovered from Santa Cruz Island (CAW2, CAO1), one from the Orizaba
Cove area that dates to the Late Holocene, and the other from Willows Canyon. Two
dogs are from the North Head site on San Nicolas Island (CINH4, CINH7), which
was occupied during the Terminal Early Period (5,000 BP) and the Middle Period
(2,000 BP). One dog derives from Santa Rosa Island (CICVD), at the Canada Verde
site, which dates to the terminal Early Period (4,000 BP). The dog from the mainland
site (CIAS) was recovered from the coastal Chumash town of Syuxtun (now a part of
modern-day Santa Barbara).
Grass Mesa, Colorado (5MT316)
Grass Mesa Village was a large village located east of the Dolores River in Colorado
(Lipe et al., 1988). It was occupied from AD 700 until roughly AD 900, and has one
of the highest artefact densities of any archaeological site in the Mesa Verde region.
The majority of faunal remains from the site were of multiple species of deer and
rabbits, although there were also small numbers of dog and unidentifiable Canis
spp. bones.
McPhee Pueblo, Colorado (5MT520)
McPhee Pueblo was part of McPhee Village, which is located 6 km northwest of Do-
lores, Colorado (Kane and Robinson, 1988). It was occupied for 200 years during the
Pueblo I and II periods (roughly AD 800-980). Over 200 bones have been recovered
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from the site that are identified as Canis spp., including coyotes, wolves, and dogs.
Yellow Jacket Pueblo, Colorado (5MT501)
Yellow Jacket Pueblo was a large village in the Central Mesa Verde located near
modern-day Cortez, Colorado. Yellow Jacket was occupied during the Late Pueblo II
through the Pueblo III periods (~AD 1050-1260) (Kuckelman, 2013). A small number
of canid remains were identified at the site, including one bone that was specifically
identified as belonging to a dog. Some of the canid bones show evidence of burning
or cut marks, suggesting that these dogs were used as food.
Baum, Ohio (AL2748)
The Baum site is a prehistoric village settlement in Paint Creek River Valley, Ohio.
This is the type site for the Baum Phase of the Fort Ancient culture, dating between
AD 950-1200 (Hart and Rieth, 2002; Trigger and Sturtevant, 1978). Abundant, well
preserved faunal remains were found at the site within refuse pits, and remains of
dogs were found ubiquitously throughout the village. These remains were described
as belonging to Indian dogs of a size and proportion similar to the bull terrier (Mills,
1906). A total of 50 dog remains, including 7 crania, were collected. All crania col-
lected were broken; it has been suggested that this was done in order to remove the
brain (Mills, 1906). Comparisons with other prehistoric dogs suggest these were of
the general Indian dog type found at contemporary sites in the region, as well as at
prehistoric sites in Texas (Mills, 1906).
While individual dog burials and associated ritual activity are known from contem-
porary sites (Morey, 2006; Nolan and Sciulli, 2014), the evidence from Baum suggests
these dogs played a more domestic role. The breakage of dog bones, similar to other
food animals, indicates that at least on some occasions dogs were used as food. Gnaw
marks from dogs on other animal bones found throughout the middens suggests that
dogs had access to food waste. Unlike earlier Archaic period sites where dogs were
regularly afforded special treatment indicated by their careful burial, later prehistoric
dogs from Baum appear to have been a utilitarian presence at the site, likely similar to
modern feral or village dogs, with deposition predominantly occurring in refuse pits.
Reinhardt, Ohio (AL2772)
The Reinhardt site is a Fort Ancient village site in the Scioto Valley, Ohio (Nolan,
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2009, 2011). Associated AMS dates from wood, charcoal and a single human burial
support the dating of the site to within the Middle Fort Ancient period (AD 1200-
1400) (Nolan, 2011), though bifaces from at least four earlier time periods have been
recovered at the site.
Excavations in 2008 revealed a small number of canid remains, including two in-
dividual dog burials (Nolan, 2009; Nolan and Sciulli, 2014). The specimen in this
study is from a fully articulated, adult, male dog with heavily worn teeth, that was
found buried under a layer of sand with a turkey bone awl (Nolan, 2009). Significant
pathologies to the dog were observed, including vertebral pathologies representing
either severe arthritis, or a healed infection, and an abscess in the right M2 (Nolan
and Sciulli, 2014). Analysis of dog burials at the Reinhardt site showed significant
variation between dogs (Nolan and Sciulli, 2014). Comparisons with other dogs
from the region indicate little change in morphology between the Archaic and later
prehistoric periods, despite intense changes in subsistence patterns and lifestyle
(Nolan and Cook, 2010; Nolan and Sciulli, 2014).
Dogs in this region were known to serve a variety of purposes, such as for trans-
portation, hunting, companionship and as a food source. Dogs also participated in
ceremonial and ritual activity, and dog sacrifices were not uncommon (Cook, 2012;
Kerber, 1997; Morey, 2006). The individual burial of dogs at Reinhardt suggests
a level of affinity remained between the Fort Ancient people and at least some of
their dogs, though isolated dog remains found throughout the site suggests that this
intimacy was not afforded to all dogs equally.
Scioto Caverns, Ohio (OSU611, OSU622, OSU624, OSU626, OSU628, OSU634, OSU638)
The Scioto Caverns sites in Ohio are a series of three limestone caverns located near
the Scioto River and Wright-Holder earthworks complex (Potter and Baby, 1964).
The bones of 25 dogs have been recovered from this deposit, including 5 nearly-
complete skulls and 11 mandibles. The dogs are likely from the Middle Woodland
or Hopewellian period, based on the nature of their burial. Based on their size, the
dogs appear similar to Archaic dogs identified from Kentucky and Alabama, and
are smaller than Woodland period dogs from the Midwest.
Apple Creek, Illinois (ISM070)
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The Apple Creek site is a Woodland village on the north bank of Apple Creek, four
miles north of Eldred, Illinois (Parmalee et al., 1972). Seven dog burials have been
recovered from the site, as well as some additional isolated elements, which show
evidence of consumption. The dog burials likely date from the Middle or Late Wood-
land periods (2,000-1,000 BP). The dogs are all terrier-sized, which is smaller on
average than most other Woodland period dogs. The dog used in this analysis was a
small, mature, male dog with more tooth wear on the right side of the maxilla and
mandible than the left.
Koster, Illinois (AL2135)
The Koster site is a complex, highly-stratified site located in a tributary valley of
the lower Illinois River in west-central Illinois (Butzer, 1978; Chapman et al., 1981;
Hajic, 1990; Houart, 1971). Cultural deposits dating from the early Archaic through
Mississippian periods were buried to depths of over 10m, providing a continuous
record of Holocene human occupation in the region (Brown and Vierra, 1983).
Excavators uncovered the burial of four dogs, found as complete, articulated skele-
tons in shallow pits (Hill, 1972; Morey and Wiant, 1992). At the time of excavation
the dogs were dated based on associated material to around 8,500 years ago. Recent
direct dating of two of the Koster dog burials dated them to between 10,130-9,680 cal
BP respectively (Perri et al., 2018), making them among the earliest dated material
from Koster, the earliest identified dogs in the Americas and the earliest dog burials
in the world (Fig. 3.1).
The specimen included in this study (AL2135) was found in a shallow, basin-shaped
pit with a metate and mano placed near its cranium, though it is not clear whether
this is associated with the burial. The skeleton is complete and the animal was
buried lying on its side, with no evidence of intentional cut marks or other trauma.
Given the presence of preserved bacula in the other dogs, the missing baculum here
suggests the dog was a female, and that it was an adult (Morey and Wiant, 1992).
Morphological comparisons of Koster canids with modern and ancient wolves and
coyotes suggested them to be domesticated dogs, based on their small size (Morey
and Wiant, 1992). In particular, a wide palate and cranial vault, distinguishing this
specimen from coyotes of a similar size, was noted.
100
Janey B. Goode, Illinois (JBG1m, JBG5, JBG11, JBG12, JBG13, JBG17, JBG19, JBG21,
JBG24, JBG26, JBG32, JBG35, JBG37, JBG41, JBG42, JBG43, JBG45, JBG48, JBG50)
The Janey B. Goode site is a settlement near Brooklyn, Illinois, that was occupied
from AD 650-1400. Janey B. Goode has one of the largest numbers of dog burials
of any archaeological site: dogs have been recovered from 102 different features
(Borgic and Galloy, 2004). The majority of these dogs have been recovered from
the Terminal Late Woodland component (AD 650-900). Many of these dogs were
recovered as complete skeletons, and were found in storage pits or buried under-
neath settlement structures. Cut marks on a Mississippian dog indicate that dogs
may have been consumed during this period; dogs from the Late Woodland and
Terminal Late Woodland periods show no evidence of consumption, but instead
have vertebral fractures, which may be suggestive of their use as pack animals prior
to the Mississippian period.
Modoc, Illinois (AL2706)
The Modoc Rock Shelter, located 2 miles south east of Prairie du Rocher, Illinois, is
one of the earliest sites of human occupation in Illinois (Fowler, 1959). The lowest
strata has been dated to 11,000-9,000 BP, and the site was occupied for 6,000 years.
Post moulds have been identified starting at 8,000 BP, along with six human burials,
but there is no trace of human occupation after 4,000 BP. Two complete dog burials
were recovered from the same strata as the human burials, one of which is included
in this study (Fowler, 1959).
Angel Mounds, Indiana (AM310A, AM310B, AM310C, AM474)
Angel Mounds is located along the Ohio River east of Evansville, Indiana. Site con-
struction began just before AD 1050 and continued through AD 1450 with the primary
occupation occurring during the Late Mississippian period between AD 1350-1450
(Monaghan and Peebles, 2010).Several dog burials and dog skulls are recorded at
Angel Mounds. Of the four dog burials listed in the Angel Mounds catalogue, only
one contains an articulated dog skeleton that can be considered as an intentional and
undisturbed dog burial (AM310A). There are also the remains of two dogs (which
are mixed in the same context) recorded as “dog burial”, AM310B and AM310C,
including a large dog’s limb bones and postcranial elements as well as a smaller
dog’s cranial and mandibular fragments (partially burned). These second and third
“burials” consist of several disarticulated bone fragments representing incomplete
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remains, and do not have any hand-drawn or photographed in situ representations
associated with them. AM310B and AM310C come from the same excavation block
as the articulated dog and AM474. Materials associated with AM474 include the
cranium of an average-sized Mississippian dog, without mandibles or postcranial
elements.
Simonsen Bison Kill, Iowa (ISM172)
The Simonsen site is located in northwest Iowa, near Quimby, and its usage dates to
the Paleoindian and Archaic periods (Frankforter and Agogino, 1960). It has been
suggested to be a bison kill site, given that the majority of remains at the site are
of bison (Agogino and Frankforter, 1960). The highest zone at the site contained
charred wood and ash suggestive of a firepit, as well as the ramus of a large dog,
which was included in this analysis.
Weyanoke Old Town, Virginia (AL3226, AL3223)
The Weyanoke Old Town site, or Hatch site, is located on a tributary of the James
River on the coastal plain southeast of Richmond, Virginia and covers over 4,329
sq. metres (Buck, 2000). Based on associated artefacts, occupation at the site spans
from at least the early Archaic through the early English Colonial period, when the
Virginia Algonquians occupied the region (Gregory, 1980). The site was home to
a Weyanoke (Weanoc tribe) village dating from the prehistoric through the early
Colonial period (McCary, 1995).
Over 112 domestic dogs have been recovered from the site, one of the largest dis-
coveries of domestic dogs in the Americas (Buck, 2000; Kerber, 1997). The dog was
the only domesticated animal of the Virginia Algonquians (Robinson and Rountree,
1991). There is no evidence that dogs at Weyanoke were used for food, as all dogs
were recovered in isolated and associated burials, articulated with no evidence of cut
marks or burning (Buck, 2000). Dogs of the Virginia Algonquians are documented
partaking in small and large game hunting and as protection from predators like
wolves and bears (Trigger and Sturtevant, 1978). Like other regions of the Midconti-
nent and Eastern Woodlands (Strong, 1985), dogs played an important role in burial
with humans at Weyanoke. It is unclear whether dogs at Weyanoke were viewed as
companions, ritual offerings, or both, but dog sacrifices were not uncommon among
contact-period tribes (Wallis, 1955).
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Descriptions of the Virginian native dog often mention a wolf-like (Harriot, 1588;
Smith, 1632) or fox-like (Brereton and Haies, 1602) appearance with an inability to
bark and a propensity for howling. In an analysis of the Weyanoke Old Town skeletal
material, Blick (Blick, 1988) noted the dogs there are clearly domesticated and not
wolf-like in their cranial and postcranial skeletal morphology. He later proposed
that admixture between local wolves and aboriginal dogs may explain the reported
“wolf-like” behaviour and appearance of Algonquian dogs (Buck, 2000). They stood
an average of 42 cm high and weighed approximately 10kg, similar to a medium-
sized Algonquian native village dog depicted in a 1585 painting by John White
(Hulton, 1984). This painting, the earliest depiction of a Native American dog by a
European, shows a knee-height, medium-sized yellow-brown dog with pricked ears
and a long tail, similar to many modern village dogs or dingoes. In contrast to this,
in 1602, John Brereton described dogs in coastal Massachusetts as “fox-like, black,
and sharp-nosed” (Brereton and Haies, 1602). The Weyanoke canids are associated
with Late Woodland period artefacts, confirming their native ancestry and lack of
inbreeding with later introduced European breeds. This is supported by direct ra-
diocarbon dating of one of the dogs used for DNA analysis (AL3223) to 985-935 cal BP.
Uyak, Alaska (AL3198)
The Uyak Site is a substantial prehistoric midden covering hundreds of acres and
located on the western side of Kodiak Island, Alaska. The site was excavated between
1933-1936 for the United States National Museum (now the National Museum of
Natural History), and consisted of house structures and hearths, stone and organic
artefacts, human remains, and a large faunal assemblage (Hrdlicˇka, 1944). Occupa-
tion of the site is suggested to date from 2,000 BP to Russian contact in the mid-18th
century (Heizer, 1956; Hrdlicˇka, 1944). Due to the long occupation history of the site,
and without direct dating, the cultural context of the study specimen can only be
inferred to span both the earlier Kachemak phase (4,000-900 cal BP) and the later
Koniag phase (900-200 cal BP), as it is clear dogs were present throughout the occu-
pation (Allen, 1939; Hrdlicˇka, 1944). Both cultures were maritime hunter-gatherers
(Hrdlicˇka, 1944; Scott, 1992).
Dogs were ubiquitous throughout the site and hundreds of domestic dog remains
have been collected. Early metric analysis identified two types of dogs, classified as
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a “small” and a “large” type (Allen, 1939). While it was originally suggested that
the small type was restricted to earliest deposits (Hrdlicˇka, 1944) and later replaced
by the large type, other studies have noted size variability among contemporary
prehistoric canids throughout the Kodiak archipelago (Clark and Milan, 1974), and
more recent work suggests the variation could be a result of sexual dimorphism
(West and Jarvis, 2015).
Excavation of the specimens was poorly recorded, so it is unknown whether the
dog remains represent intentional burials, midden/refuse deposits or some combi-
nation of deposition types. This makes an interpretation of the role of dogs at the
site difficult, though cut marks suggesting butchery were recorded on a portion of
both mandibular and cranial elements (West and Jarvis, 2015). As the region’s sole
domesticate, it is likely that dogs at Uyak fulfilled several of roles simultaneously
including as a food source and additionally serve a variety of other functions in the
Arctic, including assisting in prey acquisition, transportation, sanitation through
food waste disposal, and even warmth (Groves, 1999).
3.4.1.2 Canada
Prince Rupert Harbour, British Columbia (PRD1, PRD9, PRD10, PRW89)
Prince Rupert Harbour is on the northern Northwest Coast of North America, just
south of the Alaskan boundary. Two sites, GbTo-13 and GbTo-54, had large-scale
excavations in 2012-2013 (Eldridge et al., 2014). Components at the site date from
900 BC (radiocarbon calibrated) to about 250 BC; the main occupation was between
250 BC and AD 800, followed by slightly less intensive occupation from about AD
900-1300. Some late European contact activity also occurred, but there were no Eu-
ropean trade goods at the site, suggesting no admixture with European dogs likely
occurred in the population of dogs at this site. GbTo-13 had a smaller occupation
limited to AD 1,000–1,300.
An unprecedented number of bones from mountain goat (Eldridge et al., 2014),
grizzly and black bear, sea lion, northern fur seal, wolf, and other species otherwise
rare in Northwest Coast animal assemblages were found at both sites. A single
purposeful dog burial was found at GbTo-54, outside a house identified as a chief’s
residence based on rank-linked artefact and faunal distribution. Some 300 dog bones
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and 21 wolf bones were recovered from GbTo-54, along with 25 dog bones from
GbTo-13. Remains indicated that dogs were smaller than the wolves in the area, and
so the two species could be distinguished. Three dogs and a wolf were included in
this analysis.
Port au Choix, Newfoundland (AL3194)
The Port au Choix site is located on Newfoundland’s northwest coast on the Port au
Choix peninsula. The area encompasses a number of well-preserved localities, in-
cluding a Maritime Archaic burial ground (Port au Choix-3) with over 100 preserved
burials (Port au Choix-3, Locus II), excavated from 1967-1969 by Memorial University
of Newfoundland (Tuck, 1970, 1971, 1976). The burial ground at Port au Choix is
thought to date to approximately 4,400-3,300 years ago (Renouf, 1993).The remains
of four dogs were recovered from the Port au Choix-3 burial ground including two
complete and articulated associated burials accompanying a human burial. All the
dogs appeared to be of the Large or Common Indian dog size, though there was
some variation between them, within the range of sexual dimorphism (Tuck, 1976).
The dog analysed in this chapter (AL3194) is an older male, likely weighing between
20-25 kilograms, killed by a blow to the head, and included, along with another
male dog, in a multi-human burial (Tuck, 1976). Direct radiocarbon dating of the
dog resulted in a date of 4,402-3,912 cal BP, indicating it comes from the earliest use
of the burial ground within the Maritime Archaic period. These dogs were likely
used as companions, hunting aids, and occasionally as travois dogs due to their
well-developed muscle attachments (Tuck, 1976). Comparisons to Eskimo sledge
dogs were unfavourable, but the Port au Choix specimens were similar to other large
breed native dogs seen at the prehistoric Frontenac Island site in New York (Smith,
1947). Early descriptions of large breed native dogs described them as slender and
wolf-like, with large erect ears and a long, pointed snout (Allen, 1920).
3.4.1.3 Central America
Mayapan, Mexico (May2, May3, May4, May10)
Mayapan, located in Yucatan, Mexico, was the largest Mayan city during the Post-
classic period, and was occupied from its founding in 900 BP until its abandonment
in 450 BP (Lope et al., 2006). It consisted of a monumental centre containing temples
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and ritual buildings, surrounded by residential areas (Pollock, 1962). Over 2,000 dog
bone fragments have been identified from the site (Masson and Peraza Lope, 2008).
Dog remains were highly concentrated in the Templo Redondo Group, located in
the main plaza of the monumental centre (Masson and Peraza Lope, 2013). There is
evidence that young dogs were consumed regularly, and that older dogs were often
used in ritual contexts.
3.4.1.4 Russia
Aachim Lighthouse, Russia (CGG10, CGG11)
The Aachim Lighthouse site is located in the Aachim Peninsula on the East Siberian
Sea coast. Mandibles of two dogs included in this study were radiocarbon dated to
1,760 ± 40 BP and 1,740 ± 40 (Lee et al., 2015).
Zhokhov, Siberia (CGG1, CGG2, CGG3, CGG4, CGG5, CGG6, CGG7, CGG8, CGG9)
Zhokhov Island is located off of the northeastern coast of Siberia (Pitulko and Kas-
parov, 2017)). Human occupation of Zhokhov began in the Late Pleistocene period,
with the earliest evidence for humans at the site dating to 9,000 years ago (Pitulko and
Kasparov, 2017). Small blades and bone and ivory points have also been recovered
from the site, as well as a fairly sophisticated sledge runner for the time period. Two
fragmented dog mandibles, as well as a small number of postcranial bones, have
been recovered from the site, and date to the earliest period of human occupation.
They are smaller than wolf mandibles, and are similar in size to other ancient Arctic
dog remains that have been recovered.
Previous mitochondrial DNA sequencing demonstrated that Zhokhov dogs belong
to dog Haplogroup A, and are genetically indistinguishable from modern domestic
dogs in the hypervariable region of the mitochondrial genome (Lee et al., 2015).
3.5 Ancient DNA
3.5.1 DNA extraction and sequencing
Ancient DNA (aDNA) extractions and library preparations were carried out at the
University of Oxford under the supervision of Laurent Frantz and Greger Larson, at
University of Illinois at Urbana-Champaign under the supervision of Ripan Malhi,
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Fig. 3.1. a. A map depicting the locations and ages of the archaeological remains
analysed in this study. Each dot represents a single sample, and multiple samples
per archaeological site are grouped in boxes. Key sites mentioned are labelled. BP,
before the present. Figure adapted from Ní Leathlobhair et al. (2018). b. In situ
photographs of dog burials at Koster site, Illinois. Images provided by Del Baston,
courtesy of the Center for American Archaeology.
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Table 3.1 Summary information about ancient dog samples analysed in this chapter
including age (based on radiocarbon dating or stratigraphic context). ND (not
determined) appears for samples where dating was not performed, or for which
osteological sex was undetermined.
Sample
ID
Age (radiocarbon) Age (context) Site Latitude Longitude Sex
AL2135 10110-9680 cal BP Archaic, Transition Koster, Illinois, USA 39.209 -90.549 F
AL2748 ND 1000-700 BP Baum Village, Ohio, USA 39.282 -83.157 M
AL2772 ND 750-550 BP Reinhardt, Ohio, USA 39.779 -83.004 M
AL3194 4402-3912 cal BP Maritime Archaic Port au Choix, Canada 50.703 -57.352 M
AL3198 ND 2000-200 BP Uyak, Alaska, USA 57.519 -154.017 M
AL3223 985-935 cal BP AD 680-1430 Weyanoke Old Town, Virginia, USA 37.289 -77.066 F
AL3226 ND 750-1450 Weyanoke Old Town, Virginia, USA 37.290 -77.303 F
5MT316 ND 1100-1400 BP Grass Mesa, Colorado, USA 39.469 -107.771 ND
5MT501 ND 800-1000 BP Yellow Jacket Pueblo, Colorado, USA 37.56 -108.711 ND
5MT520 ND 1100-1300 BP McPhee Pueblo, Colorado, USA 37.47 -108.5 ND
AM310A ND 1000 BP Angel Mounds, Indiana, USA 37.943 -87.458 ND
AM310B ND 1000 BP Angel Mounds, Indiana, USA 37.943 -87.458 ND
AM310C ND 1000 BP Angel Mounds, Indiana, USA 37.943 -87.458 ND
AM474 ND 1000 BP Angel Mounds, Indiana, USA 37.943 -87.458 ND
CAO1 ND 2000-6000 BP Channel Islands, California, USA 34.045 -119.723 ND
CAW2 ND 2000-6000 BP Channel Islands, California, USA 33.961 -119.755 ND
CGG1 ND 7900-9000 BP Zhokhov site, Russia 76.141 152.733 ND
CGG10 1720-1780 cal BP ND Aachim Lighthouse, Russia 69.881 173.4682 ND
CGG11 1700-1740 cal BP ND Aachim Lighthouse, Russia 69.881 173.468 ND
CGG2 8910-8960 cal BP 7900-9000 BP Zhokhov site, Russia 76.141 152.733 ND
CGG3 ND 7900-9000 BP Zhokhov site, Russia 76.141 152.733 ND
CGG4 ND 7900-9000 BP Zhokhov site, Russia 76.141 152.733 ND
CGG5 ND 7900-9000 BP Zhokhov site, Russia 76.141 152.733 ND
CGG6 ND 7900-9000 BP Zhokhov site, Russia 76.141 152.733 ND
CGG7 ND 7900-9000 BP Zhokhov site, Russia 76.141 152.733 ND
CGG8 ND 7900-9000 BP Zhokhov site, Russia 76.141 152.733 ND
CGG9 ND 7900-9000 BP Zhokhov site, Russia 76.141 152.733 ND
CIAS ND 2000-6000 BP Syuxtun, California, USA 34.410 -119.691 ND
CICVD ND 4000 BP Canada Verde Site, Santa Rosa Island, California, USA 34.024 -120.132 ND
CINH7 ND 5000 BP or 2000 BP North Head site, San Nicholas Island, California, USA 33.27 -119.566 ND
CINHA ND 5000 BP or 2000 BP North Head site, San Nicholas Island, California, USA 33.27 -119.566 ND
CISG ND 2000 BP or 700 BP Channel Islands, California, USA 34.005 -120.181 ND
Cox6 ND 1500-3000 BP Cox Site, Alabama, USA 34.824 -86.011 ND
FR11 ND 3000-7000 BP Flint River Site, Alabama, USA 34.977 -86.539 ND
ISM070 ND 2500-1000 BP Apple Creek, Illinois, USA 40.145 -89.172 ND
AL2706 8560-8210 cal BP ND Modoc, Missouri, USA 38.063 -90.064 ND
AL2135 10110-9680 cal BP Archaic, Transition Koster, Illinois, USA 39.209 -90.549 ND
AL2704 10130-9680 cal BP Archaic, Transition Koster, Illinois, USA 39.209 -90.549 ND
JBG11 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG12 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG13 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG17 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG19 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG1m ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG21 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG24 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG26 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG32 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG35 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG37 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG41 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG42 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG43 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG45 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG48 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG5 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
JBG50 ND 1000-1400 BP Janey B. Goode, Illinois, USA 38.658 -90.162 ND
LB2 ND 3000-7000 BP Little Bear, Alabama 34.307 -87.665 ND
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Table 3.1 continued
Sample
ID
Age (radiocarbon) Age (context) Site Latitude Longitude Sex
May10 ND 1000 BP Mayapan, Mexico 20.461 -89.217 ND
May2 ND 1000 BP Mayapan, Mexico 20.461 -89.217 ND
May3 ND 1000 BP Mayapan, Mexico 20.461 -89.217 ND
May4 ND 1000 BP Mayapan, Mexico 20.461 -89.217 ND
OSU611 ND 2200-1600 BP Scioto Caverns, Ohio 40.113 -83.107 ND
OSU622 ND 2200-1600 BP Scioto Caverns, Ohio 40.113 -83.107 ND
OSU624 ND 2200-1600 BP Scioto Caverns, Ohio 40.113 -83.107 ND
OSU626 ND 2200-1600 BP Scioto Caverns, Ohio 40.113 -83.107 ND
OSU628 ND 2200-1600 BP Scioto Caverns, Ohio 40.113 -83.107 ND
OSU634 ND 2200-1600 BP Scioto Caverns, Ohio, USA 40.113 -83.107 ND
OSU638 ND 2200-1600 BP Scioto Caverns, Ohio 40.113 -83.107 ND
P35 ND 3000-7000 BP Perry, Alabama 34.915 -87.684 ND
P59 ND 3000-7000 BP Perry, Alabama 34.915 -87.684 ND
PRD1 ND 1500 BP Prince Rupert Harbour, Canada 54.305 -130.343 ND
PRD10 ND 1500 BP Prince Rupert Harbour, Canada 54.305 -130.343 ND
PRD9 ND 1500 BP Prince Rupert Harbour, Canada 54.305 -130.343 ND
and at University of Copenhagen under the supervision of Tom Gilbert. DNA was
extracted from canid teeth or bone samples in a dedicated ancient DNA labora-
tories using the appropriate sterile techniques and equipment. Most of the DNA
extractions were performed at the University of Illinois at Urbana Champaign, at the
Carl R. Woese Institute for Genomic Biology, with methods described in Witt et al.
(2015)), but a subset of extractions was performed at the Centre for GeoGenetics at
the University of Copenhagen, with methods described in Allentoft et al. (2015) and
at the University of Oxford following the protocol described in Dabney et al. (2013).
Ancient DNA laboratory work was performed by Anna Linderholm, James Haile,
Ophelie Lebrasseur, Evangelos Dimopoulos (University of Oxford), Kelsey Witt (Uni-
versity of Illinois at Urbana-Champaign), Selina Brace (Natural History Museum,
London), Jacob Enk, Alison Devault, Jean-Marie Rouillard (Arbor Biosciences) and
Mikkel-Holger Sinding (University of Copenhagen).
Libraries were sequenced on an Illumina HiSeq 2500 system (single-end 80 bp) at
the Danish National High-Throughput Sequencing Centre, on an Illumina NextSeq
500 system (single-end 80 bp) at the Natural History Museum (London) and on an
Illumina HiSeq 2500 system (80 or 100 bp) at the Roy J. Carver Biotechnology Center
at the University of Illinois.
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Table 3.2 Sequencing statistics for ancient dog samples included in mitochondrial
DNA analyses.
Sample ID Extraction lab Number of reads Endogenous content mtDNA coverage
AL2772 Oxford 13783057 4.596462164 5.058528128
AL3194 Oxford 265763856 38.33614756 116.2334549
AL3223 Oxford 125598030 16.89122194 71.07419143
5MT316 Illinois 19512 56.02706027 39.31751061
5MT501 Illinois 70113 60.39536177 76.37053865
5MT520 Illinois 4794 25.40675845 5.886829677
AM310A Illinois 32097 73.98510764 102.7144736
AM310B Illinois 22394 64.75395195 61.83386142
AM310C Illinois 25562 48.4547375 47.30860286
AM474 Illinois 23613 53.65264896 47.62306451
CAO1 Illinois 40840 73.14887365 110.2931189
CAW2 Illinois 25137 65.05151768 62.58982483
CGG1 Copenhagen 46062 56.70400764 99.49967119
CGG10 Copenhagen 60830 29.12214368 28.83158965
CGG11 Copenhagen 143208 29.26791799 96.7221259
CGG2 Copenhagen 120267 27.17453666 69.40072936
CGG3 Copenhagen 68821 28.64532628 40.03258205
CGG4 Copenhagen 233112 26.71634236 85.20930233
CGG5 Copenhagen 378999 38.50986414 129.2819394
CGG6 Copenhagen 4946724 74.33394303 57.72637054
CGG7 Copenhagen 138160 59.1806601 145.7030549
CGG8 Copenhagen 44351 27.36578657 31.15268727
CGG9 Copenhagen 83220 33.81639029 87.44449094
CIAS Illinois 16396 59.2461576 33.38847373
CICVD Illinois 892127 16.49709066 22.52561727
CINH7 Illinois 20560 63.92509728 47.10402344
CINHA Illinois 20083 68.31150724 46.00454355
CISG Illinois 36655 73.758 97.65995098
Cox6 Illinois 24459 26.281 16.97871704
FR11 Illinois 17810 13.981 7.0521
ISM070 Illinois 10188 55.477 26.36659293
AL2706 Oxford/Illinois 18608 69.34114359 52.34136426
AL2135 Oxford/Illinois 33094 70.732 71.35296228
AL2704 Oxford/Illinois 31019 67.575 77.18831829
JBG11 Copenhagen 130420 53.779 162.6978538
JBG12 Copenhagen 185720 34.443 153.6255156
JBG13 Copenhagen 114795 45.01241343 157.7362348
JBG17 Copenhagen 41931 79.16338747 165.3036408
JBG19 Copenhagen 83483 44.75282393 129.5464817
JBG1m Illinois 58193 52.39977317 55.8328451
JBG21 Copenhagen 25539 68.63228787 79.32217373
JBG24 Copenhagen 54470 71.94969708 154.409398
JBG26 Copenhagen 43857 71.20414073 137.4965027
JBG32 Copenhagen 54179 71.94484948 140.0304896
JBG35 Copenhagen 28482 34.8676357 25.7563819
JBG37 Copenhagen 73435 45.53686934 128.6252167
JBG41 Copenhagen 164370 37.65833181 168.990614
JBG42 Copenhagen 152682 60.71639093 158.2733903
JBG43 Copenhagen 670175 64.4883799 193.1227955
JBG45 Copenhagen 73704 56.19098014 154.8202905
JBG48 Copenhagen 65927 51.99690567 149.6821905
JBG5 Copenhagen 51284 54.12214336 122.7431099
JBG50 Copenhagen 31422 41.09222838 50.2458301
LB2 Copenhagen 101269 23.50373757 44.6299994
May10 Illinois 16488 24.83624454 12.72218569
May2 Illinois 31184 56.94907645 61.54397083
May3 Illinois 23276 53.93538409 42.79273032
May4 Illinois 28879 65.35198587 63.31613559
OSU611 Illinois 24002 26.62694775 13.16984516
OSU622 Illinois 97198 23.2576802 30.50002989
OSU624 Illinois 65298 38.88480505 89.69241346
OSU626 Illinois 20919 37.39662508 35.4464638
OSU628 Illinois 56784 20.31558185 29.37203324
OSU634 Illinois 1427900 13.33923944 45.14933939
OSU638 Illinois 76797 21.19874474 61.43151791
P59 Illinois 134568 17.28642768 26.48329049
P35 Illinois 27513 23.85054338 3.871644646
PRD1 Illinois 116751 71.87261779 129.2258026
PRD10 Illinois 699568 75.15180797 14.05033778
PRD9 Illinois 90571 73.43630964 127.813535
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Table 3.3 Sequencing statistics for ancient dog samples included in nuclear DNA
analyses. ’Sites’ corresponds to the number of sites out of the ~6.21 million sites that
were called in each sample.
Sample ID Extraction lab Number of reads Endogenous
content
Nuclear
coverage
Sites
AL2135 Oxford/Illinois 7,366,980 3.37 0.006 16,869
AL2748 Oxford 18,128,973 6.694 0.023 98,361
AL3198 Oxford 18,711,277 2.816 0.001 38,806
AL2772 Oxford 13,783,057 4.596 0.013 59,871
AL3226 Oxford 36,476,977 4.5 0.031 119,689
AL3223 Oxford 125,598,030 16.891 0.452 1,806,093
AL3194 Oxford 265,763,856 38.336 1.921 4,661,948
3.5.2 Data processing
Ancient DNA data processing was performed by Laurent Frantz. Raw reads were
filtered allowing one mismatch to the indices used in library preparation. Adapter
sequences were removed using AdapterRemoval (Lindgreen, 2012). Reads were
aligned using Burrows-Wheeler Aligner (BWA, v0.7.5ar405) (Li and Durbin, 2009)
to CanFam3.1 (Schubert et al., 2012). PCR duplicates were removed and BAM files
from different sequencing lanes were merged using the MergeSamFiles tool from
Picard v1.129 (http://broadinstitute.github.io/picard/).
To accommodate for the low coverage of the ancient American dog nuclear genome
sequences, genotypes were called by randomly sampling a single read of 20 bp mini-
mum and with a mapping quality (MAQ) and base quality (BQ) of at least 30 at each
covered position in the genome, excluding bases within 5 bp of the start and end of
a read (Green et al., 2010; Haak et al., 2015; Skoglund et al., 2016).
The Newgrange dog (Frantz et al., 2016; Section 3.6) was genotyped in the same way
as modern data (except for 5 bp at start and end of a read; see below).
For the mtDNA, we generated majority consensus sequences for all samples that had
at least 3× average coverage (71 samples; Table 3.2) excluding bases within 5 bp of
the start and end of a read. Molecular damage was assessed using MapDamage2.0
using default parameters (Jónsson et al., 2013). Most samples displayed clear signs
of deamination. Samples AL3231 and AL2696 displayed limited deamination pat-
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terns consistent with these being from a relatively recent time period (AD 1000-1400;
Table 3.1).
3.6 Publicly available data
Raw reads/bam files for 47 canid genomes (Fan et al., 2016; Frantz et al., 2016;
Freedman et al., 2014; Wang et al., 2016) were downloaded from NCBI or DoGSD
(Bai et al., 2015). Samples downloaded from NCBI were aligned to the CanFam3.1
reference genome using BWA mem (Li and Durbin, 2009). We computed depth of
coverage for each sample using bedtools (Quinlan and Hall, 2010). These genomes
were chosen due to their high coverage and geographic spread covering North and
South American, East Asian, and Western European (African, Indian and European)
dogs, as well as Eurasian and American grey wolves and coyotes and an outgroup
(Lycalopex culpaeus; Andean fox).
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Table 3.4 Summary information (coverage, accession, etc.) of modern whole
genomes analysed in this chapter
Accession Coverage Sample Id Population code Meta population Info Country
PRJEB7788 1.3 W_Taimyr Taimyr Ancient Wolf Wolf (ancient) Taimyr Peninsula (Siberia)
ERS403439 124.2 C_24T CTVT CTVT CTVT Australia
ERS403440 24.5 D_24H DCTVT CTVT Host Aboriginal camp dog Australia
ERS1870073 96.2 C_608T CTVT CTVT CTVT The Gambia
ERS1870074 47.7 D_608H DCTVT CTVT Host Local Gambian dog The Gambia
ERS1870075 94.3 C_609T CTVT CTVT CTVT The Gambia
ERS1870076 43.7 D_609H DCTVT CTVT Host Local Gambian dog The Gambia
ERS403441 95.1 C_79T CTVT CTVT CTVT Brazil
ERS403442 23.7 D_79H DCTVT CTVT Host American cocker spaniel Brazil
ERS747137 13.4 D_AHusky91 DAL Arctic Dogs Alaskan Husky Alaska, USA
SRS1129580 15.8 D_Mal68 DMA Arctic Dogs Alaskan Malamute Alaska, USA
DoGSD 6.3 D_Basenji BAS African Dogs Basenji Africa
SRS661477 32.8 C_Cal COY Coyotes Coyote California, USA
DoGSD 6.7 D_Dingo DIN Dingo Dingo Australia
DoGSD 14.9 D_Tibet3 DTI East Asian Dogs Village Dog Tibet
DoGSD 15.5 D_Tibet4 DTI East Asian Dogs Village Dog Tibet
SRS1129835 15.5 D_Green DGL Arctic Dogs Greenland Sledge Dog Unknown
DoGSD 15.9 D_GerShep3 DGS European Dogs Germany Shepherd Germany
DoGSD 16.3 D_GerShep6 DGS European Dogs Germany Shepherd Germany
SRS984799 61.8 D_Husky DHU Arctic Dogs Husky Unknown
SRS520064 10.0 D_India168 DID Asian Dogs Village Dog India
SRS520065 15.5 D_India60 DID Asian Dogs Village Dog India
SRS661487 43.6 W_India WME Eurasian Wolf Wolf India
SRS661488 27.3 W_Iran WME Eurasian Wolf Wolf Iran
SRS520071 9.9 D_Leb79 DLB European Dogs Village Dog Lebanon
SRS520072 10.5 D_Leb85 DLB European Dogs Village Dog Lebanon Lebanon
SRS523207 12.1 AndeanFox OUT Outgroup Andean Fox Andes
DoGSD 16.3 D_China8 DCH East Asian Dogs Village Dog China
DoGSD 16.8 D_China9 DCH East Asian Dogs Village Dog China
DoGSD 9.2 W_Mongo WAS Eurasian Wolf Wolf Mongolia
DoGSD 11.3 W_Altai WAS Eurasian Wolf Wolf Altai
SRS1135618 16.3 D_Mex DME American Dogs Mexican Hairless Dog Mexico
SRS661479 8.4 C_MidW COY Coyotes Coyote Midwest, USA
SRS661490 24.7 W_Mex1 WAM American Wolf Wolf Mexico Mexico
SRS520075 15.2 D_Na8 DNA African Dogs Village Dog Namibia
SRS520075 7.6 D_Na89 DNA African Dogs Village Dog Namibia
ERS1097373 33.6 D_NGDG DAE European Dogs Newgrange Dog (Ancient) Ireland
SRS1135617 17.5 D_Peru DPU American Dogs Peruvian Naked Dog Peru
SRS520079 18.6 D_Port61 DEU European Dogs Village Dog Portugal
SRS520080 16.2 D_Portt71 DEU European Dogs Village Dog Portugal
SRS661492 31.4 W_Port WEU Eurasian Wolf Wolf Portugal
SRS520081 12.9 D_Qatar27 DQA Asian Dogs Village Dog Qatar
SRS520082 7.5 D_Qatar5 DQA Asian Dogs Village Dog Qatar
SRS1135615 13.9 D_Husky89 DHU Arctic Dogs Siberian Husky Siberia
SRS1129824 16.6 D_SLaika DSL Spitz Dogs Siberian Laika Siberia
SRS661495 23.5 W_Spa WEU Eurasian Wolf Wolf Spain
DoGSD 13.7 D_TMastif4 DTM East Asian Dogs Tibetan Mastiff Tibet
DoGSD 15.1 D_TMastif5 DTM East Asian Dogs Tibetan Mastiff Tibet
SRS520084 10.9 D_Viet21 DVN East Asian Dogs Village Dog Vietnam
SRS520088 10.6 D_Viet59 DVN East Asian Dogs Village Dog Vietnam
SRS661496 26.8 W_Yellow1 WAM American Wolf Wolf Yellowstone, USA
SRS661497 25.7 W_Yellow2 WAM American Wolf Wolf Yellowstone, USA
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In addition, we obtained data from two publicly available CTVT genomes (Murchi-
son et al., 2014), as well as genomic data from the ancient Taimyr wolf (Skoglund et
al., 2015; Section 3.3.2) and a Late Neolithic Irish dog from Newgrange (Frantz et al.,
2016; Section 1.3). Whole genomes from two dog samples in Germany dating to the
Early and End Neolithic published by Botigué et al. (2017) have not been included in
the ensuing analyses as these were not available at the time.
We additionally obtained data from 5,406 modern dogs that were genotyped on
the semi-custom CanineHD SNP array (~185K SNPs) developed by Shannon et al.
(2015).
3.7 Genotyping
3.7.1 Normal dog samples
We used SAMtools ‘mpileup’ v0.1.19 (Li et al., 2009) to call genotypes with default
settings. Pileup files were filtered, for all samples, using the following criteria:
• Minimum depth of coverage (DoC) ≥ 6
• Exclude all sites in region of high DoC (top 5%)
• Exclude all sites within 3 bp of an indel
• Only bases with quality ≥30 within reads with mapping quality ≥ 30 were
used.
• Minimum fraction of reads supporting heterozygous (variant allele frequency
[VAF] >= 0.3) - all sites that did not pass this criteria (0 < VAF < 0.3) were coded
as missing (N).
• In the high coverage ancient sample (Newgrange dog) we also discarded the
first and last 5 bp of each read for genotype calling, to avoid incorporating
errors from deaminated sites (see above).
The Taimyr wolf (Section 3.6; Skoglund et al., 2015) was processed using the same
random read approach used for other ancient samples (see Section 3.5.2).
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3.7.2 CTVT samples
Ancestry analyses were performed using data from two previously described CTVT
genomes, 24T and 79T, (Murchison et al., 2014) in order to determine the phylogenetic
placement of the CTVT founder dog within a cohort of modern and ancient dogs.
CTVT genomes carry two types of genetic variation: germline variation inherited by
the CTVT founder dog, and somatic variation acquired during the somatic evolution
of the CTVT clone. The goal of this specific analysis was to identify CTVT germline
variation, and to use this to represent the CTVT founder individual in a phylogenetic
analysis.
We generated a list of callable sites in CTVT using the criteria outlined in Section 3.7.1.
Because CTVT is a cancer, and to limit the impact of somatic mutations, we confined
our genotyping analysis to SNPs mapping to genomic regions in CTVT that have
retained both parental chromosomal copies (i.e. germline diploidy), as previously
described (Murchison et al., 2014). Sites were further filtered to retain only those
sites in which the variant allele fraction (VAF) for a non-reference allele was ≥ 0.1
in at least one CTVT tumour, and for which no more than two nucleotides were
detected at VAF ≥ 0.1 (i.e. multi-allelic sites were rejected). These sites were defined
as single nucleotide variant (SNV) candidates.
CTVT tumour tissue biopsies contain both CTVT and host cells. The latter derive
from stromal, immune and blood vessel components. Thus DNA derived from CTVT
tumours is an amalgam of CTVT and matched host DNA. In order to identify and
exclude SNVs derived exclusively from the matched host, as well as to correctly
genotype alleles shared between CTVT and matched hosts, we took the following ap-
proach. Sites identified as SNV candidates were genotyped in genomes 24H and 79H,
the matched hosts for tumours 24T and 79T (Murchison et al., 2014). The genotypes
of 24H and 79H were inferred using the following VAF thresholds: homozygous
reference if VAF ≤ 0.2, heterozygous if VAF = [0.2-0.8], homozygous alternative if
VAF ≥ 0.8.
Using the known host contamination fractions for 24T and 79T (Murchison et al.,
2014), we used the following VAF thresholds to genotype SNV candidates in CTVT
cells. SNVs that were homozygous reference in the matched host were genotyped
in CTVT using the following VAF thresholds: homozygous reference for VAF<0.2,
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heterozygous if VAF = [0.2-0.6], homozygous alternative if VAF>0.6. SNVs that were
heterozygous in the matched host were genotyped in CTVT using the following
VAF thresholds: homozygous reference if VAF<0.3, heterozygous if VAF = [0.3-0.7],
homozygous alternative if VAF>0.7. SNVs that were homozygous alternative in
the matched host were genotyped in CTVT using the following VAF thresholds:
homozygous reference if VAF<0.4, heterozygous if VAF =[0.4-0.8], homozygous
alternative if VAF>0.8. CTVT SNVs were further processed as described below in
Section 3.7.3.
3.7.3 Ascertainment panel
Genotypes from all genome-wide samples were then merged using bedtools (Quinlan
and Hall, 2010). Ascertainment was done without outgroups (but including coyote).
We selected all bi-allelic markers excluding sites that (i) were heterozygous in only one
sample (required a minimum of two chromosomes in our set of samples to carry the
derived allele); in the case of sites only variable in CTVT we required the two CTVT
genomes (24T and 79T) to be homozygous to limit the inclusion of somatic mutations
into the list of SNPs, (ii) sites that were not covered in our outgroup (Andean fox),
and (iii) sites with more than 20% missing data across samples. All low coverage
ancient samples were excluded from this step (Table 3.3). This resulted in ~6.21
million high quality SNPs. We excluded all sites that were outside of the germline
diploid region in CTVT (Murchison et al., 2014). Singleton SNPs called exclusively
in CTVT genomes and not found in any other canid genome were excluded. This
resulted in ~2.03 million SNPs, including ~600K transversions.
3.8 Mitochondrial DNA analyses
3.8.1 RAxML
For phylogenetic analysis, we used all samples with at least 3× average mitochon-
drial coverage and consensus sequences with at least 80% coverage across the entire
mitochondrial genome were considered for further analysis (Table 3.2). We also
included previously published ancient and modern mtDNA genomes (Thalmann
et al., 2013). This data set contains representative samples of all four major dog
mitochondrial haplogroups (A, B, C, D) including 3 ancient American dogs. We
aligned the data using mafft v7.2 (Katoh and Standley, 2013). We built a maximum
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likelihood (ML) tree in RAxML (Stamatakis, 2006), with 100 bootstrap replicates,
using a General Time Reversible (GTR) substitution model with a gamma (G) model
of site heterogeneity.
We assessed whether previous studies relying on the mtDNA control region (see
Section 2.3.1) were able to identify the pre-contact monophyletic clade we have identi-
fied here.To do so, we extracted the control regions from all samples that overlapped
with the fragments analysed in (Leonard et al., 2002) and (van Asch et al., 2013) (605
bp in total), filtering out samples with more than 10% missing data and a maximum
likelihood tree with RAxML.
Lastly, we expanded our MT genome sample size to assess whether the mtDNA
haplogroup that we had identified in pre-contact dogs exists in modern America
dogs. To do so we included 942 additional mitogenomes from a global sample of
dogs, including CTVT host genomes as well as 169 village and breed dogs that were
sampled in North and South America (Björnerfeldt et al., 2006; Pang et al., 2009;
Webb and Allard, 2009; Zhao and Liu, 2016). Accession number of all additional
samples can be found in Appendix 1: Supplementary file 3.3. We combined this data
with the mtDNA genomes analysed above and built a ML tree, with 100 bootstrap
replicates using a GTR+G model as implemented in RAxML (Stamatakis, 2006).
3.8.2 Bayesian phylogenetic analysis
We used BEAST v1.8.4 (Drummond et al., 2012) to calibrate the evolutionary rate of
our canid data set. We restricted this analysis to sequences with at least 10× average
mitochondrial genome coverage (Table 3.2). The mitogenome was partitioned into
four categories (tRNA, rRNA, control region and coding sequence). We fitted a
separate substitution model to each partition: tRNA (HKY+I), rRNA (TN93+G),
control region (HKY+G+I) and coding sequence (SDR06) as selected by Akaike
information criteria (AIC) using PartitionFinder (Lanfear et al., 2017). The same tree
was used for all four partitions. The age of archaeological samples was used as prior
(uniform distribution of tip age). We used a Bayesian Skyline prior (Drummond et al.,
2005) (group size parameter = 10) and a strict molecular clock as in Thalmann et al.
(2013). An uncorrelated clock was also tested and did not result in noticeable changes.
We ran 50 million Markov chain Monte Carlo (MCMC) chains and sampled tree
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parameters every 5,000 iterations. Convergence was evaluated with Tracer v1.6.0 (ESS
for each parameter≥100). Trees were summarised using Maximum Clade Credibility
as implemented in TreeAnnotator v1.8.4 (10% burn-in).
3.9 Nuclear analyses
3.9.1 Nomenclature
Hereafter, I will refer to the ancient dog individuals sampled in North America as pre-
contact dogs (PCD) although I do not formally define this group until Sections 3.11.1
and 3.11.2 based the results of phylogenetic analyses.
3.9.2 PCA
Principal Component Analysis (PCA) was performed using smartpca (Patterson
et al., 2006) on a set of 2.03 million SNPs using the following projections and data
sets:
(i) Pre-contact samples projected
(ii) Dog samples only with pre-contact samples projected
(iii) Dog samples only with pre-contact and CTVT samples projected
For PCD we used all 7 samples for which we could call at least 10,000 sites (minimum
number of sites suggested for ancient DNA analysis (Allentoft et al., 2015)). We used
all available sites (sites covered in at least 1 ancient sample; ~1.5 million SNPs) to
compute the eigenvectors and then projected PCD onto that space. We also projected
CTVT to ensure that their placement was not an artefact of somatic mutations.
3.9.3 Neighbour-joining tree
An Identity By State (IBS) matrix was computed using plink v1.9 (Purcell et al., 2007)
and using all 2.03 million SNPs. This matrix was used to build a neighbour-joining
tree (NJ) using the R package “ape” (Paradis et al., 2004). We built a phylogeny using
nuclear genotypes with MrBayes 3.2 (Ronquist and Huelsenbeck, 2003). To do so
we used PGDSpider 2.0.9.2 (Lischer and Excoffier, 2012) to build a Nexus file with
discrete SNP format (0=reference, 1 = heterozygous, 2 = homozygous alternative).
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We used the Mkv model (Stamatakis, 2006) implemented in MrBayes (ordered char-
acter), which provides a likelihood framework for data sets that contain only variable
characters. We also imposed a minimum distance of 10Kb between SNPs to limit the
influence of linkage disequilibrium (LD) and lastly included only PCD samples with
higher coverage (AL3194 and AL3223; Table 3.3; ~30K SNP total).
We ran two independent runs of four MCMC chains with two million samples.
Trees were summarised discarding 25% as burn-in. To limit biases from missing data
we limited this analysis to transversions that were covered in 90% of our samples.
Convergence was assessed by ensuring that average standard deviation of split fre-
quencies was below 0.01 and that the potential scale reduction factor was close to 1
for all parameters.
3.9.4 f3 statistics
We computed outgroup f3-statistics (3-population tests) (Patterson et al., 2012) using
ADMIXTOOLS to explore the relationship between pre-contact dogs and present-day
dog populations. We computed f3(Pre-contact dogs, X; outgroup) where X is any
other dog population (Table 3.4), to quantify the amount of genetic drift shared
between pre-contact dogs and other dogs, using only transversions.For this analysis,
we used only the higher coverage PCD samples (AL3194 and AL3223; Tables 3.1 and
3.3), with ~1.9× and ~0.5× coverage, respectively.
3.9.5 TreeMix
To relate the population history of pre-contact dogs and CTVT to other dog popula-
tions and to test the topology suggested by phylogenetics and f3 statistics analyses
we used TreeMix (Pickrell and Pritchard, 2012) to reconstruct admixture graphs. We
only used 3 representatives from each major dog group:
• West Eurasian dogs: Portuguese village dogs (DEU), German Shepherd (DGS)
• East Asian dogs: Vietnamese village dogs (DVN) because they lack admixture
from European dogs (see above) and Tibetan village dogs (DTI)
• Pre-contact dogs (PCD): Port au Choix (AL3194) and Weyanoke Old Town
(AL3223) samples (Table 3.1)
• Arctic dogs: Malamute (DMA) and Greenland dogs (DGL)
119
• CTVT: 24T and 79T
• Eurasian wolves (WEU) from Spain and Portugal
• North American wolves (WAM) from Yellowstone
• Coyotes (COY) as an outgroup
Malamute and Greenland dogs were chosen as they are the least admixed with
Western dogs. We only used transversions in order to limit the effect of DNA damage
on the analysis and only used sites that were covered in all samples (~60,000 SNPs).
3.9.6 qpGraph
QpGraph (Patterson et al., 2012) was used to fit admixture graphs to nine populations
(see below) representing PCD, CTVT, and each of the three major dog groups, plus
wolves and coyotes.
• West Eurasian dogs: Portuguese village dogs (DEU)
• East Asian dogs: Vietnamese village dogs (DVN)
• Pre-contact dogs (PCD): AL3194 (Port au Choix) and AL3223 (Weyanoke Old
Town; Table3.1)
• CTVT: 24T and 79T
• Arctic dogs: Alaskan malamute (DMA)
• Eurasian wolves (WEU) from Spain and Portugal
• North American wolves (WAM) from Yellowstone
• Coyotes (COY) from California
• Andean fox (OUT) as the outgroup
We only used transversions in order to limit the effect of DNA damage on the analysis.
This resulted in 600,991 high quality SNPs.
To explore the space of all possible admixture graphs we implemented a heuris-
tic search algorithm. Given an outgroup with which to root the graph, a stepwise
addition order algorithm was used for adding leaf nodes to the graph. At each
step, insertion of a new node was tested at all branches of the graph, except the
outgroup branch. Where a node could not be inserted without producing f4 outliers
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(i.e. |Z|≥3) then all possible admixture combinations were also attempted. If a
node could not be inserted via either approach, that sub-graph was discarded. If the
node was successfully inserted, the remaining nodes were recursively inserted into
that graph. All possible starting node orders were attempted to ensure full coverage
of the graph space.
As the number of possible graphs grows super-exponentially with each additional
leaf node, we initially excluded CTVT from the search space and looked for mod-
els which fit the remaining eight populations. We fitted 480,166 unique admixture
graphs for these populations and recorded the 892 graphs that left no f4 outliers
(i.e. |Z| < 3). We then fitted a further 309,525 unique models, testing all possible
insertions of CTVT into the 892 eight-population graphs, and recorded the 1,655
graphs that left no f4 outliers.
TreeMix analysis was also performed using the same nine populations, with six
admixture edges (the maximum number seen in the qpGraph analyses; see Sec-
tion 3.9.6). The most plausible qpGraph model (Fig. 3.14) was chosen by comparing
all fitted models to the neighbour-joining tree, Bayesian tree, D-statistics analyses
and a TreeMix tree with the same sampling.
3.9.7 D-statistics
D-statistics were computed using ADMIXTOOLS (Patterson et al., 2012). For these
analyses we used only the two higher coverage PCD genomes (AL3194 and AL3223;
Table 3.3), with average genome coverage ~1.9× and ~0.5× respectively, except where
explicitly stated (e.g. Koster dog AL2135; see below). Results are based on all 2.03
million SNPs. The Andean fox was used as an outgroup for these analyses. We
obtained standard errors using a block jackknife procedure over 1 megabase (1Mb)
blocks in the genome.
• For each pair of samples (Pop 3, Pop 4) we computed D(Outgroup, PCD, Pop 3,
Pop 4) where Population 3 (Pop 3) was fixed as either European dogs, Asian
dogs, Arctic dogs, or CTVT and Population 4 (Pop 4) represented any other
positive sample. Positive values imply that pre-contact dogs shared more
derived alleles with the population on the y axis, while negative values imply
that PCD are closer to other dog populations.
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• To test for admixture from wild North American canids into PCD (AL3194,
AL3223), we computed D(Outgroup, Coyote or North American Wolf, Pop 3,
Pop 4) where Pop 3 and Pop 4 could represent any possible pair of populations.
• To test for additional admixture from wild canids into PCD we ran D(Outgroup,
Coyote, AL3194, AL3223) and D(Outgroup, American Wolf, AL3194, AL3223).
• We computed D(Outgroup, Coyote, CTVT, Pop 4) and D(Outgroup, American
Wolf, CTVT, Pop 4) where Pop 4 could represent any other dog population to
determine whether there was detectable admixture from coyote and American
wolf populations into the CTVT founder dog specifically.
• We used whole genome data to assess admixture from the ancient Taimyr
wolf into PCD, Arctic dogs and CTVT by computing D-statistics of the form
D(Outgroup, Taimyr, PCD or Arctic dogs, European, Asian, or Arctic dogs).
• We tested for admixture from European dogs into East Asian dogs. Following
Shannon et al. (2015) and Frantz et al. (2016), we used Vietnamese village dogs
as the reference East Asian population to test for by computing D(Outgroup,
Portugal, Vietnam, Pop 4) (Table 3.9).
• To test for coyote admixture in the Koster dog (AL2135), we computed D(Outgroup,
North American wolf or coyote or Taimyr wolf, AL2135, AL3194). This analysis
was restricted to AL3194 as it was the highest coverage PCD sample available
(Table 3.3).
• D-statistics were used to test for admixture from PCD into Arctic breeds since
their MRCA by computing D(Outgroup, PCD (AL3194), Arctic dogs, Arctic
dogs) (Table 3.10).
• Lastly, to determine whether admixture from Eurasian dogs could affect the
result of the previous D-statistic test, we quantified D(Outgroup, Asian or
European Dogs, Arctic dogs, Arctic dogs).
3.9.8 f4 ratio estimation
We used SNP array data obtained from Shannon et al. (2015) to assess the degree to
which modern dog populations in the Americas have retained ancestry from pre-
contact dogs. This SNP panel contained 28 genotyped populations from North and
South America, such as Peruvian village dogs, Alaskan village dogs and Carolina
dogs (Table 3.5 for the full list).
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Fig. 3.2. Schematic representation of the assumed phylogeny for the f4 ratio test
used to estimate pre-contact ancestry into modern North American dogs. Here,
alpha represents the degree of ancestry from pre-contact dogs. Figure adapted from
Ní Leathlobhair et al. (2018).
f4 ratios were computed using ADMIXTOOLS (Patterson et al., 2012; Reich et al., 2009)
to estimate admixture proportions (α) from pre-contact dogs into these populations
by computing:
α = f4(A,O;X,C)÷ f4(A,O;B,C)
Where A is CTVT, O is the Andean fox (outgroup), B is PCD (AL3194 and AL3223),
C is any European or East Asian population (Table 3.5) and X is any American dog
(Table 3.5 and Fig. 3.2). We computed α for all combinations of European/Asian and
modern American dog populations. Jackknifing was performed with a block size of
1 centiMorgan (cM). To test whether Alaskan village dogs interbred with pre-contact
dogs we computed every possible combination of the same f4 ratio as before but
using only the Arctic subset of American dogs. Outgroup f3 statistics were also used
to assess the degree of shared drift between various populations available on the
SNP array and PCD.
3.9.9 ADMIXTURE
To further assess this we used ADMIXTURE (Alexander et al., 2009) on a subset of
the SNP array samples including all modern North American populations as well as
Arctic dogs, “basal” breeds (Larson et al., 2012) and selected European and Asian
123
Table 3.5 Sample codes used as population names for SNP array analysis
Sample code Dog type Type group
AED American Eskimo Dog American Dogs
AM Alaskan Malamute Northern Dogs
APBT American Pit Bull Terrier American Dogs
AST American Staffordshire Terrier American Dogs
BAS Basenji African Dogs
BAS2 Basenji African Dogs
BEA Beagle European Dogs
BOX Boxer European Dogs
CBR Chesapeake Bay Retriever American Dogs
CC Chow Chow East Asian Dogs
CD Carolina Dog American Dogs
CHI Chihuahua American Dogs
CLD Catahoula Leopard Dog American Dogs
COO Chinook American Dogs
COY Coyote Coyotes
CSP Chinese Shar-pei East Asian Dogs
CTVT CTVT CTVT
DAE Ancient European European Dogs
DAL Alaskan Husky Northern Dogs
DCH Chinese Village Dog East Asian Dogs
DEU European Village Dog European Dogs
DGL Greenland Dogs Northern Dogs
DGS German Shepard European Dogs
DHU Husky Northern Dogs
DID Indian Village Dog Asian Dogs
DIN Dingo Dingo
DLB Lebanese Village Dog European Dogs
DMA Malamute Northern Dogs
DME Mexican Hairless Dog American Dogs
DNA Namibian Village Dog African Dogs
DPU Peruvian Hairless Dog American Dogs
DQA Qatari Village Dogs Asian Dogs
DSL Siberian Laika Northern Dogs
DTI Tibetan Village Dog East Asian Dogs
DTM Tibetan Mastiff East Asian Dogs
DVN Vietnamese Village Dog East Asian Dogs
EUR Eurasier Northern Dogs
FS Finnish Spitz Northern Dogs
GSD Greenland Sledge Dog Northern Dogs
NEW Newfoundland American Dogs
NGSD New Guinea Singing Dog East Asian Dogs
NSDTR Nova Scotia Duck Tolling Retriever American Dogs
PCD Pre-Colombian Dogs Pre-Colombian Dogs
PIO Peruvian Inca Orchid American Dogs
SAM Samoyed Northern Dogs
SH Siberian Husky Northern Dogs
VDB Village Dog Belize American Dogs
VDB2 Village Dog Brazil American Dogs
VDC Village Dog Colombia American Dogs
VDCR Village Dog Costa Rica American Dogs
VDDR Village Dog Dominican Republic American Dogs
VDH Village Dog Honduras American Dogs
VDP Village Dog Panama American Dogs
VDPA Village Dog Peru-Arequipa American Dogs
VDPC Village Dog Peru-Cusco American Dogs
VDPI Village Dog Peru-Ica American Dogs
VDPL Village Dog Peru-Loreto American Dogs
VDPP Village Dog Peru-Puno American Dogs
VDPR Village Dog Puerto Rico American Dogs
VDUA Village Dog US-Alaska American Dogs
VDIC Village Dog India-Chennai Asian Dogs
VDID Village Dog India-Dehli Asian Dogs
VDIH Village Dog India-Hazaribagh Asian Dogs
VDIM Village Dog India-Mumbai Asian Dogs
VDIO Village Dog India-Orissa Asian Dogs
VDIB Village Dog Indonesia-Borneo East Asian Dogs
VDIJ Village Dog Indonesia-Jakarta East Asian Dogs
VDPNGEH Village Dog Papua New Guinea-East Highlands East Asian Dogs
VDPNGPM Village Dog Papua New Guinea-Port Moresby East Asian Dogs
VDVCB Village Dog Vietnam-Cao Bang East Asian Dogs
VDVHG Village Dog Vietnam-Ha Giang East Asian Dogs
VDVLS Village Dog Vietnam-Lang Son East Asian Dogs
VDVLC Village Dog Vietnam-Lao Cai East Asian Dogs
WAM American Wolf American Wolf
WAS Asian Wolf Eurasian Wolf
WEU European Wolf Eurasian Wolf
WME Middle-east Wolf Eurasian Wolf
XOL Xoloitzcuintli American Dogs
TAI Taimyr Ancient Wolf
OUT Andean Fox Outgroup
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populations (e.g. Boxer and Chow-Chow). K = 4 was selected as the best K value
based on 10 fold cross validation. We tried to separate PCD/Arctic ancestry with
higher K values.
3.10 CTVT mutation rate analysis
3.10.1 Experimental design
Our goal was to estimate the CTVT somatic mutation rate and to use this to estimate
the time at which CTVT originated. To do this, we collected biopsies from a pair
of CTVT tumours involved in a naturally occurring direct transmission event, and
identified mutations that had arisen during the known transmission time interval to
define a somatic mutation rate. We then estimated the number of somatic mutations
in the entire CTVT lineage and applied our somatic mutation rate to estimate the
time of CTVT origin. Previous estimates of CTVT time of origin are described in
Chapter 1 (Section 1.2.1.7).
3.10.2 Sample collection
This project was approved by the Department of Veterinary Medicine, University of
Cambridge, Ethics and Welfare Committee (reference CR174). A 1-2 mm3 biopsy
was sampled from Dog 609’s vaginal tumour (609T). A 1-2 mm3 biopsy was sampled
from one of Dog 608’s skin tumours on the same day (608T). Biopsies were also
collected from 609H and 608H host tissues (ovary and testis, respectively). CTVT
diagnosis was confirmed as previously described (Strakova et al., 2016).
3.10.3 Sample case histories
Dog 609H was a mixed-breed free-ranging dog from the Gambia with an approxi-
mately 31 cm3 vaginal CTVT tumour. Her ten-month-old male pup, Dog 608, had
several CTVT tumours on the ventral skin. This unusual CTVT presentation in Dog
608 suggested that CTVT cells were likely engrafted from its mother’s vaginal tumour
during parturition.
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Fig. 3.3. Samples sequenced in this study.
Sample 608T is a CTVT biopsy from the skin of a 10-month old puppy. This tumour
was likely transmitted during birth and engrafted from the mother’s vaginal tumour
(609T). Tumour (608T, 609T) and host (608H, 609H) DNA was sequenced from the
two individuals shown. Images are reproduced with permission from Michael
Meyer.
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3.10.4 Variant calling
3.10.4.1 Extraction and filtering
We used Somatypus (https://github.com/baezortega/somatypus), a Platypus (Rim-
mer et al., 2014) based variant calling and genotyping pipeline, to identify SNVs and
indels. In order to make an initial call, SNVs were required to have ≥3 supporting
reads in at least one of the four sequenced CTVT or matched host samples (608T,
608H, 609T, 609H). Indels were input to GATK Realigner Target Creator (McKenna
et al., 2010) for local realignment and SNVs were re-called from realigned genomes.
The following in-built Platypus flags were used to exclude SNVs at two stages,
before and after genotyping: badReads, MQ, QD, strandBias, SC.
The following post-processing filters were also implemented:
• Strand bias filter. For each SNV, the total coverage, as well as forward and
reverse strand read support were extracted. For low total coverage positions
(≤10 reads across all four samples), we discarded calls with less than two
supporting reads in either forward or reverse direction. For high total coverage
positions (>10 reads across all four samples), we discarded calls with less than
20% support on either the forward or reverse sequencing strands.
• Simple repeat filter. SNVs within simple repeats, as defined by the UCSC table
browser (CanFam3.1), were excluded.
• Extreme depth filter. SNVs within regions of high read depth were also ex-
cluded. To detect high read depth (HRD) regions we first generated BigWig
coverage files from matched normal whole genome sequence data files (608H,
609H). We then identified areas with coverage 12 standard deviations higher
than the mean read coverage, on a chromosome by chromosome basis. Com-
mon intervals between normal samples were identified using bedtools multi-
inter (Quinlan and Hall, 2010) and were merged using bedtools merge. The
maximum allowed distance between regions to be merged was 250 bp. HRD
regions spanning less than 500 bp were excluded. Any HRD region that over-
lapped with gene regions as defined by the UCSC table browser (CanFam3.1,
Genes and Gene Predictions, Ensembl Genes) was excluded.
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• Low VAF filter. SNVs with VAF>0 and VAF<0.2 in both 608H and 609H were
discarded if (i) they were not detected in 608T or 609T or (ii) they were found
with VAF>0 and VAF<0.1 in either or both of 608T and 609T.
• Regions filter. SNVs occurring in the mitochondrial genome or on unassigned
scaffolds were excluded. In addition, to avoid problems caused by variable
coverage in hosts, SNV analysis was restricted to autosomes.
3.10.4.2 Germline and consensus filtering
SNVs identified in 608T and 609T will belong to one or more of the following cate-
gories:
(i) contaminating germline SNPs from matched host,
(ii) germline SNPs inherited by the CTVT founder dog, and
(iii) somatic mutation SNVs.
In order to enrich for somatic mutations, we filtered our candidate SNVs against a
panel of 28,812,954 canid germline SNPs. We excluded any genomic site that was
reported in any of the following variant catalogues:
• 608H and 609H (sites with ≥5 reads coverage and ≥2 reads supporting a non
reference allele were considered SNVs)
• The Variant and Systematic Error Catalogue (VSEC) (Decker et al., 2015)
• The CanineHD 170K SNP array (Vaysse et al., 2011)
• The ascertainment panel generated in this study prior to incorporating CTVT
samples (see Section 3.7.3)
• A complete genome from a Greenland sledge dog (Wang et al., 2016; Table 3.4)
included in the ascertainment panel was additionally genotyped. This provided
additional SNVs beyond those in the ascertainment panel, as the ascertainment
panel excluded SNVs that were found on only one chromosome; thus SNVs
that were exclusively found in the Greenland sledge dog individual and CTVT
would not have been included in the ascertainment panel that we filtered
against, but were excluded in this step (see Section 3.7.1).
Next, we further filtered the remaining SNVs using the following criteria:
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• We retained only those SNVs that had that had≥2 reads supporting the variant
all with minimum base quality of 20 and minimum mapping quality of 35, in
at least one of the two tumours using the alleleCount tool https://github.com/
cancerit/alleleCount.
• We retained only those SNVs that were identified by GATK Haplotype Caller.
The GATK engine was restricted processing candidate loci.
• We required that the matched host must have coverage of at least 20 reads
total at the candidate SNV position. Candidate SNVs that did not reach this
threshold in one or both tumours were discarded.
• We discarded SNVs with≥10 reads total (regardless of whether they supported
the variant) with base quality <20 and mapping quality <35 in matched hosts
1,934,103 and 1,934,125 tumour-only SNVs remained in 608T and 609T respectively
after these steps; 1,933,897 of these were shared by 608T and 609T. Of the SNVs in
this set that mapped to genomic regions retaining both parental copies, almost all
SNVs were heterozygous. Thus, the majority of these SNVs are likely to be somatic;
however, some germline variation that was present in the CTVT founder dog, but
that is not represented in the germline panel used here likely still remains. It is also
likely that some somatic mutations, which occurred in the same sites as germline
SNVs represented in our panel, have been removed.
3.10.4.3 Tumour-unique SNVs
We next filtered tumour-only SNVs, as defined above, for those unique to either 608T
or 609T. In order to be considered unique to a single tumour, a variant was required to
be present with≥2 supporting reads in only one tumour, with minimum base quality
of 20 and minimum mapping quality of 35 for those reads supporting the variant.
This method yielded 206 tumour-unique SNVs in 608T and 228 tumour-unique SNVs
in 609T.
3.10.5 Mutational spectrum
Each tumour-only SNV was classified as one of six possible mutation types in the
pyrimidine context (C>A, C>G, C>T, T>A, T>C, T>G). The immediate 5’ and 3’
sequence contexts for each mutation was extracted from the CanFam3.1 dog reference
genome (Lindblad-Toh et al., 2005) yielding 96 mutation types.
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3.10.5.1 Signature fitting
We performed mutational signature fitting in order to estimate the number of muta-
tions contributed by different exposures to the CTVT mutational spectrum. Validated
mutational signatures were obtained from the Catalogue of Somatic Mutations in
Cancer (COSMIC) database (Forbes et al., 2015) and renormalised to the CanFam3.1
dog reference genome (Lindblad-Toh et al., 2005). In addition, we generated a “dog
germline” signature, from the germline mutational spectrum of a Greenland sledge
dog (see Section 3.10.4.2).
Murchison et al. (2014) previously showed that COSMIC mutational signature 1
(5-methylcytosine deamination), signature 5 (unknown etiology), and signature 7
(ultraviolet light exposure) are operative in CTVT, and that these three signatures
are sufficient to describe the pattern of somatic substitutions observed in CTVT. We
therefore fitted these three signatures, together with the dog germline signature, to
the CTVT tumour-only mutation spectrum (Table 3.7). Results were similar to previ-
ous findings (Murchison et al., 2014). Signatures were fitted using the sigfit v1.1.0
package in R (Gori and Baez-Ortega, 2018). Simulations were run using 100 chains
with 10,000 iterations each. Importantly, the Dog Germline signature accounted for
only 5.5% of the tumour-only SNVs, suggesting that the majority of the SNVs in this
set are indeed somatic.
3.10.6 Copy number analysis
Average mappability and GC-content were generated for the dog reference genome
(Lindblad-Toh et al., 2005; http://www.ensembl.org/Canis_familiaris/Info/Index)
with the generateMap, mapCounter, and gcCounter tools in the HMMcopy package
(Ha et al., 2012). GC content and genomic mappability biases for read counts in
non-overlapping 1 kb windows were corrected using HMMcopy. Copy number esti-
mation was then performed on GC- and mappability-corrected read counts using a
bespoke copy number calling pipeline (https://github.com/ymk1/cnv_pipeline.git).
Tumour purity in 608T and 609T was evaluated based on the VAF distribution of
tumour only SNVs. Tumour purity was estimated as follows:
Purity = 2 ∗ V AFmed
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Where VAFmed is the median VAF value of tumour-only SNVs. Using this method,
608T was estimated to be 49.3% CTVT cells and 609T was estimated to be 65% CTVT
cells.
3.10.6.1 Clonal tumour-unique SNVs
We categorised tumour-unique SNVs in 608T and 609T as either clonal or subclonal,
that is, present in all or a fraction of tumour cells within a sample, respectively (see
Table 3.6). To do this, we first examined the VAF distributions of germline SNPs in
608T and 609T for each copy number (CN) state (CN1, CN2, CN3, CN4, CN6). We
used a Gaussian mixture model (k = 2), implemented using the R package MCLUST
(Fraley et al., 2012), to define VAF clusters for heterozygous and homozygous SNPs.
Next, we fitted this model to VAF distributions of tumour-unique SNVs. SNVs
that fell below the 5% lower bound were defined as subclonal; all other SNVs were
considered clonal. The results of this analysis are shown in Table 3.8.
3.10.7 Phenotype information
Considering the evidence of introgression between wild North American canids
and the pre-contact domestic dog population, we assessed the presence of a marker
associated with melanism, which has introgressed from dogs into North American
gray wolves and coyotes, in the higher coverage pre-contact dog genomes (Port du
Choix sample: AL3194, ~2×; Weyanoke old town sample: AL3223, ~0.5×).
3.11 Results
In the following subsections, I present results that follow from the research questions
posed at the beginning of this chapter (Section 3.3.4).
3.11.1 Ancestry of the CTVT founder
To investigate the ancestry of the CTVT founder dog, we analysed two previously
published CTVT genomes (Murchison et al., 2014) alongside a panel of modern
and ancient canid genomes. We generated low coverage nuclear genomes of seven
pre-contact dogs (~0.005 - 2.0×), including the earliest dog remains on the continent
(Perri et al., 2018), from six locations in North America with time frames spanning
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609T (Mother) 609T (Son) Interpretation
Clonal Clonal Occurred before Mother-Son MRCA cell
Clonal Subclonal Son infection was polyclonal with clone a
and clone b; clones a and b were sampled
in the son, only clone a was sampled in the
mother
Clonal Absent Arose in MRCA609T cell; MRCA609T cell was
either unique to mother or we did not sam-
ple that subclone in the son
Subclonal Clonal We sampled a fraction of tumour in son that
derived from a subclone in the mother’s tu-
mour.
Subclonal Subclonal Polyclonal seeding and sampling: both sub-
clones exist in son and in mother
Subclonal Absent Occurred subsequent to MRCA609T , was not
transmitted to son or we did not sample it
in son
Absent Clonal Occurred in MRCA608T ; either arose in son
subclone, or was present in mother but we
sampled a different subclone in the mother
Absent Subclonal Occurred subsequent to MRCA608T ; either
arose in son subclone, or was present in 609T
and there was polyclonal seeding but we
sampled a different subclone in the mother
Table 3.6 Interpretation of clonal and subclonal mutations in mother-son direct
transmission pair
approximately 9,000 years. These data allowed us to assess the relationship between
CTVT and ancient dogs as well as where native dogs in the Americas originated.
A neighbour-joining tree analysis generated using single nucleotide polymorphisms
confirmed that PCD individuals clustered in a distinct monophyletic lineage that
is more closely related to global dog populations than to either Eurasian or North
American wolves (Fig. 3.4b). The closest related sister clade to PCD consisted of
present-day Arctic dogs from the Americas (including Alaskan malamutes, Green-
land dogs and Alaskan huskies) and Eurasia (Siberian huskies). TreeMix, D-statistics
and outgroup f3 statistics results were concordant with this phylogenetic topology.
Importantly, CTVT clustered with PCDs on neighbour-joining trees (bootstrap=100),
a Bayesian tree (posterior probability [PP] = 1), TreeMix, PCA and admixture graphs
(Fig. 3.4). This result is further supported by both outgroup f3 statistics and D-
statistics (Fig. 3.10). Altogether, these findings indicate that the CTVT founder dog
is more closely related to PCDs than to modern Arctic dogs.
3.11.2 The origin of pre-contact dogs
We generated 71 complete mitochondrial genomes from archaeological dog remains
in North America and Siberia (Fig. 3.1a; Tables 3.1 and 3.2). We analysed these
alongside 145 mitogenomes derived from ancient dogs and a global population of
modern canids. Phylogenetic trees constructed from these sequences confirmed that
all sampled pre-contact dogs, apart from one individual, form a highly supported
monophyletic clade within dog haplogroup A (bootstrap value=87; Fig. 3.5). The
most closely related mitochondrial lineage to the PCD clade, from the sampled dog
populations, were ancient sledge dogs from Zhokhov island in Eastern Siberia (Pit-
ulko and Kasparov, 2017).
Molecular clock analyses (Fig. 3.6) based on mtDNA suggest that all pre-contact
dogs shared a matrilineal common ancestor ~14,666 years ago (95% highest poste-
rior density interval (HPDI): 12,965-16,484 years ago), that had diverged from an
ancestor shared with Zhokhov dogs roughly 1000 years earlier, ~15,606 years ago
(95% HPDI:13,739-17,646 years ago). These time frames are broadly concurrent with
early migrations into the Americas (Jakobsson et al., 2017; Moreno-Mayar et al., 2018;
Raghavan et al., 2015).
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Fig. 3.4. a. Bayesian tree based on ~26K transversions. b. A neighbour-joining tree
built with whole genomes. c. An admixture graph constructed with Treemix (on the
basis of transversions) (Pickrell and Pritchard, 2012) depicting the relationship
between PCDs (including the Port au Choix (AL3194) and Weyanoke Old Town
(AL3223) samples) and other dog, wolf, and CTVT populations. The scale bar shows
10 times the average standard error (s.e.) of the entries in the sample covariance
matrix (Pickrell and Pritchard, 2012). d. Principal Component Analysis plot (PC1
versus PC2) of 44 dog samples (excluding wolves and coyotes) based on 2,063,129
SNPs ascertained using the genome-wide data set. All pre-contact dog and CTVT
samples were projected. Figure adapted from Ní Leathlobhair et al. (2018).
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Fig. 3.5. Maximum likelihood tree based on mtDNA data. The four major dog
haplogroups are indicated: A (red), B (purple), C (green), D (orange). Red tip labels
are newly sequenced samples. Light red highlighted clades (CGG1-9) are Zhokhov
Island samples (~9 kya sled dogs). CGG10-11 are more recent sledge dogs from
Siberia (~1.5 kya). Node labels indicate bootstrap replicates.
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While it was found that the major dog mitochondrial haplogroups (A, B, C, D) can
be distinguished using the control region (Fig. 3.7), it is not possible to distinguish
between pre-contact dogs and other dogs within haplogroup A using the mtDNA
control region alone.
It should be noted that samples CGG10 and CGG11 fall outside of the Zhokhov/pre-
contact clade (Fig. 3.5) as these are relatively recent sledge dogs from Chukotka,
Russia (~1.5 kya; Table 3.1). Lastly, one sample from the Prince Rupert Harbour site
(PRW89; ~1.5 kya) clustered with North American wolves (Fig. 3.5). Wolves and
dogs were poorly distinguished at this site (Section 3.4.1.1); it is possible that this
sample derives from a wolf or possibly represents a wolf-dog hybrid.
As demonstrated in Chapter 2, the CTVT founder dog’s mitogenome has been re-
placed as a result of multiple mitogenome horizontal transfers from dog hosts to
CTVT (Rebbeck et al., 2011; Strakova et al., 2016); thus, we could not determine
the mitochondrial haplotype of the CTVT founder dog, and analysis of the CTVT
founder’s ancestry was limited to the nuclear genome. However, the combined
mitochondrial and nuclear results confirm that CTVT is more closely related to PCD
than to any other dog populations.
These analyses also indicate that PCD were not domesticated in situ from North
American wolves but instead migrated alongside humans into the Americas via
Beringia from a population that was closely related to modern Arctic dogs.
3.11.3 Estimating the CTVT mutation rate and time-of-origin
Presented with the finding that CTVT was closely related to an early lineage of dogs
present in Siberia and the Americas, resolving the ’age’ of CTVT became crucial to
understanding whether CTVT arose before or after dogs entered North America. In
order to gain a more accurate estimate of the CTVT time-of-origin, we sequenced the
genomes of two CTVT tumours involved in a naturally occurring direct transmission
event, 609T (mother) and 608T (pup). This section describes the results of the somatic
variation analysis described in Section 3.10 which were used to derive a lower bound
for the somatic mutation rate in CTVT.
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Fig. 3.6. Bayesian tree of wolf, coyote and dog mtDNA, including modern and
pre-contact dog samples. Red, purple and green circles represent nodes with >0.9,
>0.7 and >0.5 posterior probability respectively. Blue bars represent confidence
intervals of divergence times (scaled in years before present). Figure adapted from
Ní Leathlobhair et al. (2018).
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Fig. 3.7. Maximum likelihood tree based on 605 bp of the control region. All
samples starting with prefix HQ were obtained from Leonard et al. (2002) while all
samples starting with prefix AY were obtained from van Asch et al. (2013). The four
major dog haplogroups are indicated with different branch colours: A (red), B
(purple), C (green), D (orange). All pre-contact dogs are highlighted in red. Node
labels indicate bootstrap replicates.
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Table 3.7 Fitting of COSMIC mutational signatures 1, 5, 7 and Dog Germline
signature to 1,933,897 CTVT tumour-only SNVs shared between 608T and 609T.
Mutational signature Fit Number of SNVs
1
Mean (15.4%) 297,820.1
Lower bound (15.2%) 293,952.3
Upper bound (15.5%) 299,754
5
Mean (40.1%) 775,492.7
Lower bound (40.0%) 773,558.8
Upper bound (40.3%) 779,360.5
7
Mean (38.95%) 753,252.9
Lower bound (38.9%) 752,285.9
Upper bound (39%) 754,219.8
Germline
Mean (5.5%) 106,364.3
Lower bound (5.3%) 102,496.5
Upper bound (5.7%) 110,232
3.11.3.1 CTVT mutation rate
The clocklike mutational signature 1 (Alexandrov et al., 2015) is largely composed of
cytosine-to-thymine (C>T) mutations at NpCpG dinucleotides, where N is any base
(N[C>T]G mutations). Of the 1,933,897 CTVT tumour-only SNVs (Section 3.10.4.2),
shared by 608T and 609T, 222,072 were N[C>T]G (Fig. 3.8).
We identified 183 and 174 clonal mutations unique to tumours 608T (pup) and 609T
(mother), respectively (Table 3.8). It was determined that 27 and 23 clonal tumour-
unique N[C>T]G SNVs had arisen in 608T and 609T, respectively, since divergence
from their most recent common ancestor (MRCA).
In order to estimate the CTVT mutation rate, we needed to estimate the time intervals
during which clonal tumour-unique mutations arose in 608T and 609T. These time
intervals (i608T and i609T) correspond to:
i608T = tMRCA-608T − tMRCA-608T/609T
i609T = tMRCA-609T − tMRCA-608T/609T
where tMRCA-608T and tMRCA-609T are time-points defining the MRCA cells of 608T and
609T respectively, and tMRCA-608T/609T is the time-point defining the MRCA cell of both
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Fig. 3.8. a. CTVT mutation spectrum. 1,933,897 tumour-only mutations in CTVT are
displayed by mutation type (in pyrimidine context) with immediate 5’ and 3’
context. Each of the 96 mutation classes is displayed on the horizontal axis.
Mutation proportions are displayed relative to CanFam3.1. b. Fraction of CTVT
tumour-only mutations attributable to COSMIC Signatures 1, 5, 7, and the dog
germline signature, estimated using sigfit. c. Reconstruction of CTVT tumour-only
spectrum using COSMIC signatures 1,5 and 7 and the dog germline signature.
Figure adapted from Ní Leathlobhair et al. (2018).
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Sample CN state Total Clonal
608T
CN1 40 33
CN2 140 125
CN3 22 21
CN4 3 3
CN6 1 1
206 183
609T
CN1 43 30
CN2 159 125
CN3 21 15
CN4 5 4
228 174
Table 3.8 Number of clonal tumour-unique SNVs in 608T and 609T
CN, copy number. "Total" refers to the complete set of tumour-unique SNVs,
"Clonal", indicates only those that are clonal.
608T and 609T.
We assumed that the clones that seeded the sampled 608T and 609T biopsies diverged
in the period after infection of the mother (Dog 609) but before transmission to the
pup (Dog 608) i.e. that tMRCA-608T/609T occurred during 609T tumour development.
This implied that the earliest time point for tMRCA-608T/609T would coincide with the
time at which Dog 609 (mother) was infected with CTVT, i.e. month 0.
We assumed that the mother (Dog 609) was infected during the heat cycle in which
she conceived Dog 608. While we cannot be certain that this assumption is valid,
we observed that the mother’s tumour appeared to be of a similar size to the pup’s
tumour. Unless CTVT tumours have a large variation in growth rate, we believe it is
unlikely that the mother was infected with CTVT in the heat cycle prior to that in
which she conceived Dog 608.
Given that the gestation period in domestic dogs can range from 57-72 days (Concan-
non et al., 1983; Gavrilovic et al., 2008; Okkens et al., 1993), we estimated that Dog
609 was infected with CTVT approximately 2 months prior to when her son, Dog 608,
was born and infected. This implies that the latest time-point for tMRCA-608T/609T is 2
months after Dog 609 was infected with CTVT. Thus tMRCA-608T/609T = 0 to 2 months,
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where month 0 as the month at which the mother (Dog 609) was infected with CTVT.
Assuming no polyclonal seeding, tMRCA-608T either arose in the pup (Dog 608), or
was the cell that transmitted from mother (Dog 609) to pup (Dog 608), and thus
tMRCA-608T = 2 to 12 months, where month 0 is the month at which the mother (Dog
609) was infected with CTVT, and 12 months corresponds to the time of sampling.
tMRCA-609T could have occurred at any time during 609T tumour development. Thus
tMRCA-609T = 0 to 12 months, where month 0 is the month at which Dog 609 (mother)
was infected with CTVT, and 12 months corresponds to the time of sampling. Thus,
we estimate both i608T and i609T to be 0 to 12 months.
We determined that 608T and 609T had acquired 183 and 174 mutations since their
divergence from their MRCA (MRCA608T/609T) and before the MRCA of the clone biop-
sied in 608T (MRCA608T) and the MRCA and the clone biopsied in 609T (MRCA609T).
These mutations will likely have arisen as part of clocklike ageing-associated muta-
tional signatures 1 and 5 and possibly as part of mutational signature 7 (exposure to
ultraviolet light).
The signature 1 mutation rate is believed to be highly dependent on cell division
(Alexandrov et al., 2015). Due to the small number of tumour-unique mutations,
signature fitting cannot give us an accurate estimate of the respective contributions
of these signatures to tumour-unique SNV sets. As mutational signature 1 is largely
composed of N[C>T]G mutations (where N is any base), we used N[C>T]G as a
proxy for signature 1. 27 and 23 N[C>T]G mutations were unique to 608T and 609T
respectively, and 222,072 N[C>T]G mutations arose in the somatic lineage from the
CTVT founder dog until MRCA608T-609T.
As 608T harbours more clonal N[C>T]G mutations than 609T (Table 3.8), we in-
fer that MRCA608T existed more recently than MRCA609T. Assuming that i608T is up to
12 months (see above), then the slowest rate at which N[C>T]G mutations accumulate
is 27 N[C>T]G mutations/ year.
Applying this rate to the complete set of clocklike somatic mutations in the CTVT lin-
eage (221,385 N[C>T]G mutations, see above), we estimated that the CTVT founder
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dog lived up to 8,225 years ago. This time frame postdates the initial arrival of
dogs into the Americas, and is compatible with the possibility that CTVT may have
originated in a dog living in North America.
3.11.3.2 Comparison with mutation rates in human cancer
Signature 1 mutation rate varies between human cancer tissue types (Alexandrov
et al., 2015). The mutation rate lower bound that we have derived for CTVT N[C>T]G
mutations (>12.56 mutations / Gb / year) is comparable to the N[C>T]G mutation
rates found in human cancers (Alexandrov et al., 2015). Cervical cancer was reported
to have the highest estimated rate of accumulation of N[C>T]G somatic mutations of
36 human cancer types (16.61 N[C>T]G somatic mutations / Gb / year)(Alexandrov
et al., 2015). Applying the cervical cancer N[C>T]G mutation rate to the CTVT lineage
would provide an estimate of 6,195 years since CTVT’s origin.
3.11.4 Pre-contact dogs and global dog clade structures
Previous studies of nuclear genome data have highighted two major modern clades
of dogs worldwide: a West Eurasian clade (including European, Indian, and African
dogs) and an East Asian clade (including dingoes) (Frantz et al., 2016; van Asch et al.,
2013; Wang et al., 2016). These analyses placed modern Arctic dogs such as Siberian
huskies and Greenland sledge dogs in either West Eurasian (Vonholdt et al., 2010) or
East Asian (Frantz et al., 2016) groups. Phylogenetic analyses of nuclear genomes
indicate that the clade formed by PCD and modern Arctic dogs (PCD/Arctic) is
basal to both West Eurasian and East Asian dogs and suggests the existence of a
third monophyletic clade of dogs (Fig. 3.4b). Outgroup f3 statistics also support the
observation that PCD/CTVT and Arctic breeds are equally related to all other dogs,
except for Basenji and one Indian dog, which could be due to admixture from wolves
into these two samples (e.g. Indian wolf or golden wolf; Fig. 3.10). Arctic breeds also
appear more closely related to PCD/CTVT than any other dog population (Fig. 3.10b
and c).
Although nodes leading to all three clades were well supported, the relationships be-
tween these groups were inconsistent across different analyses. Admixture analysis
showed that all East Asian dogs, excluding Vietnamese village dogs, are significantly
admixed with European dog populations (Table 3.9). Such disproportionate ad-
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Fig. 3.9. Tumour evolution in 609T and 608T
a.Clonal expansion occurs in association with the acquisition of de novo mutations.
MRCA, most recent common ancestor. With time, the cells (MRCA 609T and MRCA
608T) that give rise to the sampled CTVT tumours appear. b. Schema of the interval
estimates used in estimating the CTVT mutation rate. A founder cell from within
the mother’s lesion is transmitted to the pup, initiating a new tumour growth (end
of tMRCA−608T/609T and beginning of tMRCA−608T ); time of birth acts as a hard upper
bound on tMRCA−608T and tMRCA−609T . tMRCA is the time of the MRCA of the tumour
cell.
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Fig. 3.10. Shared genetic drift measured by f3(Outgroup; Y, X) where Y is either a.
Weyanoke Old town dog (AL3223), b. Alaskan Malamute (D_Mal68), c.Greenland
sledge dog (D_Green) and X represents modern dog populations. Error bars
represent 1 standard error (SE). Figure adapted from Ní Leathlobhair et al. (2018).
mixture could affect the topology of the tree. For example, if specific East Asian
dogs where there is evidence of gene flow with European dogs (Wang et al., 2016)
were excluded, East Asian dogs became the most basal clade, and PCD and modern
Arctic dogs appeared as a sister clade to West Eurasian dogs. Conversely, admixture
graphs and TreeMix suggested that West Eurasian dogs were more basal and that
PCD/Arctic dogs were closest to East Asian dogs. These conflicting topologies,
illustrated by previous analyses of nuclear data (Frantz et al., 2016; Larson et al., 2012;
Wang et al., 2016), could result either from a near simultaneous divergence of all
three lineages or from substantial post-divergence gene flow among Eurasian dogs,
as previously suggested (Frantz et al., 2016; Wang et al., 2016).
3.11.5 Pre-contact dog ancestry in modern Arctic dogs
As we have previously outlined (Section 3.11.1), nuclear genome data indicated
that modern Arctic dogs sampled from both Siberia and North America cluster in a
distinct phylogenetic group that forms a sister taxon to pre-contact dogs (Fig. 3.4b)
suggesting that PCDs are not the direct ancestor of modern American Arctic (Alaskan
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Table 3.9 D-statistics for D(Outgroup, Portuguese village dogs, Vietnamese village
dogs, Asian dogs). The Andean fox was used as an outgroup for these analyses. n
corresponds to the number of SNPs where all populations have data. Standard error
for these statistics was obtained by performing a weighted block jackknife over 1Mb
blocks. Statistics show evidence of admixture in all East Asian populations tested in
this study.
Pop 2 Pop 3 Pop 4 D Z BABA ABBA n
D_Port61 D_Viet21 D_China8 0.1029 11.106 52,952 43,074 934,713
D_Port61 D_Viet21 D_China9 0.0557 6.079 48,963 43,796 924,557
D_Port61 D_Viet59 D_China8 0.0965 10.469 52,395 43,172 941,437
D_Port61 D_Viet59 D_China9 0.0481 5.589 47,976 43,576 920,022
D_Port61 D_Viet21 D_Tibet3 0.0663 6.823 49,504 43,352 922,535
D_Port61 D_Viet21 D_Tibet4 0.0599 6.610 49,756 44,134 914,979
D_Port61 D_Viet59 D_Tibet3 0.0575 6.277 49,026 43,693 929,474
D_Port61 D_Viet59 D_Tibet4 0.0513 5.871 49,127 44,333 921,845
D_Port61 D_Viet21 D_Mastif4 0.0714 7.278 49,690 43,069 894,260
D_Port61 D_Viet21 D_Mastif5 0.0643 7.229 49,757 43,747 913,367
D_Port61 D_Viet59 D_Mastif4 0.0639 6.791 48,007 42,240 898,585
D_Port61 D_Viet59 D_Mastif5 0.0587 6.929 48,421 43,054 917,851
malamutes, Alaskan huskies, and Greenland dogs) and Eurasian Arctic (Siberian
huskies) dogs. It is possible that modern Arctic dogs are the descendants of dogs
introduced to the continent by the Paleo-Eskimos (~6,000 years ago) or by the Thule
people (~1,000 years ago) (Raghavan et al., 2014).
Moreover, both mitogenomic and low-coverage nuclear genomic data from a late
Paleo-Eskimo dog from Alaska (Uyak site sample AL3198; Fig. 3.1) indicate that
this dog was more closely related to PCDs than to modern American Arctic dogs.
This finding suggests that modern American Arctic dogs are not the descendants of
Paleo-Eskimo dogs and that Paleo-Eskimos brought dogs from Siberia derived from
the same source population as PCDs or adopted local dogs in North America.
We also used D-statistics on genome-wide data to test for admixture from PCD
into Arctic breeds since their MRCA. We found that both Alaskan malamute and
Greenland sledge dogs have a significant amount of ancestry from PCD (Table 3.10).
We tested whether this signal could be due to admixture from Eurasian dogs into
Siberian husky dogs (making derived alleles in Alaskan malamute and Greenland
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Table 3.10 D-statistics for D(Outgroup, PCD (AL3194), Arctic dogs, Arctic dogs). n
corresponds to the number of SNPs where all populations have data. Standard error
for these statistics was obtained by performing a weighted block jackknife over 1Mb
blocks. Statistics with Z>3 and Z<-3 are shown in bold.
Pop 3 Pop 4 D Z ABBA BABA n
D_Mal68 D_Green 0.0001 0.010 38,564 38,555 926,919
D_Husky89 D_AHusky91 0.0059 0.416 29,524 29,174 749,696
D_Husky D_Husky89 0.0166 1.254 33,365 32,275 797,067
D_Husky D_AHusky91 0.0176 1.324 37,461 36,164 913,221
D_Husky89 D_Green 0.0437 3.261 38,311 35,101 790,543
D_Husky89 D_Mal68 0.0455 3.384 39,192 35,781 775,433
D_AHusky91 D_Green 0.0470 3.555 44,116 40,158 897,276
D_AHusky91 D_Mal68 0.0450 3.596 44,737 40,883 884,940
D_Husky D_Green 0.0619 5.021 48,948 43,246 955,940
D_Husky D_Mal68 0.0609 5.050 49,177 43,528 942,665
Fig. 3.11. A map showing the locations of dog populations obtained from Shannon
et al. (2015) and their degrees of relatedness (D-statistics) to the ~4,000 year old Port
au Choix dog (AL3194). Higher values (in red) represent closer relatedness. The
location of the founder CTVT individual, labelled in the plot, is unknown. Figure
adapted from Ní Leathlobhair et al. (2018).
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sledge dogs (GSD) match PCD more often; Table 3.12) as D-statistics suggest that
all sampled modern Arctic breeds are a mixture of the basal lineage (leading to the
CTVT founder and PCD) and of the Eurasian dog lineage (Table 3.11). We found
evidence that the Siberian husky and Alaskan malamute genomes analysed in this
chapter received gene flow from European dogs (Table 3.12). However, we found no
evidence that GSD received gene-flow since the MRCA of Arctic breeds, suggesting
that Eurasian admixture did not affect our result. This could also be the result of
ancient substructure within Arctic dogs.
We found no signal that either Alaskan malamute or Greenland sledge dogs shared an
excess of derived alleles with PCD compared with each other (D(Outgroup, AL3194,
Alaskan malamute, Greenland sledge dog) = -0.0001, sd = -0.010). D-statistics suggest
that there was no additional gene-flow between PCD and these dog lineages since
their divergence from each other. This finding suggests that the signal detected above
(excess shared derived alleles between American Arctic dogs and PCD) is due to
ancient substructure within Arctic dogs (Eriksson and Manica, 2012).
3.11.6 Pre-contact ancestry in modern American dogs
While our results so far have indicated that only modern Arctic dogs and CTVT share
a genetic affinity with PCD, multiple studies have argued that modern American
dog populations possess a genetic signature from indigenous dogs (Parker et al.,
2017; Shannon et al., 2015; van Asch et al., 2013).
To test this hypothesis, we analysed nuclear data obtained from more than 5,000
modern dogs (including American village dogs) genotyped on a semi-custom 185K
SNP array (Shannon et al., 2015). The results of the f4 test depicted in Fig. 3.2 show
that, apart from Alaskan Village dogs, we detect no significant signal of pre-contact
ancestry in modern North American populations (α always <4% and Z always < 3;
Table 3.13). Alaskan village dogs, on the other hand, have between 11-20% (Z always
> 4.5; Table 3.13) ancestry derived from pre-contact dogs. f4 ratio analysis did not
detect a significant admixture signal from PCDs in any modern American dogs of
European ancestry (Table 3.5 for list of American dogs).
Alaskan village dogs were the population of North American village dog with the
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Table 3.11 D-statistics for D(Outgroup, Asian or European dogs, PCD or CTVT,
Arctic dogs). n corresponds to the number of SNPs where all populations have data.
Standard error for these statistics was obtained by performing a weighted block
jackknife over 1Mb blocks.
Pop2 Pop3 Pop4 D Z BABA ABBA n
D_China8 AL3194 D_AHusky91 0.0752 7.65 47,384 40,759 879,166
D_China8 AL3194 D_Green 0.0606 6.01 47,406 41,994 920,449
D_China8 AL3194 D_Husky 0.0693 7.253 51,412 44,755 936,527
D_China8 AL3194 D_Husky89 0.0825 8.407 41,900 35,513 768,218
D_China8 AL3194 D_Mal68 0.0655 6.538 46,698 40,958 907,759
D_China8 C_24T D_AHusky91 0.0907 9.461 61,440 51,230 1,115,093
D_China8 C_24T D_Green 0.0753 7.523 61,012 52,472 1,167,919
D_China8 C_24T D_Husky 0.0819 8.781 66,255 56,230 1,189,650
D_China8 C_24T D_Husky89 0.0987 9.798 54,693 44,866 985,295
D_China8 C_24T D_Mal68 0.0796 8.128 60,682 51,739 1,151,059
D_China9 AL3194 D_AHusky91 0.064 6.644 45,860 40,348 849971
D_China9 AL3194 D_Green 0.0812 8.035 47,827 40,641 893422
D_China9 AL3194 D_Husky 0.0684 7.323 50,481 44,022 905549
D_China9 AL3194 D_Husky89 0.087 8.783 41,939 35,228 760651
D_China9 AL3194 D_Mal68 0.065 6.504 45,784 40,195 877630
D_China9 C_24T D_AHusky91 0.0776 7.936 59,705 51,110 1,078553
D_China9 C_24T D_Green 0.0926 9.696 61,461 51,046 1,133912
D_China9 C_24T D_Husky 0.0799 8.709 65,471 55,786 1,150989
D_China9 C_24T D_Husky89 0.1001 9.815 54,894 44,904 974829
D_China9 C_24T D_Mal68 0.0743 7.814 59,571 51,330 1,113510
D_Port61 AL3194 D_AHusky91 0.0981 9.344 49,646 40,780 897394
D_Port61 AL3194 D_Green 0.0733 7.059 49,098 42,391 939,704
D_Port61 AL3194 D_Husky 0.0994 10.286 54,206 44,402 956,025
D_Port61 AL3194 D_Husky89 0.1006 9.791 43,556 35,593 784,550
D_Port61 AL3194 D_Mal68 0.1044 9.88 49,860 40,438 926,900
D_Port61 C_24T D_AHusky91 0.1115 10.706 64,216 51,337 1,137,495
D_Port61 C_24T D_Green 0.088 8.191 63,226 53,005 1,191,621
D_Port61 C_24T D_Husky 0.1125 11.651 70,044 55,878 1,213,643
D_Port61 C_24T D_Husky89 0.1181 11.113 57,125 45,064 1,005,524
D_Port61 C_24T D_Mal68 0.1167 11.029 64,747 51,223 1,174,636
D_Portt71 AL3194 D_AHusky91 0.0949 9.146 48,273 39,904 877,094
D_Portt71 AL3194 D_Green 0.0814 8.348 48,157 40,909 918,351
D_Portt71 AL3194 D_Husky 0.0967 10.277 52,649 43,367 934,632
D_Portt71 AL3194 D_Husky89 0.1035 10.427 42,550 34,572 765,611
D_Portt71 AL3194 D_Mal68 0.1047 10.09 48,497 39,308 906,275
D_Portt71 C_24T D_AHusky91 0.1122 10.895 62,687 50,038 1,112,724
D_Portt71 C_24T D_Green 0.0994 9.888 62,205 50,964 1,165,580
D_Portt71 C_24T D_Husky 0.1139 12.371 68,354 54,374 1,187,444
D_Portt71 C_24T D_Husky89 0.124 11.829 55,911 43,573 982,083
D_Portt71 C_24T D_Mal68 0.1214 11.729 63,196 49,518 1,149,527
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Table 3.12 D(Outgroup, Asian or European Dogs, Arctic dogs, Arctic dogs). The
Andean fox was used as an outgroup for these analyses. n corresponds to the
number of SNPs where all populations have data. Standard error for these statistics
was obtained by performing a weighted block jackknife over 1Mb blocks.
Pop 2 Pop 3 Pop 4 D Z ABBA BABA n
D_Portt71 D_AHusky91 D_Husky89 0.0000 0.001 37,394 37,394 954,618
D_Portt71 D_Mal68 D_Husky89 0.0005 0.040 47,184 47,141 988,232
D_Portt71 D_Husky D_Mal68 0.0009 0.086 58,360 58,259 1,190,049
D_Port61 D_AHusky91 D_Mal68 0.0016 0.149 55,075 54,905 1,143,740
D_Port61 D_Mal68 D_Husky 0.0018 0.186 59,906 59,692 1,217,824
D_Portt71 D_Husky89 D_Husky 0.0026 0.250 42,139 41,923 1,014,889
D_Port61 D_Husky89 D_Mal68 0.0029 0.271 48,766 48,481 1,013,144
D_Portt71 D_AHusky91 D_Mal68 0.0046 0.412 53,778 53,282 1,117,362
D_Port61 D_AHusky91 D_Husky 0.0060 0.586 48,323 47,748 1,179,281
D_Portt71 D_AHusky91 D_Husky 0.0060 0.596 46,884 46,321 1,151,944
D_Port61 D_Husky89 D_AHusky91 0.0077 0.675 38,794 38,202 979,116
D_Port61 D_Husky89 D_Husky 0.0098 0.948 43,569 42,725 1,040,592
D_Portt71 D_Green D_AHusky91 0.0197 1.780 53,880 51,794 1,133,450
D_Portt71 D_Green D_Husky 0.0242 2.401 59,660 56,844 1,207,389
D_Portt71 D_Green D_Mal68 0.0281 2.433 49,870 47,151 1,171,857
D_Portt71 D_Green D_Husky89 0.0267 2.466 47,462 44,995 1,007,512
D_Port61 D_Green D_Husky89 0.0283 2.625 48,938 46,241 1,033,241
D_Port61 D_Green D_AHusky91 0.0301 2.628 55,922 52,657 1,160,778
D_Port61 D_Green D_Husky 0.0341 3.348 61,488 57,440 1,236,161
D_Port61 D_Green D_Mal68 0.0375 3.355 51,677 47,947 1,199,625
D_China8 D_Husky89 D_AHusky91 0.0017 0.158 37,346 37,218 959,372
D_China9 D_Mal68 D_AHusky91 0.0040 0.424 52,229 51,810 1,085,883
D_China9 D_Green D_Husky89 0.0063 0.586 46,453 45,871 1,003,859
D_China8 D_Green D_Mal68 0.0066 0.628 48,381 47,747 1,175,269
D_China8 D_Husky D_AHusky91 0.0068 0.744 46,638 46,006 1,155,853
D_China8 D_Mal68 D_Husky 0.0071 0.780 58,261 57,441 1,193,177
D_China8 D_Husky D_Husky89 0.0078 0.820 42,094 41,441 1,019,519
D_China9 D_Husky D_Green 0.0081 0.846 57,408 56,484 1,178,134
D_China9 D_AHusky91 D_Husky 0.0085 0.957 45,878 45,108 1,120,029
D_China9 D_Mal68 D_Husky 0.0096 1.121 57,254 56,163 1,156,324
D_China8 D_Green D_Husky 0.0124 1.296 58,444 57,014 1,211,379
D_China9 D_Husky D_Husky89 0.0141 1.428 42,263 41,090 1,009,765
D_China9 D_AHusky91 D_Green 0.0152 1.493 52,310 50,746 1,106,207
D_China8 D_Mal68 D_AHusky91 0.0146 1.553 53,877 52,324 1,120,670
D_China8 D_Mal68 D_Husky89 0.0160 1.601 47,812 46,307 992,341
D_China8 D_Green D_AHusky91 0.0193 1.872 53,594 51,565 1,137,595
D_China9 D_Husky89 D_AHusky91 0.0208 1.901 37,871 36,329 950,029
D_China9 D_Mal68 D_Green 0.0205 2.167 48,324 46,381 1,142,965
D_China9 D_Mal68 D_Husky89 0.0224 2.288 47,913 45,810 982,870
D_China8 D_Green D_Husky89 0.0250 2.488 47,327 45,021 1,012,257
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Table 3.13 Results of f4 ratio analysis depicted in Fig. 3.2 with Z>2 (Table 3.5) for
population codes).
PopA PopO PopX PopC PopA PopO PopB PopC Alpha Std.Err Z
CTVT OUT VDUA VDPNGPM : CTVT OUT PCD VDPNGPM 0.204 0.013 15.412
CTVT OUT VDUA VDPNGEH : CTVT OUT PCD VDPNGEH 0.194 0.013 14.816
CTVT OUT VDUA BEA : CTVT OUT PCD BEA 0.204 0.016 13.09
CTVT OUT VDUA CSP : CTVT OUT PCD CSP 0.180 0.016 11.361
CTVT OUT VDUA VDIJ : CTVT OUT PCD VDIJ 0.202 0.018 11.011
CTVT OUT VDUA DEU : CTVT OUT PCD DEU 0.197 0.018 10.884
CTVT OUT VDUA DTM : CTVT OUT PCD DTM 0.200 0.019 10.731
CTVT OUT VDUA VDVLS : CTVT OUT PCD VDVLS 0.177 0.017 10.671
CTVT OUT VDUA BOX : CTVT OUT PCD BOX 0.205 0.020 10.281
CTVT OUT VDUA DCH : CTVT OUT PCD DCH 0.181 0.018 9.878
CTVT OUT VDUA CC : CTVT OUT PCD CC 0.167 0.017 9.692
CTVT OUT VDUA VDVLC : CTVT OUT PCD VDVLC 0.159 0.016 9.692
CTVT OUT VDUA VDIB : CTVT OUT PCD VDIB 0.159 0.016 9.676
CTVT OUT VDUA VDVHG : CTVT OUT PCD VDVHG 0.154 0.017 9.148
CTVT OUT VDUA DLB : CTVT OUT PCD DLB 0.182 0.020 8.898
CTVT OUT VDUA DGS : CTVT OUT PCD DGS 0.198 0.023 8.702
CTVT OUT VDUA DTI : CTVT OUT PCD DTI 0.166 0.020 8.373
CTVT OUT VDUA VDVCB : CTVT OUT PCD VDVCB 0.138 0.017 8.041
CTVT OUT VDUA NGSD : CTVT OUT PCD NGSD 0.183 0.023 7.815
CTVT OUT VDUA DAE : CTVT OUT PCD DAE 0.128 0.020 6.375
CTVT OUT VDUA DVN : CTVT OUT PCD DVN 0.117 0.025 4.768
most PCD admixture. This is not surprising as these are closely related to Arctic
breeds (Brown et al., 2015; Shannon et al., 2015). The f4 ratio conducted above was
not completely appropriate for this population (as it assumes close relatedness to
Eurasian dogs; Fig. 3.2). We tested whether Alaskan village dogs had any PCD
ancestry (interbred with pre-contact dogs) by computing every possible combination
of the same f4 ratio (Fig. 3.2) but using only Arctic breeds (now including Alaskan
village dogs). We found that both Alaskan malamute and Greenland sledge dog
have a significant amount of ancestry from PCD (Tables 3.14 and 3.15). might be
the result of substructure among Arctic dogs. ADMIXTURE results supported the
f4 ratio analysis showing that the majority of modern American dog populations,
including 138 village dogs from South America and multiple “native” breeds (e.g.
Mexican hairless dogs and Louisiana catahoula leopard dogs), possess <4% PCD
ancestry (Fig. 3.12).
We found varying degrees of PCD/Arctic ancestry in three individual Carolina
dogs (0-33%; Fig. 3.12). Such signal might not have been detected by f4 analysis as a
result of the variable amount of ancestry in this population. This analysis also re-
vealed an affinity between Chinook and the PCD/CTVT/Arctic population (12-15%;
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Table 3.14 SNP array results of f4 ratio analysis used to estimate proportion of PCD
ancestry in Arctic breeds. Statistics with Z>2 are shown in bold.
PopX PopC PopB PopC alpha std.err z
AM VDUA : PCD VDUA 0.122 0.021 5.882
GSD VDUA : PCD VDUA 0.132 0.024 5.503
AM SH : PCD SH 0.097 0.023 4.266
GSD SH : PCD SH 0.105 0.026 4.004
GSD DAL : PCD DAL 0.096 0.039 2.443
AM DAL : PCD DAL 0.076 0.036 2.095
SH VDUA : PCD VDUA 0.028 0.02 1.413
DAL VDUA : PCD VDUA 0.043 0.034 1.268
DAL SH : PCD SH 0.02 0.03 0.651
GSD AM : PCD AM 0.008 0.026 0.311
AM GSD : PCD GSD -0.007 0.027 -0.279
SH DAL : PCD DAL -0.019 0.032 -0.601
VDUA DAL : PCD DAL -0.043 0.037 -1.171
VDUA SH : PCD SH -0.028 0.021 -1.351
DAL AM : PCD AM -0.080 0.042 -1.893
DAL GSD : PCD GSD -0.103 0.048 -2.165
SH GSD : PCD GSD -0.116 0.033 -3.552
SH AM : PCD AM -0.106 0.028 -3.825
VDUA GSD : PCD GSD -0.152 0.032 -4.745
VDUA AM : PCD AM -0.138 0.027 -5.138
Table 3.15 Genome-wide array results of f4 ratio analysis used to estimate
proportion of PCD ancestry in Arctic breeds. Statistics with Z>2 are shown in bold.
PopX PopC PopB PopC alpha std.err z
DMA DHU : PCD DHU 0.114 0.027 4.209
GSD DHU : PCD DHU 0.122 0.028 4.41
GSD DAL : PCD DAL 0.116 0.031 3.743
AM DAL : PCD DAL 0.104 0.03 3.496
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Fig. 3.12. ADMIXTURE results based on SNP array data for K = 4, 10 and 15. VD,
Village Dog. Figure adapted from Ní Leathlobhair et al. (2018).
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Fig. 3.12). This is not all that surprising given that Chinook dogs belong to the sledge
dog grouping. With K = 4, however, it was not possible to distinguish between PCD
and Arctic dog ancestry. The PCD/Arctic component in Carolina dogs and Chinook
might have been introduced as a result of admixture with Arctic dogs and not from
PCD. To test this we tried to separate PCD/Arctic ancestry with higher K values.
Both K = 10 and K = 15, however, failed to differentiate PCD and Arctic dog ancestry
but instead differentiated American Arctic dogs (Alaskan malamute and Greenland
sledge dogs) from Eurasian Arctic dogs (Fig. 3.12).
3.11.7 Pre-contact ancestry in Eurasian dog populations
Returning to the mtDNA analysis, out of the 667 modern domestic dog mitochondrial
genomes analysed in this chapter, only five modern samples were found carrying a
pre-contact mtDNA haplogroup: a Terrier cross from San Juan del Sur, Nicaragua
(GenBank accession: KU291094), a Chihuahua (GenBank accession: EU408262), a
Japanese Spitz (GenBank accession: EU789755), a non-breed dog from Shanxixian,
China (GenBank accession: EU789669) and a non-breed dog from Laem Ngop, Thai-
land (GenBank accession: EU789664). Two out of five of these sequences derive from
dogs in the Americas. Three, however, are from East Asia. This suggests a very low
frequency (~2.5%) of the PCD mtDNA haplogroup in East Asia .
All five of the aforementioned modern samples cluster together with ancient Mexican
dogs from Mayapan. We inferred the age of the MRCA between the Mayapan dogs
and the five modern dogs identified as monophyletic with PCD. We found that
these five modern dogs diverged from the Mayapan dogs between 6,289-9,865 years
ago (95% HPDI) suggesting that their divergence postdates the flooding of the land
bridge between Western and Eastern Beringia. Given this result, it is less likely that
the mtDNA haplotype of these dogs originated in Eurasia. These results instead
suggest that dogs carrying PCD ancestry were transported from the Americas into
East Asia. This most likely took place during recent times and could be linked to the
creation of hairless dog breeds in Asia (Drögemüller et al., 2008). However, further
work is required to test these possibilities.
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Table 3.16 D-statistics for D(Outgroup, North American wolf or Coyote or Taimyr
wolf, PCD, PCD). n corresponds to the number of SNPs where all populations have
data. Standard error for these statistics was obtained by performing a weighted
block jackknife over 1Mb blocks
Pop2 Pop3 Pop4 D Z BABA ABBA n
C_Cal AL3194 AL3223 0.0152 1.460 5,681 5,511 285,638
C_Cal AL3223 AL3194 -0.0152 -1.460 5,511 5,681 285,638
C_MidW AL3194 AL3223 0.0035 0.277 3,443 3,419 181,671
C_MidW AL3223 AL3194 -0.0035 -0.277 3,419 3,443 181,671
W_Mex1 AL3194 AL3223 -0.0130 -1.086 7,394 7,588 282,977
W_Mex1 AL3223 AL3194 0.0130 1.086 7,588 7,394 282,977
W_Yellow1 AL3194 AL3223 -0.0083 -0.785 7,501 7,626 281,684
W_Yellow1 AL3223 AL3194 0.0083 0.785 7,626 7,501 281,684
W_Yellow2 AL3194 AL3223 -0.0067 -0.622 7,513 7,615 282,189
W_Yellow2 AL3223 AL3194 0.0067 0.622 7,615 7,513 282,189
TAI AL3194 AL3223 -0.0001 -0.005 3,026 3,026 116,212
TAI AL3223 AL3194 0.0001 0.005 3,026 3,026 116,212
3.11.8 Introgression from wild American canids
The relatedness between the CTVT founder dog and PCD, as well as the time of
CTVT origin, is compatible with the possibility that the CTVT founder dog was in
North America. To further assess the plausibility of this scenario, we quantified
introgression from North American endemic canids (coyotes and North American
wolves) into pre-contact dogs, modern Arctic dogs, and the CTVT founder dog.
The CTVT founder dog showed weak evidence of admixture with coyotes, but
does not appear to have admixed with North American wolves (Fig. 3.13).
These analyses also indicated that PCDs from Port au Choix and Weyanoke (~2× and
~0.5× coverage, respectively; Fig. 3.1a) share a significant number of derived alleles
with coyotes and North American wolves, indicative of admixture (Fig. 3.13 and 3.14).
We also tested for extra admixture from wild canids into our higher coverage PCD
genomes (AL3194; AL3223) but found no evidence of this (Table 3.16).
PCA suggests that the Koster dog (AL2135; ~9,900 cal BP) was admixed with wild
canids. We found borderline significant results (|Z|>2; Table 3.17) suggestive of
admixture from Coyote into AL2135. This sample, however, was very low coverage
(only ~17K SNPs were called). Its placement on the PCA and this positive admixture
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Fig. 3.13. Box plots representing D-statistics for every combination of a.
D(Outgroup, North American Wolf, Pop3, Pop4) c. D(Outgroup, Coyote, Pop3,
Pop4) where Population 3 (Pop 3) and Population 4 (Pop 4) represent every possible
combination of dog populations. Box plots representing significance of D-statistics
are shown in b. and d. The y-axis represents Pop 3. Positive values support a close
relationship between Pop 3 and the test population (Coyote or North American
Wolf) while negative support a close relationship between Pop 4 and the test
population. Figure adapted from Ní Leathlobhair et al. (2018).
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Fig. 3.14. Qpgraph model with admixture fractions including West Eurasian dogs
(Portuguese village dogs), East Asian dogs (Vietnamese village dogs), pre-contact
dogs (PCD) (Port au Choix, AL3194 and Weyanoke Old Town, AL3223), Arctic dogs
(Malamute), CTVT (79T and 24T), Eurasian wolves from Spain and Portugal, North
American wolves from Yellowstone, and coyotes as an outgroup. Figure adapted
from Ní Leathlobhair et al. (2018)
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Table 3.17 D-statistics for D(Outgroup, North American wolf or Coyote or Taimyr
wolf, PCD, PCD). The Andean fox was used as an outgroup for these analyses. n
corresponds to the number of SNPs where all populations have data. Standard error
for these statistics was obtained by performing a weighted block jackknife over 1Mb
blocks. Statistics with Z>3 and Z<-3 are shown in bold.
Pop2 Pop3 Pop4 D Z BABA ABBA n
W_Mex1 AL2135 AL3194 0.0690 1.024 112 98 2,762
W_Mex1 AL3194 AL2135 -0.0690 -1.024 98 112 2,762
W_Yellow1 AL2135 AL3194 0.0808 1.304 124 106 2,758
W_Yellow1 AL3194 AL2135 0.0808 -1.304 106 124 2,758
W_Yellow2 AL2135 AL3194 0.0792 1.248 120 102 2,764
W_Yellow2 AL3194 AL2135 -0.0792 -1.248 102 120 2,764
C_Cal AL2135 AL3194 -0.0004 -0.006 87 87 2,794
C_Cal AL3194 AL2135 0.0004 0.006 87 87 2,794
C_MidW AL2135 AL3194 -0.1814 -2.034 43 62 1,863
C_MidW AL3194 AL2135 0.1814 2.034 62 43 1,863
TAI AL2135 AL3194 0.1284 1.217 53 41 1,098
TAI AL3194 AL2135 -0.1284 -1.217 41 53 1,098
signal might therefore a result to this low coverage.
It had been suggested that some North American wolves obtained a mutation lead-
ing to black coat colour possibly via admixture with early American dogs (Anderson
et al., 2009). However, no evidence was found for the CBD103△G23/ KB mutation
in either of the two higher-coverage ancient PCDs analysed (AL3194 and AL3223;
Table 3.3) or in CTVT. Additional ancient genomes are necessary to determine if this
allele was present in the PCD population.
3.11.9 Introgression from the archaic Taimyr wolf
Skoglund et al. (2015) previously presented evidence for introgression from an
ancient Siberian wolf lineage into modern dog breeds from northeast Siberia and
Greenland. Testing for Taimyr admixture in our ancient and modern dog sample
set using D-statistics (Section 3.9.7), we found few values with |Z|>3 (AL3194 and
malamute; Table 3.18). Lowering the threshold to |Z|>2.5, we found admixture
from the Taimyr wolf into PCD (both AL3194 and AL3223) as well as in all Arctic
dogs (husky, Greenland sledge dog, and malamute) and CTVT. No evidence was
found for excess admixture from the Taimyr wolf into either CTVT, PCD or Arctic
populations (Table 3.19). This suggests that the Taimyr wolf introgression into Arctic
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Table 3.18 D-statistics for D(Outgroup, Taimyr, PCD/Arctic dogs, European, Asian,
or Arctic dogs). n corresponds to the number of SNPs where all populations have
data. Standard error for these statistics was obtained by performing a weighted
block jackknife over 1Mb blocks. Statistics with Z>3 and Z<-3 are shown in bold.
Pop2 Pop3 Pop4 D Z BABA ABBA n
TAI AL3194 D_India168 -0.0274 -3.377 13,074 13,812 297,919
TAI AL3194 D_Peru -0.0267 -3.293 17,139 18,079 384,525
TAI AL3194 D_India60 -0.0247 -3.254 17,383 18,264 372,784
TAI AL3194 D_Na8 -0.0256 -3.199 16,614 17,489 366,726
TAI D_Mal68 D_Na8 -0.0206 -3.127 19,530 20,350 459,311
TAI AL3194 D_Port61 -0.0236 -3.006 17,398 18,239 387,777
TAI D_Mal68 D_Peru -0.0195 -2.856 20,182 20,983 482,639
TAI D_Mal68 D_India60 -0.0189 -2.789 20,930 21,735 465,930
TAI D_Mal68 D_Port61 -0.0204 -2.768 20,358 21,206 485,553
TAI AL3194 D_Viet59 -0.0227 -2.753 13,212 13,824 308,811
TAI D_Green D_Na8 -0.0202 -2.674 20,383 21,224 465,676
TAI D_Husky89 D_India168 -0.0205 -2.664 13,042 13,588 314,547
TAI D_Green D_India60 -0.0198 -2.607 21,505 22,372 472,462
TAI D_Husky89 D_Port61 -0.0215 -2.571 17,284 18,043 413,104
TAI D_Husky89 D_Peru -0.0201 -2.525 17,191 17,896 410,031
TAI D_Green D_Port61 -0.0197 -2.506 21,204 22,058 492,659
TAI AL3194 D_Husky -0.0199 -2.498 16,444 17,111 394,720
TAI AL3194 D_SLaika -0.0194 -2.485 16,821 17,487 379,149
TAI D_Green D_India168 -0.0178 -2.481 15,728 16,296 377,110
TAI D_Mal68 D_Na89 -0.0195 -2.481 12,195 12,680 289,545
TAI D_Green D_Peru -0.0194 -2.455 20,782 21,605 488,730
TAI D_Husky89 D_India60 -0.0186 -2.44 17,456 18,117 394,520
TAI AL3194 D_Mex -0.0193 -2.426 17,007 17,675 380,509
TAI AL3194 D_Viet21 -0.0204 -2.419 13,088 13,634 303,723
TAI AL3194 D_Tibet3 -0.0184 -2.41 16,776 17,403 375,015
TAI AL3194 D_Portt71 -0.0185 -2.366 16,997 17,637 379,175
159
dogs suggested in Skoglund et al. (2015) may have taken place after the PCD, Arctic
dog and CTVT lineage diverged from Eurasian dogs but before the divergence of the
Arctic dog and PCD/CTVT lineages.
3.12 Discussion
In this section, I reconstruct a narrative of CTVT emergence and pre-contact dog
population history consistent with results outlined above. I discuss the limitations
of this work results and identify further research questions arising from the results
of this chapter.
3.12.1 Emergence of CTVT
This analysis infers an upper bound for the emergence of CTVT, 8,225 years ago based
on mutation count data from a case of direct transmission of CTVT from mother
to pup during birth. Although we have determined that CTVT first arose in a dog
that was closely related to PCDs, this analysis does not pinpoint the precise location
in which CTVT originated. As coyotes are currently restricted to North America,
evidence of coyote introgression (Fig. 3.13c) suggests the CTVT founder dog may
have been in North America; however, due to sampling limitations, we were unable
to ascertain the degree of coyote ancestry in ancient PCD-related dogs outside of
America (such as the Zhokhov Island dogs in Northern Siberia). Genome-wide data
from the ancient Zhokhov dog population will provide valuable insight into the
geographic origin of CTVT as well as PCD population history.
A reconstructed phylogeography of the CTVT clone, described in Chapter 2 (Sec-
tion 2.6.5), rather indicates that the earliest dispersals of the lineage were in Asia,
suggesting that CTVT originated in Northern or Central Asia. Further, the phylogeny
suggests a later, post-contact introduction of the modern CTVT lineage found in
the Americas followed by rapid dispersal (Fig. 2.7; Fig. 2.15). However, we cannot
exclude the possibility that the clone first arose in America and then dispersed early
into Asia before being reintroduced to America.
Both scenarios raise the intriguing possibility that CTVT may have contributed
to PCD demise. Intriguingly, a recent study proposed that infectious disease may
have constrained the spread of dogs into South America and explains the relatively
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Table 3.19 D-statistics for D(Outgroup, Taimyr, PCD or Arctic dogs, CTVT or Arctic
dogs or PCD). n corresponds to the number of SNPs where all populations have
data. Statistics indicate that there has been no extra admixture from the Taimyr wolf
into other populations.
Pop2 Pop3 Pop4 D Z BABA ABBA n
TAI AL3194 C_24T -0.0239 -2.258 10,176 10,674 380,938
TAI AL3194 C_79T -0.0267 -2.364 8,948 9,438 346,188
TAI AL3194 D_AHusky91 -0.0126 -1.58 15,165 15,554 370,227
TAI AL3194 D_Green -0.0059 -0.681 15,468 15,650 387,439
TAI AL3194 D_Husky -0.0199 -2.498 16,444 17,111 394,720
TAI AL3194 D_Husky89 -0.0076 -0.915 13,258 13,462 321,758
TAI AL3194 D_Mal68 -0.0025 -0.312 15,225 15,301 382,193
TAI C_24T AL3194 0.0239 2.258 10,674 10,176 380,938
TAI C_24T C_79T -0.0014 -0.654 5,721 5,737 441,374
TAI C_24T D_AHusky91 0.0045 0.587 19,419 19,247 461,923
TAI C_24T D_Green 0.009 1.179 19,495 19,147 483,404
TAI C_24T D_Husky -0.0028 -0.381 20,900 21,018 493,025
TAI C_24T D_Husky89 0.0071 0.929 17,107 16,865 405,779
TAI C_24T D_Mal68 0.0102 1.321 19,467 19,075 476,690
TAI C_79T AL3194 0.0267 2.364 9,438 8,948 346,188
TAI C_79T C_24T 0.0014 0.654 5,737 5,721 441,374
TAI C_79T D_AHusky91 0.0041 0.539 17,112 16,972 416,326
TAI C_79T D_Green 0.0062 0.786 17,041 16,832 435,794
TAI C_79T D_Husky -0.0021 -0.279 18,489 18,566 446,651
TAI C_79T D_Husky89 0.0081 1.039 14,690 14,454 358,654
TAI C_79T D_Mal68 0.0113 1.419 17,079 16,698 429,798
TAI D_AHusky91 AL3194 0.0126 1.58 15,554 15,165 370,227
TAI D_AHusky91 C_24T -0.0045 -0.587 19,247 19,419 461,923
TAI D_AHusky91 C_79T -0.0041 -0.539 16,972 17,112 416,326
TAI D_AHusky91 D_Green 0.0083 1.034 17,900 17,607 470,340
TAI D_AHusky91 D_Husky -0.0081 -1.105 15,523 15,775 478,592
TAI D_AHusky91 D_Husky89 0.0009 0.115 12,481 12,458 394,759
TAI D_AHusky91 D_Mal68 0.0072 1.009 18,163 17,904 463,584
TAI D_Green AL3194 0.0059 0.681 15,650 15,468 387,439
TAI D_Green C_24T -0.009 -1.179 19,147 19,495 483,404
TAI D_Green C_79T -0.0062 -0.786 16,832 17,041 435,794
TAI D_Green D_AHusky91 -0.0083 -1.034 17,607 17,900 470,340
TAI D_Green D_Husky -0.0137 -1.839 19,216 19,750 501,352
TAI D_Green D_Husky89 -0.0025 -0.296 15,501 15,578 416,390
TAI D_Green D_Mal68 -0.0002 -0.029 16,258 16,266 485,928
TAI D_Husky AL3194 0.0199 2.498 17,111 16,444 394,720
TAI D_Husky C_24T 0.0028 0.381 21,018 20,900 493,025
TAI D_Husky C_79T 0.0021 0.279 18,566 18,489 446,651
TAI D_Husky D_AHusky91 0.0081 1.105 15,775 15,523 478,592
TAI D_Husky D_Green 0.0137 1.839 19,750 19,216 501,352
TAI D_Husky D_Husky89 0.0123 1.655 14,207 13,860 419,790
TAI D_Husky D_Mal68 0.013 1.913 19,767 19,258 494,030
TAI D_Husky89 AL3194 0.0076 0.915 13,462 13,258 321,758
TAI D_Husky89 C_24T -0.0071 -0.929 16,865 17,107 405,779
TAI D_Husky89 C_79T -0.0081 -1.039 14,454 14,690 358,654
TAI D_Husky89 D_AHusky91 -0.0009 -0.115 12,458 12,481 394,759
TAI D_Husky89 D_Green 0.0025 0.296 15,578 15,501 416,390
TAI D_Husky89 D_Husky -0.0123 -1.655 13,860 14,207 419,790
TAI D_Husky89 D_Mal68 0.0043 0.587 15,803 15,667 408,271
TAI D_Mal68 AL3194 0.0025 0.312 15,301 15,225 382,193
TAI D_Mal68 C_24T -0.0102 -1.321 19,075 19,467 476,690
TAI D_Mal68 C_79T -0.0113 -1.419 16,698 17,079 429,798
TAI D_Mal68 D_AHusky91 -0.0072 -1.009 17,904 18,163 463,584
TAI D_Mal68 D_Green 0.0002 0.029 16,266 16,258 485,928
TAI D_Mal68 D_Husky -0.013 -1.913 19,258 19,767 494,030
TAI D_Mal68 D_Husky89 -0.0043 -0.587 15,667 15,803 408,271
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late appearance of dogs on the continent (~6,000 years after their arrival in North
America) (Mitchell, 2017). Given that CTVT is a contagious allograft, it is possible
that it more effectively colonised and caused more severe morbidity in hosts with
which the tumour shared genetic affinity. Previous analyses of heterozygosity in the
founder have suggested that CTVT first emerged in a relatively inbred population
of dogs as an opportunistic pathogen (Murchison et al., 2014; Murgia et al., 2006;
Rebbeck et al., 2009). It is possible that the success of CTVT as a ’coloniser’ relied
on a reservoir of inbred individuals to host the tumour in its early stages; early
competition for hosts within a small population of dogs may even have facilitated
pathogenic genome adaptation in CTVT.
3.12.1.1 Assumptions underlying time-of-origin estimate
The model I have used to derive a somatic mutation rate for CTVT relied on the
following assumptions: (i) the mother’s tumour (609T) was seeded either by a single
CTVT cell or a single clone of identical CTVT cells (i.e. monoclonal seeding), (ii)
the age estimate provided for the pup (Dog 608) is accurate, (iii) the mother (Dog
609) was infected with CTVT at the time of the heat cycle during which she con-
ceived the pup (Dog 608), (iv) the contribution of variable mutation opportunity to
our estimates was negligible and the N[C>T]G rate has remained constant, (v) the
contribution of back-mutations to our estimates was negligible, (vi) estimates of the
total somatic mutation burden in CTVT are accurate, (vii) mutation false discovery
rate in tumour-unique and tumour-only variant sets was equivalent.
In addition, I based my estimate of the CTVT mutation rate on a single observation of
transmission. Future studies could address this, and account for sampling variation,
by measuring mutation rates either across other samples derived from direct trans-
missions or spatially separated samples of the same tumour. Multi-region sampling
and sequencing of tumour biopsies derived from the mother and pup sampled in
this study would be useful in confirming clonal and subclonal populations within
the tumours and could stand to refine our estimate of CTVT origin.
Despite these limitations, this analysis provides a plausible estimate of the CTVT
somatic mutation rate, and is comparable with clock-like mutation rates observed in
human cancers (Alexandrov et al., 2015).
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3.12.2 Origin of pre-contact dogs
The earliest evidence of dogs in the North American archaeological record, dates to
~10,000 years ago (Perri et al., 2018). Our molecular clock analysis indicates that the
PCD lineage appeared ~6,500 years after North American human lineages (Ragha-
van et al., 2015). A time frame in which dogs were brought to the Americas several
thousand years after the first human migration (Moreno-Mayar et al., 2018), before
the flooding of the Bering land bridge ~11,000 years ago (Jakobsson et al., 2017),
would be compatible with both the archaeological record and the PCD divergence
time estimate.
Although this study does not address the question of domestication, the findings of
this chapter are broadly consistent with a single domestication followed by an early
split into three geographically isolated groups, in line with recent studies (Botigué
et al., 2017; Loog et al., 2018) and in contrast to the recent suggestion that extant
global dog populations arose from two independent domestications (Frantz et al.,
2016).
An in-depth exploration of dog history in the Americas will require more com-
plete genomes along with higher coverage genomes, both nuclear and mitochondrial,
from ancient and modern dogs. Notably, our sampling did not include dogs from
sites associated with the Thule culture; these samples would be especially interesting
considering that modern American Arctic dogs are plausibly the descendants of
dogs introduced by the Thule. The seven pre-contact nuclear genomes generated
as part of this study were sequenced to (0.005 to 2×), far lower than the coverage
achieved in other aDNA studies (Botigué et al., 2017; Frantz et al., 2016), making it
difficult to comprehensively genotype variants and limiting the types of analyses
that could be applied.
3.12.3 Evolutionary history of pre-contact dogs
The evolutionary history of dogs in North America is characterised by multiple
introductions and replacements (Fig. 3.15a) This analysis suggests, as discussed, that
an initial dog population entered North America and then dispersed throughout
the Americas, where it remained isolated for at least 9,000 years. Within the past
1,000 years, however, at least three independent migrations of dogs into the Americas
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have occurred (Fig. 3.15a). The first may have consisted of Arctic dogs that arrived
with the Thule culture ~1,000 years ago (Brown et al., 2015). Then, beginning in the
15th century, Europeans brought a second wave of dogs that appear to have almost
completely replaced native dogs. Lastly, Siberian huskies were introduced to the
American Arctic during the Klondike or Alaskan gold rush (Derr, 2005). As a result
of these more recent introductions, the present-day population of American dogs is
largely derived from Eurasian breeds.
Based on our results of our analyses (Section 3.11.5), it is likely that the Eurasian Arctic
dogs that were recently brought into the Americas, as far as Greenland, originated
from a population that was more closely related to PCD dogs than other Arctic dogs.
The high degree of mtDNA divergence detected within ancient (~9,000 BP) Eurasian
Arctic dogs from Zhokhov Island suggests that ancient substructure with Arctic dogs
is a plausible scenario.
3.12.4 Disappearance of pre-contact dogs
The most puzzling aspect of PCD population history is their almost total disap-
pearance. The results presented in this chapter suggest that European dogs almost
completely replaced native dog lineages in the Americas. The decline of pre-contact
dogs may have been influenced by changing cultural preferences, possibly influenced
by the arrival of Europeans, or by persecution of native dogs (Derr, 2005). Similar to
indigenous human populations in the Americas (Lindo et al., 2016), native dogs may
have experienced high mortality rates during the early contact period as a result of
newly introduced infectious diseases to which pre-contact dogs were susceptible
(Velasco-Villa et al., 2017). It is also worth noting that while our mitogenome evidence
suggests that PCD-like dogs were in North-East Siberia ~9,000 years ago, dogs with
a close affinity to the PCD clade have not been sampled in modern Siberia.
However, it is plausible that the modern American Arctic dogs included in our
analysis, such as Alaskan malamutes and Greenland dogs, are the descendants of
dogs introduced to the Americas during the Thule expansion. Alternatively, Thule
dogs may form part of the pre-contact dog lineage and the modern American Arctic
dogs sampled in this study may be the descendants of Eurasian Arctic dogs, many of
which were recently introduced during the 19th-century Alaskan gold rush and as
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Fig. 3.15. a. A map depicting multiple migrations of dogs into the Americas
consistent with archaeological and genetic data. Note that these arrows do not
depict exact geographic migration routes. Key archaeological sites from which dog
remains were analysed in this chapter are labelled. BP, before present. AD, Anno
Domini. Figure adapted from Ní Leathlobhair et al. (2018). b. Tree schematic of four
independent dog introductions to the Americas. Branch lengths are not meaningful.
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sledge dog racing stock. In either case, the descendants of pre-contact or Thule dogs
would both have admixed with Eurasian dogs. Finally, it is also possible that, similar
to human populations (Ebenesersdóttir et al., 2018), extensive genetic drift resulting
from a founder effect could explain the divergence of modern Arctic dogs from their
pre-contact dog source population. This hypothesis has not yet been tested, however.
Mitochondrial ancestry analyses did detect the presence of the PCD mitochondrial
haplotype in three East Asian dogs (Section 3.11.6). Multiple scenarios could explain
the finding of East Asian dogs within the PCD clade: for instance, the clade to which
these East Asian samples belong could have diverged from pre-contact dogs prior to
their introduction into the Americas or there were back and forth migratory move-
ments between the continents after the flooding of the land bridge between Western
and Eastern Beringia ~11,000 years ago.
A major direction for future data collection would be to fill in sampling gaps in
extant dog populations. We cannot rule out that some larger degree of PCD ancestry
may remain in American dogs that have not yet been sampled. A further survey of
the diversity and ancestry of dogs in North-East Asia, the North American Arctic
and South America is warranted with special emphasis on ’indigenous’ dog groups.
3.12.5 Summary
Pre-contact dogs represent a relatively unexplored evolutionary branch of the dog
population. This lineage could be invaluable in understanding the history of dog
domestication and genomic changes associated with early population bottlenecks.
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Chapter 4
Investigating the transmission of urogenital carcinoma in
California sea lions
4.1 Chapter abstract
This chapter deviates from the theme of the origin and evolution of the Canine
Transmissible Venereal Tumour to consider the emergence of contagious cancer
in other animal species, a possibility I discussed in the introduction to this thesis
(Section 1.2.3). During the four years since the beginning of my PhD, six further
transmissible cancers were discovered in multiple species (Metzger et al., 2015, 2016;
Pye et al., 2016). These findings raise the possibility that other cancers could be due
to transmission of cancer cells, specifically those that occur at high prevalence and
those with a plausible route of transmission. Recent studies have also shown that
transmissible cancer cells can transmit within marine environments (Metzger et al.,
2015, 2016) and that these rogue cells might be common infectious agents.
Urogenital carcinoma is a highly metastatic cancer in California sea lions (Zalo-
phus californianus) and is one of the most commonly observed cancers in wildlife.
Although a putative viral agent (Otarine herpesvirus-1, OtHV-1) has been suggested
and is associated with lesions, a causative role for this virus has not been confirmed.
The genital localisation of primary tumours suggests the possibility that coital trans-
mission of an infectious agent could underlie this disease.
Here, I investigate the etiology of a highly prevalent cancer in sea lions and, specifi-
cally, the possibility that UGC might be clonally transmitted by testing for genetic
differences between tumour and host cells. Analysis of mitochondrial DNA control
region sequences in seven matched tumour and host pairs confirmed that tumour
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genotypes were identical to those of their matched hosts and did not show similarity
with tumours from other individuals. Thus our findings suggest that urogenital
carcinoma in California sea lions is not clonally transmitted, but rather that tumours
derive from transformed host cells.
4.2 Publications associated with this chapter
This study was published in Wellcome Open Research as a Research Note on 27th June
2017 (Ní Leathlobhair et al. (2017); see Appendix 2 for the full reference).
4.3 Introduction
Cancer is widespread in animal populations and the reported incidence of neopla-
sia in wildlife species is increasing (Pesavento et al., 2018). Global climate change
and anthropogenic activities environmental toxins such as plastics and mutagens.
There are obvious challenges in diagnosing and monitoring cancer in wildlife species.
Urogenital carcinoma (UGC) is the most commonly observed neoplasm in Cali-
fornia sea lions (Browning et al., 2015). This cancer was first reported in sea lions on
the west coast of North America in 1979 (Gulland et al., 1996), and over a fourteen-
year period, from 1998 to 2012, the disease was found in 26 per cent of adult animals
examined post-mortem at The Marine Mammal Center, California (Browning et al.,
2015). The prevalence of the disease in the wider sea lion population is unknown
UGC affects both male and female animals, and is most frequently found in sexually
mature adults (Colegrove et al., 2009; Lipscomb et al., 2010). The disease typically
presents with extensive multi-organ metastases; however, primary lesions involving
the genital epithelium can usually be identified (Lipscomb et al., 2000).
Three aetiological factors have been proposed for the development of UGC: infection,
host genetics, and environmental factors. Otarine herpesvirus-1 infection, a gamma-
herpesvirus related to Kaposi’s sarcoma-linked human herpesvirus-8 (King et al.,
2002; Lipscomb et al., 2000) has been associated with UGC (Buckles et al., 2006; King
et al., 2002; Lipscomb et al., 2000); however, this virus has not been confirmed as a
causative agent. An association between UGC and genital bacterial infection has also
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Fig. 4.1. Urogenital Carcinoma presentation in California Sea Lions. Primary masses
in the urinary and genital tract can be observed as well as metastatic masses in the
adrenals, ovaries, liver, kidney, spleen and serosal surfaces. Images are reproduced
with permission from Frances Gulland (The Marine Mammal Center, Sausalito, CA).
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been proposed (Johnson et al., 2006). Genetic studies have indicated that individuals
with high parental relatedness (Acevedo-Whitehouse et al., 2003), homozygosity at
the heparanase-2 (HSPE2) locus (Browning et al., 2014), or one or more copies of
the Zaca-DRB.A MHC class II locus (Bowen et al., 2005) have increased risk of UGC.
Environmental contaminants, such as organochlorines, have also been proposed as
causative agents in UGC carcinogenesis (Ylitalo et al., 2005).
Several features of UGC are compatible with the possibility that this cancer is clonally
transmissible: epidemiological observations of UGC are consistent with an infec-
tious aetiology for the disease (Gulland et al., 1996); and, in particular, its genital
localisation could provide a coital route of transmission (Buckles et al., 2007), as
observed in CTVT.
In the introduction, I have covered features of UGC pathogenesis that make this
cancer a reasonable suspect for clonal transmission. The straightforward aim of this
chapter was to test whether urogenital carcinoma in sea lions could be a transmissible
cancer in collaboration with researchers at The Marine Mammal Center.
4.4 Methods
4.4.1 Sample collection
This study was approved by The Marine Mammal Center Institutional Animal Care
and Use Committee (Sausalito, CA) and the National Marine Fisheries Service MMPA
(permit number 18786).
Tissues from seven wild stranded adult California sea lions were collected at The
Marine Mammal Center, Sausalito, CA. Complete gross and histopathological ex-
aminations were performed on each animal to confirm UGC diagnosis. Tumour
(metastasis) and host tissue (liver or muscle) biopsies were collected into RNAlater
during post-mortem examination and were stored at -70°C until processing. Jinhong
Wang (Cambridge) and Barbie Halaska assisted with sample collection.
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4.4.2 DNA extraction
Representative tissue sampled from tumour and host biopsies was used for DNA ex-
traction using the Qiagen DNeasy Blood and Tissue Kit according to manufacturer’s
instructions. DNA was quantified using a Qubit 2.0 fluorometer.
4.4.3 PCR
A 1289 bp fragment of the mtDNA control region was amplified using the following
primer set, described by Wolf et al. (2007): Dloop_F, 5’ CCTCCCTAAGACTCAAGGA-
AGAA 3’; Dloop_R, 5’ GCCAGGACCAAACCTTTGTGT 3’. PCR was performed using
an Eppendorf Mastercycler Nexus GSX1 with conditions as follows: 40ng of genomic
DNA was amplified in a total volume of 20µl containing 0.5µmol of each primer,
0.2mmol of each dNTP and 0.02 units of Taq DNA polymerase per reaction. Cycling
conditions were 95°C for 3 min, 30 cycles of 95°C for 15 s, 60°C for 30 s, 72°C for 45
s and a final extension step at 72°C for 5 min. PCR products were purified using a
QIAquick PCR purification kit. Purified PCR products were capillary sequenced at
Source BioScience LifeSciences Genomic Services.
4.4.4 Sequence alignment and variant calling
Sequences were aligned to the California sea lion mtDNA reference genome (NCBI
Reference Sequence NC_008416) (Arnason et al., 2006) using Sequencher DNA Se-
quence Analysis Software (v5.4.6). Alignment errors were inspected manually and
corrected. Variant positions were identified by viewing alignments, as well as
by manual assessment of sequence chromatograms using FinchTV (v1.4.0). Vari-
ants were only assessed within a 397 bp region of the product, comprising region
MT:15490–15886 in NC_008416.
4.5 Results
Tumours derived from clonally transmissible cancers carry the genetic material of
the original animal that first gave rise to the cancer; thus, transmissible cancers are
characterised by shared genotypes that are distinct from those of their matched hosts.
To determine whether UGC is clonally transmissible, we assessed 397 base pairs of the
mtDNA control region in seven UGC tumours and their matched hosts. The analysis
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Table 4.1 Mitochondrial DNA (mtDNA) genotypes at nine polymorphic sites in sea
lion hosts and matched tumours. Coordinates are relative to the sea lion mtDNA
reference genome, NC_00841621. Individual California sea lions are labelled
numerically and matched hosts and tumours are represented side-by-side. Alleles
that differ from the reference are shaded in grey.
mtDNA
base
posi-
tion
Reference CSL1
(H)
CSL1
(T)
CSL2
(H)
CSL2
(T)
CSL3
(H)
CSL3
(T)
CSL4
(H)
CSL4
(T)
CSL5
(H)
CSL5
(T)
CSL6
(H)
CSL6
(T)
CSL7
(H)
CSL7
(T)
MT:15524 T T T T T T T T T T T C C T T
MT:15527 T T T T T T T C C C C C C T T
MT:15528 T T T T T T T C C C C C C T T
MT:15550 G G G G G G G A A A A A A G G
MT:15551 A A A A A A A G G G G A A A A
MT:15629 C C C C C C C C C C C C C T T
MT:15652 A A A A A A A A A A A G G A A
MT:15660 T T T T T T T C C C C C C T T
MT:15812 G G G G G G G A A A A A A G G
identified nine polymorphic sites characterising four unique genotypes within the
sampled sea lion population (Table 4.1). In all cases, the alleles present in tumours
were identical to those found in matched host tissue (Table 4.1). Chromatograms
were closely examined at polymorphic sites to rule out the presence of a possibly
under-amplified sequence, but no evidence for amplification of additional alleles in
tumour tissues was found (Riquet et al., 2017).
4.6 Discussion
This is one of the first systematic studies that attempts to test the hypothesis of
clonal transmission of wildlife cancers. Given that transmissible cancers are clonal
lineages, tumour cell morphology and tissue architecture is generally very similar
between tumours (Karlson and Mann, 1952; Loh et al., 2006). However, previous
research has shown that UGCs appear to develop through histologically distinct
stages (Lipscomb et al., 2000), which further supports the idea of step-wise onco-
genic transformation of host tissue rather than direct transmission of a cancer lineage.
While the results of this study do not support the hypothesis that UGC is clon-
ally transmitted, we cannot exclude the possibility that undetected UGCs may be
clonally transmitted. The genital localisation of this cancer, and the likely accessibility
of UGC cancer cells to other individuals during coitus, mean that UGC tumours may
pose a particular risk for the emergence of a transmissible cancer clone. It is possible
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that short-lived transmissible cancers may arise in a population and infect secondary
hosts but die out before they are detected.
Future research exploring the role of viral agents, host genetics and environmental
factors, as well as somatic genetics, will be important for understanding the carcino-
genic processes that cause UGC. It is interesting to note that an OtHV-1-associated
UGC has been reported in a South American fur seal (Arctocephalus australis) (Da-
gleish et al., 2013), indicating that other pinnipeds are susceptible to UGC, and
further implicating OtHV-1 as a causative agent. Furthermore, analysis of cytological
smears collected from California sea lions in the Gulf of California revealed that
transformation of the genital epithelium may be relatively common in this species
(Barragán-Vargas et al., 2016).
There are a number of limitations concerning this analysis. We only examined
genetic variation at one mtDNA locus. As we have shown, at least one transmissible
cancer has been observed to sporadically capture mtDNA from its hosts (Rebbeck
et al., 2011); thus, mtDNA may not be the most reliable marker for assessing clonality
in transmissible cancers. Horizontal transfer of mitochondrial DNA has been de-
tected only twenty times in a cohort of 640 CTVT tumours (Strakova et al., 2016); thus
even if mtDNA capture had occurred, it would not be expected that tumours would
genetically match their hosts as frequently as we have observed in UGC. There is also
the potential risk of amplifying nuclear mitochondrial DNA segments. Although the
occurrence of NuMTs has not yet been reported in California sea lions, NuMTs are a
major confounder in a wide variety of mammals (Calabrese et al., 2017), as discussed
in Section 2.3.7. While this first screen largely refutes the hypothesis that UGC is
clonally transmitted, an increased sample size and the inclusion of nuclear molecular
markers would undoubtedly provide more robust evidence for this conclusion.
Wildlife models of cancer can provide novel insights into general mechanisms of
cancer development (McAloose and Newton, 2009). Like pathogens and parasites,
cancer, especially transmissible cancer, can have a negative impact on host fitness
in wildlife populations and is an important, but often overlooked, feature of animal
ecosystems (Vittecoq et al., 2013). Furthermore, an understanding of the aetiological
factors underlying commonly observed cancers in wildlife is essential for conserva-
tion and biomonitoring. In this study, we have found no evidence that UGC, one of
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the few “cancer epidemics” in wildlife (Browning et al., 2015; McAloose and Newton,
2009), is clonally transmitted. Ruling out this mode of carcinogenesis is an important
step in our understanding of UGC, and paves the way towards further research
investigating the processes underlying this aggressive disease in sea lions.
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Chapter 5
Conclusions and Perspectives
5.1 Summary of the main findings
This thesis describes two major sequencing studies aimed at understanding aspects
of the origin and evolution of CTVT. Together, these studies unravel new insights
into the biology of transmissible cancers, as well as canine genetics, and suggest
exciting future avenues of research.
The main results of this thesis, motivated by the research questions established
out in each chapter, are as follows:
1. Horizontal DNA transfer is frequently observed in CTVT. CTVT has
captured mtDNA from its transitory hosts via horizontal DNA transfer
at least twenty times over the last two thousand years. Eighteen of these
mtDNA horizontal transfer events define distinct CTVT clades, whose
locations and timings track the global migration patterns of dogs over
two millennia. For instance, we found evidence that CTVT was probably
introduced to South America concordant with Spanish colonisation, and
that CTVT arrived in Australia subsequent to European contact.
2. Recent repeated horizontal transfer of a specific dog mtDNA haplo-
type. A comparison of CTVT phylogenies generated from nuclear and
mitochondrial data revealed 13 instances of mtDNA horizontal transfer
involving mtDNA from the same dog mitochondrial haplogroup (A1d1).
This intriguing finding suggests that this haplotype may possess either
an adaptive or selfish selective advantage facilitating its propagation and
maintenance in the CTVT mitochondrial population.
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3. A similar process underlies somatic mtDNA mutation in CTVT and
in human cancers. The endogenous, strand-asymmetric signature ob-
served in CTVT mtDNA is most likely linked with mtDNA replication
and is similar to the mutational signature active in human cancers and in
the germline of several animal species.
4. Negative selection acts to limit the accumulation of gene-disrupting
mutations in CTVT mtDNA. Intuitively, we might expect negative se-
lection to operate in cancer, however, evidence for its activity has been
minimal, possibly due to heterogeneity in cancer vulnerabilities between
tissue types. Our analysis thus implicates functional mtDNA as a poten-
tial cancer driver in CTVT, providing strong genetic evidence underlining
the importance of mtDNA in CTVT evolution.
5. Ancient and recent DNA recombination activity has reorganised tu-
mour mitochondrial genomes in CTVT. Using phylogenetic techniques,
we found evidence for an ancient recombination event in a CTVT clade
1 mitochondrial haplotype found throughout Central and South Amer-
ica. Using PacBio long read sequencing, we were able to phase complete
mtDNA molecules, identifying evidence for complex real-time mtDNA
recombination in a CTVT tumour. This analysis has revealed a novel
genetic mechanism, possibly functioning in DNA repair, which may be
widespread but previously undetected in cancer.
6. A pre-contact American dog lineage survives as a transmissible ca-
nine cancer. Analysis of sequencing data derived from ancient dog re-
mains sampled in North America showed that the CTVT founder dog
belonged to a monophyletic lineage of dogs once present throughout
the Americas. This thesis reports the first ancient nuclear genomes from
multiple pre-contact dogs.
7. CTVT first arose in a founder dog individual that lived up to 8,225
years ago. I reported the first sequencing data from samples involved in
a direct CTVT transmission and used this data to calibrate a CTVT molec-
ular clock. Re-analysis of the timing of CTVT’s origin is an important
contribution to the field and frames the context of CTVT evolution.
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8. Pre-contact dogs in the Americas were not domesticated in situ. In-
stead, they were introduced by humans migrating from Asia ~17,000-
13,000 years ago from a source population related to modern Arctic dogs.
This lineage was subsequently isolated from Eurasian dogs for at least
9,000 years, most likely until a later introduction of dogs during the Thule
expansion.
9. Modern dog populations retain minimal genetic ancestry from pre-
contact dogs. In fact, most modern dogs in the Americas trace their
ancestry from populations introduced by Europeans. Modern Arctic
dogs in North America and Siberia share ancestry with PCD, but are not
their direct descendants.
10. Analysis of mitochondrial DNA single-nucleotide polymorphisms
indicates that urogenital carcinoma in California sea lions is not clon-
ally transmitted (see Chapters 1, 2, and 5.)
The results of Chapters 2 and 3 unravel new insights into the origin, evolution
and global spread of CTVT and suggest exciting future avenues of research while
Chapter 4 points towards Both studies have also generated data sets that will benefit
the wider research community and contribute to future studies of canine genetics
(host mitochondrial sequences in Chapter 2; pre-contact mitochondrial and nuclear
genome sequences in Chapter 3). Combining modern and ancient DNA analyses
as part of collaborative project, this thesis has shed light on when and where CTVT
first arose as well as the enigmatic dog population in which the disease is likely
to have emerged. Like many recent ancient human studies, this study combines
the resolving power of genomics with the time depth of archaeology to reconstruct
patterns of evolutionary history.
5.2 Implications and future perspectives
Overall, the data presented in Chapter 2 indicates an important role for functional
mitochondria in maintaining CTVT cell fitness. In this context, it is likely that spo-
radic capture of host mitochondria may have provided a selective advantage in
CTVT. Elucidation of these mechanisms goes some way towards understanding how
CTVT has managed to maintain genome stability in evolving tumour cell populations.
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Major themes for future research arising from this work would be understanding
how defective mtDNA may have altered the metabolic environment in CTVT as
well as understanding the pathophysiological significance of mtDNA horizontal
transfer and recombination. Understanding the mechanism and triggers of hor-
izontal transfer and, in particular, the reason for the recent, repeated uptake of
a specific haplotype (see Section 2.7.3) would be a particularly exciting direction
in light of the work presented here. Our analysis has reported the first evidence
for mtDNA recombination in cancer; not only does this challenge the dogma that
mitochondria in animal genomes is recombination inert but this process could be
a widespread DNA repair mechanism in cancer, and may be of therapeutic relevance.
One particularly exciting and unexpected direction of research in the context of
this thesis is the history of dogs in the Americas.
• First, a further inquiry into the origins and ancestry of dogs in South America
will be an interesting area for future study. During our analysis, we found that
a mitogenome derived from 1,000-year old dog remains in Argentina clusters
within the PCD group, suggesting that PCD contributed ancestry to pre-contact
dogs in South America. However, there is little evidence for PCD in modern
South American dog populations, suggesting that, similar to North America,
dogs harbouring PCD ancestry in South America were replaced by European
dogs after colonial contact.
• Second, although this study detected evidence of introgression from wild
North American canids (wolves and coyotes) in pre-contact and modern dog
populations this thesis does not address which population or populations of
wolves and coyotes, when introgression might have taken place, how many
introgression events there were and whether introgressed genes are under
selection. While qpGraph modelling (Fig. 3.14) suggests that the direction of
this admixture is from wolves to dogs, we cannot rule out gene flow from dogs to
wolves. Higher coverage genomes from pre-contact dogs as well as both North
American wolves and coyotes are necessary to robustly assess the direction
of this admixture and map it across the genome. Similarly, estimating the
timing of introgression would be challenging and require many high coverage
genomes in order to characterise of the size of admixture blocks in the genome.
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CTVT is intrinsically interesting as an evolutionary oddity: a mammalian cell rewired
for immortality. Assuming that CTVT’s infection cycle is roughly six months and
that this has been true since the cancer first emerged, then we can estimate that there
have been roughly 16,450 transmissions. Like Lenski’s famous long-term evolution
experiment (LTEE) with E. coli (Lenski et al., 1991), the extreme lifespan of CTVT,
make it a unique model for long-term evolutionary processes operating in cancer
over several thousand years. Furthermore, study of CTVT provides an opportunity to
probe genetic vulnerabilities in cancer and to identify novel host-tumour interactions.
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Publicly available data associated with this thesis
This appendix contains a summary list of all the data related to this thesis that have
been made publicly available.
Chapter 2
Sequencing reads associated with this study are available through the European
Nucleotide Archive (ENA) with the study accession number PRJEB13152. Complete
mtDNA sequence data associated with this study are available in FASTA format
at GenBank (https://www.ncbi.nlm.nih.gov/genbank/) with accession numbers:
KU290400 - KU291095.
Supplementary file 2.1: Sample information.
Summary of information available for 449 CTVT tumours and 338 hosts sequenced
in this study. Includes data on location, year of collection, CTVT mtDNA clade, tu-
mour and host mtDNA haplotypes, breed, age and sex. DOI: 10.7554/eLife.14552.015
Supplementary file 2.2: Sequencing coverage and tumour cell fraction.
a. Average per-base coverage for whole genome (CanFam3.1) and for mtDNA genome
(CanFam3.1; NC_002008). (b.) List of 11 CTVT hosts with low coverage mtDNA re-
gions. c. Estimated tumour cell fraction for 449 CTVT tumours; tumour cell fraction
was estimated by calculating the average VAF for variant substitutions present in
tumour but not in matched host for each tumour. DOI: 10.7554/eLife.14552.016
Supplementary file 2.3: Confirmation of CTVT diagnosis.
Quantitative PCR (qPCR) was performed for LINE-MYC, a CTVT-specific rearrange-
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ment (Katzir et al., 1985). ’Normalised input’ represents the relative LINE-MYC
input detected in each sample normalised to ACTB (see Section 2.4.2). Normalised
input >0.05 as indicative of presence of LINE-MYC. Sufficient DNA was not avail-
able for samples 1380T and 1381T; diagnosis in these cases was performed with
histopathology. Sample 2T, marked by an asterisk was grown as a xenograft. DOI:
10.7554/eLife.14552.017
Supplementary file 2.4: Single point somatic and germline substitution variant lists.
a. Total number of substitution variants (n = 1005) identified in 449 CTVT tumours.
b. CTVT tumour somatic substitutions list (n = 928), including the average VAF
value normalised for host contamination (see Section 2.4.9.1). Back mutations are
not included on the list. c. CTVT tumour conservative somatic substitutions list
(n = 835), including the average VAF value normalised for host contamination (see
Section 2.4.9.1). Back mutations are not included on the list. d. Germline clade
defining substitutions lists. Substitutions present in the pool of host substitutions
and also shared between all samples within a clade (see Section 2.4.9.1). e. Potential
somatic substitutions lists. Substitutions not present in the pool of host substitutions,
but shared between all samples within a clade (see Section 2.4.9.1). (f.) Total number
of substitution variants (n = 1152) identified in 338 CTVT host samples and 252
publicly available dog mitochondrial genomes (see Supplementary file 2.8). DOI:
10.7554/eLife.14552.018
Supplementary file 2.5: Summary of small insertions and deletions (indels).
a. Total number of insertions and deletions identified in tumours (n = 27), including
the average VAF value normalised for host contamination (see Materials and meth-
ods) b. Total number of homoplasmic insertions and deletions in CTVT hosts (n = 7),
including the average VAF value. DOI: 10.7554/eLife.14552.019
Supplementary file 2.6: Annotation of single point substitutions.
Annotation of individual point substitution mutations in a. 449 CTVT tumours (see
list Supplementary file 2.4a, excluding back mutations) and b. 338 CTVT hosts (see
list Supplementary file 2.4f). Annotation was performed using Variant Effect Predic-
tor (McLaren et al., 2010). In cases where a single substitution affects two different
genes, the two annotations are shown on different lines. DOI: 10.7554/eLife.14552.020
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Supplementary file 2.7: Annotation of insertions and deletions (indels).
Annotation of individual indels a. unique to CTVT tumours and b. homoplasmic
in CTVT hosts. Annotation was performed using Variant Effect Predictor (McLaren
et al., 2010). DOI: 10.7554/eLife.14552.021
Supplementary file 2.8: Publicly available mitochondrial dog genomes used in the
study.
Summary of Genbank accession numbers and metadata for 252 publicly available
dog mitochondrial genomes analysed in this Chapter (see Section 2.4.6.8 and Supple-
mentary file 2.4f). DOI: 10.7554/eLife.14552.022
Supplementary file 2.9: Sample mtDNA haplotype lists.
Full mtDNA haplotype names provided for 449 CTVT samples and 338 host samples.
DOI: 10.7554/eLife.14552.025
Supplementary file 2.10: Substitution VAF lists.
Substitutions with corresponding VAF (before normalisation) for each of 449 CTVT
tumours and 338 CTVT hosts. DOI: 10.7554/eLife.14552.026
Supplementary file 2.11: Indel VAF lists.
Indels with corresponding VAF (before normalisation) for each of 438 CTVT tumours
and 334 CTVT hosts. Samples with very high coverage of the mitochondrial genome
were excluded from the indel analysis (see Section 2.4.7). DOI: 10.7554/eLife.14552.027
Supplementary file 2.12: Source data for maximum likelihood phylogenetic tree of
CTVT mtDNA (Data Set 1).
Maximum likelihood phylogenetic tree constructed for 1039 samples (449 complete
CTVT mitochondrial genomes and 590 complete dog mitochondrial genomes). All
sequences are labelled with the corresponding sample identifier, country, breed
and haplotype name. The sample identifier for CTVT hosts is the sample name
(Supplementary file 2.1), the sample identifier for the publicly available dogs is the
Genbank accession number. Scale bar corresponds to base substitutions per site.
DOI: https://doi.org/10.7554/eLife.14552.004
Supplementary file 2.13: Source data for maximum likelihood phylogenetic trees
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of CTVT clades 1 to 5.
Maximum likelihood phylogenetic trees for CTVT mtDNA in a. clade 1 (n = 170)
b. clade 2 (n = 252) c. clade 3 (n = 22) d. clade 4 (n = 3) and e. clade 5 (n = 2),
rooted with haplotypes CTVT1 to CTVT5 respectively, which contain clade-defining
germline and potential somatic substitutions specific to each clade. Bootstrap values
were calculated from 100 bootstrap replicates and are shown where bootstrap values
≥60. Scale bars correspond to base substitutions per site. Clade 5 contains only two
tumours, which are identical both to each other and to the CTVT5 haplotype; thus
the tree for this clade was created separately and does not have a scale bar. DOI:
10.7554/eLife.14552.005
Supplementary file 2.14: Source data supporting mtDNA recombination in CTVT
clade 1.
Maximum likelihood cladograms constructed using clade 1 mtDNA positions a.
MT:1-5429 and b. MT:5430-16176 (see Section 2.6.8). Trees were constructed with 153
clade 1 CTVT mtDNAs rooted with the CTVT1 haplotype, which contains clade 1
clade-defining germline and potential somatic substitutions (see Section 2.4.9.1).Boot-
strap values were calculated from 100 bootstrap replicates and are shown where
bootstrap values ≥60. DOI: 10.7554/eLife.14552.014
Supplementary file 2.15: Summary of back mutations
List of back mutations attributable and non-attributable to a putative recombination
event. DOI: 10.7554/eLife.14552.024
Chapter 3
Sequencing reads for the ancient dog data analysed in Chapter 3 were deposited at
the ENA with project number PRJEB22026. Sequencing reads for the CTVT genomes
sequenced as part of this study were deposited at the European Nucleotide Archive
(ENA) with project number PRJEB22148.
The following data are available in the Dryad digital repository:
Supplementary file 3.1: Mitochondrial DNA FASTA file.
FASTA file containing 1166 dog mtDNA genomes analysed in Chapter 3. DOI:
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10.5061/dryad.s1k47j4/1
Supplementary file 3.2: NEXUS tree data.
Maximum likelihood tree (RAxML) of 1166 dogs mtDNA genomes analysed in Chap-
ter 3. DOI: 10.5061/dryad.s1k47j4/2
Supplementary file 3.3: Genbank summary.
Summary of Genbank accession numbers and publication sources for 1166 mtDNA
genomes analysed in Chapter 3. DOI: 10.5061/dryad.s1k47j4/3
Supplementary file 3.4: Genotype plink file (bed).
Plink file (bed) containing genotype data for 54 dogs. DOI: 10.5061/dryad.s1k47j4/4
Supplementary file 3.5: Genotype plink file (bim).
Plink file (bim) containing genotype data for 54 dogs. DOI: 10.5061/dryad.s1k47j4/5
Supplementary file 3.6: Genotype plink file (fam).
Plink file (fam) containing genotype data for 54 dogs. DOI:DOI: 10.5061/dryad.s1k47j4/6
Supplementary file 3.7: Neighbour-joining tree.
Neighbour-joining tree in Fig. 3.4b. DOI: 10.5061/dryad.s1k47j4/7
Supplementary file 3.8: Nexus file for Bayesian tree.
Nexus file used for producing Fig. 3.6 (MKV model in MrBayes). DOI: 10.5061/dryad.s1k47j4/8
Supplementary file 3.9:
Bayesian tree in Fig. 3.6. DOI: 10.5061/dryad.s1k47j4/9
Chapter 5
Chapter 5 presents analysis of matched tumour and host tissues from seven in-
dividual California sea lions affected with urogenital carcinoma. Partial mtDNA
sequence data associated with this study are available in GenBank with accession
numbers: MF000998 - MF001011.
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